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Abstract 
 
This thesis describes the development of a novel one-pot reaction (Scheme 
1).  The reaction combines organo- and enzyme-catalysis in an aldol/aldol cascade 
for the first time.  The bicatalytic, three-component assembly involves two aldol 
reactions: an organocatalysed reaction and an aldol reaction catalysed by an 
aldolase.  
 
 
Scheme 1 
 
The feasibility of the one-pot reaction was evaluated by testing whether the 
aldol intermediates 3 were substrates for the E192N aldolase variant of N-
acetylneuraminic acid lyase.  A range of compounds was selected as potential 
substrates for the enzyme.  The synthesis of the compounds, and their 
characterisation as substrates for the aldolase variant, is described.  
 
The development of common conditions under which both organo- and 
enzyme-catalysis could occur was then investigated.  To do so, a number of 
potential organocatalysts suitable for the one-pot reaction were prepared.  The 
catalysts were evaluated in a screening reaction which yielded optimal conditions 
for the organocatalysed reaction.  The organocatalytic conditions were tested for 
compatibility with the E192N aldolase variant using an appropriate enzyme assay.  
The optimised process was a sequential one-pot reaction in which the 
organocatalysed reaction was conducted before the addition of the variant enzyme.  
The scope of the optimal process was determined and a range of novel acids of 
general structure 4, were prepared.  
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Chapter 1 
1 Introduction  1 
 
 The development of cascade reactions is an emerging field within synthetic 
organic chemistry.  Cascade reactions can generate sophisticated chemical 
skeleta from simple building blocks and create molecular complexity rapidly.  
Cascade reactions provide the organic chemist with the synthetic weaponry to 
prepare complex products efficiently.  Such reactions have the potential to 
minimise the waste of economic and chemical resources, and their synthetic utility 
has provided the motivation for substantial research in the area.  This subject is 
summarised in numerous comprehensive reviews.1-4 
 
This thesis describes the development of a novel bicatalytic cascade reaction 
which exploits both organo- and enzymatic-catalysis in two consecutive aldol 
reactions.  To place this approach into context, the introduction will describe the 
value of the aldol reaction and catalytic cascade reactions to synthetic chemistry, 
with particular emphasis on examples from the recent literature. 
 
1.1 The Aldol Reaction  
 
The aldol reaction is one of the most useful and versatile transformations in 
organic synthesis.5  Discovered in the 19th century, the aldol reaction is a powerful 
tool for the organic chemist and has been used extensively due to the occurrence 
of 1,3-oxygenation pattern in a wide range of natural products.6, 7  The reaction 
involves the addition of an enolisable carbonyl donor to an aldehyde or ketone 
acceptor (Scheme 2).8  The addition thus forms a new carbon-carbon bond and up 
to two stereogenic centres in the aldol product 5.  
Angela Kinnell, University of Leeds 
 2 
 
Scheme 2: The Aldol Reaction.  The two general classes are the indirect and direct aldol reactions. 
 
There are two general classes of aldol reactions: indirect and direct aldol 
reactions (Scheme 2).  In the indirect version, an enolate (6), or enolate equivalent 
(7) is pre-formed and subsequently attacks the carbonyl acceptor (9).  Examples of 
enolates (6) or enolate equivalents (7) used in the indirect aldol reaction include 
metal enolates,5 boron enolates5, 9 or silyl enol ethers.10-18  
 
In contrast, direct aldol reactions involve the formation of an enolate 
equivalent in situ, which then reacts with the carbonyl acceptor 10 under the same 
reaction conditions.  This introduction will only focus on catalytic direct aldol 
reactions; however, there are many reviews that describe indirect aldol reactions.13, 
14, 19
 
1.1.1 Catalytic Direct Aldol Reactions 
 
There are three major classes of catalytic direct aldol reactions: aldolase-
catalysed (section 1.1.1.1), metal-catalysed (section 1.1.1.2) and organocatalysed 
(section 1.1.1.3) aldol reactions.  The catalysis of direct aldol reactions by catalytic 
antibodies20-22 is beyond the scope of this introduction. 
 
1.1.1.1 Aldolase-Catalysed Direct Aldol Reactions 
 
Enzymes are remarkably efficient catalysts as they can increase the rate of 
a reaction dramatically.23  Enzymes operate under mild, aqueous reaction 
conditions and are bio-degradable, rendering them both economically and 
Angela Kinnell, University of Leeds 
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environmentally attractive.  Most importantly, the regio-, diastereo- and enantio-
selectivities observed in aldolase-catalysed reactions are often extremely high.19, 24  
 
Over thirty aldolases have been discovered to date, many of which have 
been used successfully in synthesis.25 These aldolase enzymes may be classified 
by their mechanism as either Type I or II (Scheme 3).  The Type I aldolases form a 
Schiff base and thereby activate the aldehyde or ketone donor for attack on the 
acceptor carbonyl.  The Type II aldolases utilise Zn2+ as a co–factor.19   
a)  
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
Scheme 3: The two mechanism of aldolase-catalysed aldol reactions.  The major differences 
between the mechanisms are illustrated for the two classes of fructose-1,6-diphosphate (FDP) 
aldolase which catalyse the condensation between dihydroxyacetone phosphate (DHAP, 11) and 
glyceraldehyde 3-phosphate (12) a) In the rabbit muscle Type I aldolase (RAMA), the lysine residue 
forms a Schiff base with DHAP which attacks the carbonyl group of glyceraldehyde 3-phosphate b) 
In the Type II, FDP aldolase a zinc enoliolate is formed which attacks the acceptor aldehyde, 
glyceraldehyde 3-phosphate 12.19 
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The aldolases may also be classified by the structure of their donor of which 
there are four major classes: pyruvate-, dihydroxyacetone phosphate-, 
acetaldehyde- and glycine-dependent aldolases (Scheme 4). 
 
 
Scheme 4: The four major classes of aldolases classified by donor structure 
 
1.1.1.1.1  Direct Aldol Reactions Catalysed by Pyruvate-
Dependent Aldolases  
 
N–Acetylneuraminic acid lyase (NAL or sialic acid aldolase) is a pyruvate-
dependent aldolase and has been the focus of this project.  NAL is a commercially 
available enzyme that catalyses the reversible aldol reaction between a range of 
acceptor aldehydes (18) and pyruvate to give aldol products (19) (Scheme 5).  The 
aldolase has a relatively wide substrate scope, accepting a range of substrates 
with differing groups in the C-2 and C-5 position (carbons are numbered based on 
18).  However, aldehyde substrates normally require a hydroxyl group at C-3 and 
aldehydes with fewer than five carbon atoms are poor substrates.  NAL is usually 
used synthetically with excess pyruvate, allowing the efficient synthesis of many 
sialic acid derivatives.26 
Angela Kinnell, University of Leeds 
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Scheme 5: Wild-type NAL substrate scope: NAL accepts a range of substrates 25 
 
NAL is a Type I aldolase where the formation of a pyruvate enamine 
intermediate (22) is followed by its addition to the acceptor aldehyde (e.g. N-Acetyl-
D-mannosamine, ManNAc 20) forming the carbon-carbon bond and resulting in a 
new stereocentre (Scheme 6).  The enamine intermediate 22 can attack either the 
re- or si-face of the acceptor aldehyde 21 to  form either diastereomeric product 
(4R- or 4S-23)  Although NAL is a synthetically useful enzyme, it exhibits poor 
facial stereoselectivity and the stereochemical outcome is often thermodynamically 
controlled by the relative stabilities of the two products.19, 26-29  In theory, the 
preparation of the less thermodynamically favoured product is feasible under 
kinetic control, by isolating the product before equilibrium is reached. 
 
 
Scheme 6  Mechanism of NAL where the re-attack and si-attack of the aldehyde 21 leads to the 
4R- and 4S-23 configured aldol products respectively 
 
 
Angela Kinnell, University of Leeds 
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NAL has often been used synthetically for example in the preparation of 
aza-sugars.  The condensation of N-Cbz-D-mannosamine 24 with pyruvate yielded 
the sialic acid analogue 25, which was subsequently transformed into the 
glycosylase inhibitor 3-(hydroxymethyl)-6-epicastanospermine 26 (Scheme 7)30  
This chemoenzymatic approach is shorter than any previous synthesis allowing the 
3-(hydroxymethyl)-6-epicastanospermine 26 to be prepared in eight steps.  
 
 
Scheme 7: The synthesis of aza-sugars using NAL 
 
1.1.1.1.2  Direct Aldol Reactions Catalysed by Dihydroxyacetone 
Phosphate-Dependent Aldolases  
 
The dihydroxyacetone phosphate-dependent (DHAP) aldolases catalyse a 
variety of stereoselective aldol reactions.25  The DHAP-dependent aldolase, 
fructose 1,6-diphosphate aldolase (FDP), has been used in a short and efficient 
synthesis of the thiosugar 30 which avoids the more traditional approaches 
typically involving protecting group chemistry and naturally occurring sugars.31  
Thus, the sugar 29 was prepared using a FDP-mediated aldol condensation with 
aldehyde 27, followed by a dephosphorylation reaction and reduction to give the 
thio-sugar 30 (Scheme 8).32   
 
Scheme 8: Chemoenzymatic Synthesis of the thio-sugar 30 using the DHAP-dependent aldolase 
FDP aldolase  
Angela Kinnell, University of Leeds 
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1.1.1.1.3  Direct Aldol Reactions Catalysed by Acetaldehyde-
Dependent Aldolases 
 
2-Deoxyribose 5-phosphate aldolase (DERA) is an important acetaldehyde-
dependent aldolase and is an unusual aldolase as both the donor and the acceptor 
are aldehydes.25, 33, 34  The wild-type enzyme catalyses the reversible aldol 
condensation between acetaldehyde and a range of aliphatic aldehydes and has 
been used successfully in synthesis.  For example, DERA has been exploited in 
the synthesis of the carbohydrate analogue 33 (Scheme 9).34  The DERA-
catalysed aldol reaction between acetaldehyde and the aldehyde 31 was 
stereoselective and gave the aldol product 32; hydrogenation gave the aza-sugar 
33.  DERA has also been used effectively in a one-pot enzymatic cascade reaction 
in the preparation of simple sugars, (section 1.2.3). 
 
 
Scheme 9 Synthesis of aza-sugar 33 using DERA 
 
As the previous examples have demonstrated, enzymes offer great potential 
as catalysts for a variety of organic transformations, often exhibiting high efficiency 
and control.  However, to date, the application of aldolases in synthetic chemistry 
has been restricted by their limited substrate repertoire.   
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1.1.1.1.4  Directed Evolution of Aldolases with Tailored 
Properties for Organic Synthesis  
 
Directed evolution is an approach which aims to generate proteins with 
novel functions.  Initially, diversity is introduced into the gene of interest creating a 
library of variant genes and, hence, a library of variant proteins.  The protein library 
is then subjected to a screening or selection pressure, and the variant proteins with 
the desired function may be identified.  The cycle may be repeated until the desired 
function is optimised.   
 
The directed evolution approach has been used to broaden the range of 
enzymes with synthetically valuable properties.  The approach can also offer many 
additional benefits to the synthetic organic chemist, such as increased tolerance to 
organic solvents35, 36 or altered stereoselectivity37-39 and has been reviewed 
extensively.40-45   
 
The evolution of a number of important aldolases in order to yield a variety 
of useful mutant aldolase has been performed.  The wild-type NAL enzyme has a 
wide substrate scope in comparison to other aldolases, but shorter-chain 
aldehydes are poor substrates (section 1.1.1.1.1).25  The challenge of broadening 
NAL substrate scope motivated Gavin Williams to engineer an aldolase which 
accepted aldehyde, 35a, to give the resultant sialic acid derivative 36a (Scheme 
10).46, 47  A semi-rational approach was used, which involved initial analysis of the 
X–ray crystal structure of NAL from H. influenzae in complex with 4-oxo-sialic acid 
(Figure 1)48 in order to identify the potential residues which were likely to be 
important in governing substrate specificity.  Saturation mutagenesis was 
performed upon the identified residues, and the mutant enzyme E192N was found 
to be an effective catalyst for the cleavage of 36a.  The variant enzyme E192N 
was, in terms of specificity constants (kcat/KM) for their respective substrates (Table 
1), six times more efficient at substrate cleavage than the wild-type enzyme.  
 
Angela Kinnell, University of Leeds 
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Figure 1 X-ray crystal structure of NAL from Haemophilus influenze in complex with 4-oxo-sialic 
acid (34).48  The structure shows distances between the heteroatoms of the acid 34 and the 
residues D191, E192 and S208.  The residues are numbered according to the E. coli and distances 
are in Ångströms. 49 
 
 
Scheme 10: Direct evolution of N–acetylneuraminic acid lyase 
 
kcat KM kcat/KM 
Variant Substrate 
(min-1) (mM) (min-1mM-1) 
WT sialic acid (23) 260 ± 6 4.4 ± 0.3 59 
E192N 36a 130 ± 3 0.39 ± 0.04 340 
 
Table 1: Steady-state kinetics data for wild type and E192N variant of NAL.  The E192N mutant is 
approximately six times more efficient at substrate cleavage (23 and 36a) when comparing kcat/KM 
for their respective substrates.46, 47 
 
The directed evolution of other aldolases has also been achieved.  DERA 
catalyses the aldol reaction of D-glyceraldehyde-3-phosphate 37 and acetaldehyde 
to give D-2-deoxyribose-5-phosphate 38 (Scheme 11 and section 1.1.1.1.3).  By 
analysing the active site via X-ray crystallography, and performing site-directed 
HO
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9
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mutagenesis, the variant, S238D, was discovered, which catalyses the aldol 
reaction between the unphosphorylated substrate glyceraldehyde 39 and 
acetaldehyde.50  The variant was demonstrated to accept a range of substrates not 
accepted by the wild type enzyme. 
 
 
Scheme 11: The creation of a new enzyme mutant by directed evolution of DERA  
 
The demand for enantiomerically pure molecules renders the development 
of highly stereoselective reactions essential in modern synthetic chemistry.  NAL 
distinguishes poorly between the faces of aldehyde 21 (section 1.1.1.1.1) and, 
thus, displays poor facial stereoselectivity.  In many NAL-catalysed syntheses, the 
stereochemical outcome of the reaction is thermodynamically controlled.27  
Therefore, an alternative approach would be to engineer a stereoselective enzyme 
which would control kinetically the configuration of the products. 
 
A pair of stereochemically complementary aldolases to allow the conversion 
of 35a into either possible diastereomeric of the aldol product (4R- and 4S-36a) 
was created by Gavin Williams and Tom Woodhall (Scheme 12).51  The variant 
aldolase E192N was used as the starting point.  Variant aldolases were screened 
for the ability to cleave the 4S-configured acid (4S-36a) and not the 4R-configured 
acid (4R-36a).  By applying the principle of microscopic reversibility, variants that 
cleaved the 4S- configured acid (4S-36a) and not 4R- configured acid (4R-36a) 
would also allow the synthesis of the 4S-product (4S-36a) in preference to the 4R-
Angela Kinnell, University of Leeds 
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product (4R-36a).  The variant aldolases, which were able to synthesise the 4R- 
and 4S-configured compounds 4R-36a and 4S-36a respectively, were identified by 
screening and counter-screening variants able to cleave compounds 4R-36a and 
4S-36a.  Error-prone PCR (ep-PCR) was used initially to introduce diversity into 
the E192N scaffold, and hence identified residues important for stereoselectivity.  
Effective variant aldolases identified were then improved upon by saturation 
mutagenesis, to yield the highly stereoselective NAL variants.  The R–selective 
variant is the triple mutant E192N/T167G/S208V and the S–selective variant is the 
double mutant E192N/T167G.   
 
The stereoselectivity of NAL variants may be quantified by the selectivity 
ratio defined as the ratio, S, of the kcat/KM values for the cleavage of for the two 
diastereomeric screening substrates 4R-36a and 4S-36a  {i.e. [kcat/KM(4R-36a)]/ 
[kcat/KM(4S-36a)]}, where R-selective enzymes have ratios greater than 1 and S-
selective enzymes less than 1 (Table 2).51  The E192N variant is moderately S-
selective, S = 0.58.  The R–selective enzyme variant exhibited S = 48 and was 80 
times more R–selective than the parent enzyme E192N.  The S–selective enzyme 
had S < 0.02 and was at least 30 times more S–selective than the E192N variant. 
Angela Kinnell, University of Leeds 
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Scheme 12: Pair of stereoselective complementary aldolases evolved from sialic acid aldolase. 
 
Dipropylamide (4S-36a) 
 
Dipropylamide (4R-36a) 
 
S 
 
Variant 
 
 
 
kcat 
(min-1) 
KM  
(mM) 
kcat/KM 
 (min-1mM-1) 
kcat 
(min-1) 
KM  
(mM) 
kcat/KM  
(min-1mM-1) 
[kcat/KM(4R-36a)]/ 
[kcat/KM(4S-36a)] 
WT 
E192N 
E192N/T197G 
E192N/T197G/S208V 
230 ± 6 
450 ± 14 
5 ± 0.1 
0.1± 0.003 
12 ± 1 
0.8 ± 0.07 
0.5 ± 0.03 
8.5 ± 0.4 
19 
563 
10 
0.012 
73 ± 4 
130 ± 3 
NMa 
1.1 ± 0.04 
11 ± 2 
0.4 ± 0.04 
NMa 
1.9 ± 0.2 
6.6 
325 
<0.2a 
0.58 
0.35 
0.58 
<0.02a 
48 
 
Table 2 Steady-state parameters of the wild-type and variant enzymes a No activity greater than the background rate.
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As the previous examples demonstrate, directed evolution has been an 
effective mechanism in broadening the substrate scope of many enzymes, and 
hence has provided enzyme catalysts which are useful tools in synthesis.  Further 
examples of directed evolution of aldolases are described in recent reviews.52, 53  
 
1.1.1.2 Metal-Catalysed Direct Aldol Reactions 
 
Despite the precedent of enzyme-catalysed direct aldol reactions, the first 
instance of an asymmetric metal-catalysed direct aldol reaction has only been 
reported relatively recently.54  The heterobimetallic BINOL complex 41, 
LaLi3tris(binaphthoxide) (R-LLB) (Figure 2) was shown to catalyse a wide range of 
direct aldol reactions with good diastereo- and enantio-selectivity (Scheme 13).54-56  
The LLB complex 41 is bifunctional with both Lewis acidic (Lanthanum atom) and 
Brønsted basic (binaphthoxide moiety) sites which activate both donors and 
acceptors simultaneously.  The mechanism of aldol condensation is broadly 
analogous to the Type II aldolases.  
 
 
Figure 2: Metal-based catalysts for direct aldol reactions 
 
 
Scheme 13: R- LLB-catalysed direct cross aldol reaction 
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Various alternative direct aldol catalysts based on BINOL have also been 
developed, including the dinuclear zinc catalyst, Zn-Zn-linked BINOL, 42 (Figure 
2).57  The dinuclear zinc catalyst 42 catalyses a range of selective reactions 
including the synthetically useful reaction of α-hydroxy ketones 47 with aldehydes 
46 (Scheme 14). 
 
 
Scheme 14: Zn-Zn-linked BINOL catalysed direct aldol reaction of α-hydroxyl ketones 
 
1.1.1.3 Organocatalysed Direct Aldol Reactions 
 
The last decade has witnessed dramatic growth in the area of 
organocatalysis.58-61  Organocatalysis is defined as the acceleration of reactions by 
using a substoichiometric quantity of an organic compound,58 and the approach 
has been used to catalyse a wide range of organic reactions.58-63  The use of small 
organic molecule catalysts has several advantages over more traditional options 
such as organometallic- or enzyme-catalysed systems.  The benefits include: the 
reactions can be performed aerobically with wet solvents; the catalysts are 
inexpensive and normally bench-stable;58 more efficient recycling of the catalysts 
by attachment to solid supports can be possible; and the lack of metal 
contamination in the products.64 
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1.1.1.3.1  Proline Catalysed Direct Aldol Reactions 
 
Despite initial discovery over thirty years ago,65-67 enantioselective proline-
catalysed aldol reactions were, until recently, poorly understood and their potential 
scope not evident.  The first reported example of an enantioselective proline-
catalysed aldol reactions was the intramolecular cyclisation of triketones, such as 
51 (known as the Hajos–Parrish–Eder–Sauer–Weichert reaction, Scheme 15 a).65-
67
  The remarkable enantioselectivity and yield observed (93% e.e. and 99% yield) 
were not matched by intermolecular examples until 2000 (Scheme 15, b).68 
 
Scheme 15: Proline-catalysed direct asymmetric aldol reaction 
 
The proline-catalysed intermolecular aldol reaction has wide substrate 
scope (Scheme 15 c and d)57, 61 and there are many examples displaying near 
quantitative yields and high enantioselectivities.  Proline’s activity has been 
exploited in other important and powerful reactions such as the Mannich reaction, 
pericyclic reactions, oxidations and reductions where good selectivity has also 
been observed.69-71 
Angela Kinnell, University of Leeds 
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Although originally hypothesised over thirty years ago, the mechanism and 
stereoselectivity of proline-catalysed aldol reactions has only recently been 
supported by computational and experimental evidence.72, 73  Enamine catalysis is 
now widely accepted to be responsible for the observed reaction.73  The general 
mechanism for the proline-catalysed aldol reaction is depicted below (Figure 3) and 
is analogous to that of Type I aldolases.  The mechanism involves attack of the key 
enamine intermediate 61 on the acceptor aldehyde 62. 61  The stereoselectivity of 
the process has been proposed to stem from constraint of the transition state by 
hydrogen-bonding. 
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Figure 3: Proposed mechanism of proline-catalysed aldolisations.61  The catalytic cycle is initiated 
by the ketone/aldehyde 60 condensation with L-proline to give the enamine 61. The aldehyde 62 
undergoes attack from enamine 61 to give the iminium ion 64.  Hydrolysis of 64 gives the aldol 
product 65 along with L-proline, which completes the catalytic cycle.  Houk has proposed a 
transition state to explain the stereoselectivity observed. 61   
 
 
The enamine mechanism was first proposed in the 1970s74 and it is also 
believed that only one proline is involved in the catalytic cyclic.73, 75  The 
stereoselectivity observed can be explained by Houk’s model (63, Figure 3) based 
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on the computations of a number of systems.72  In general, the acceptor aldehyde 
is attacked on the re-face and thus places the acceptor aldehyde’s substituents in 
a pseudo equatorial arrangement.  Houk’s model has been tested successfully by 
predicting correctly the enantio- and stereo-selectivities observed in a number of 
inter- and intra-molecular aldol reactions.72, 76, 77  
 
1.1.1.3.2  Alternatives to Proline in Organocatalysed Direct Aldol 
Reactions 
 
The interest in organocatalysis has led to the development of many novel 
organocatalysts for asymmetric aldol reactions.  A plethora of asymmetric aldol 
catalysts have been reported which are mainly based around the proline scaffold.  
These catalysts can offer greater selectivities, higher yield, or greater or alternative 
scope (such as 68).78   The catalysts can also have more favourable properties, 
such as increased solubility in organic solvents (such as 67)79 or compatibility with 
water, (such as 69 and 70).80, 81  
 
 
Figure 4: Organocatalysts for asymmetric direct aldol reactions 
 
Despite the many organocatalysts developed for asymmetric aldol reactions, 
very few operate in water.82-85   The appendage of long alkyl groups onto proline 
and proline derivatives has led to some successful asymmetric aldol 
organocatalysts, which do operate in water.  Barbas reported the use of the 
diamine 69 as a good catalyst for asymmetric aldol reactions between aliphatic 
ketones 71 and benzylic aldehydes 72 (Scheme 16).86 
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Scheme 16: Organocatalysed asymmetric aldol reactions in water 
 
The discovery that by increasing the alkyl chain length of the diamine 69 the 
enantioselectivity of the reactions is also improved, led the authors to hypothesise 
that the diamine 69 diminishes contact between the substrates and bulk water.  A 
water-free transition state may help to explain the observed enantioselectivity of 
the reaction. 
 
Independently Hiyashi et al. reported a very similar proline–based catalyst.80  
The ester 70 was shown to catalyse asymmetric aldol reactions between pairs of 
aldehydes 74 and 75 in water (Scheme 17).  Again, the length of the alkyl group 
affected the enantioselectivity with a 10-carbon chain being optimal.  Although the 
reaction mechanism is unclear, the formation of an emulsion is critical and 
enhances both stereoselectivity and activity.87 
 
 
Scheme 17: Asymmetric aldol reaction between aldehydes in water catalysed by ester 70 
 
Despite the aldol reaction being one of the oldest named reactions, it still 
holds the attention of synthetic chemists and remains at the forefront of current 
research.  The continued interest in the reaction is surely owed to the fact that it is 
Angela Kinnell, University of Leeds 
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one of the most useful reactions in organic chemistry for preparing complex 
molecules in a diastereo- and enantio-selective manner. 
 
1.2 Catalytic Cascade Reactions 
 
The ability to prepare complex molecular skeletons with ease and speed has 
long been a goal of synthetic chemistry.  Cascade reactions achieve this goal 
effectively, offering many advantages over traditional stepwise construction of 
target molecules.  Cascade reactions show greater efficiency with fewer reagents, 
solvents, work-ups, energy, waste and labour than stepwise constructions, and 
often exhibit excellent selectivities.1, 2  Although nature has long performed 
cascade reactions using highly efficient, and tailored catalysts (enzymes), synthetic 
catalytic cascade reactions have only recently been developed.  Despite this fact, 
cascade reactions have already been used successfully with good yields and 
selectivities observed with many elegant examples in the recent literature.3, 4  
Catalytic cascade reactions have exploited many different types of catalysts; 
however, this section focuses on cascade reactions involving at least one enzyme- 
or organo-catalysed step.  
 
1.2.1 Organocatalysed Cascade Reactions 
 
Cascade reactions involving organocatalysis are relatively rare.  Most 
examples rely upon the dual reaction modes of amino catalysts: enamine and 
iminium catalysis, which enhance the nucleophilicity and electrophilicity of 
substrates respectively.  Organocatalysed cascade reactions have has been 
pioneered by MacMillan who has used the imidazolidinone catalyst 82 in the 
enantioselective synthesis of a variety of products, such as the aldehyde 83, in 
high yields and with exquisite enantioselectivity (Scheme 18).88  
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Scheme 18: An example of an organocatalysed cascade reaction  
 
The cascade leading to the aldehyde 83 exploits both iminium and enamine 
activation (Scheme 19).  Mechanistically, it is thought that the α,β-unsaturated 
aldehyde 81, condenses with the catalyst 82 to give an iminium species 84.  This 
iminium species is attacked by a nucleophile (79) to form an enamine 85 which is 
intercepted by electrophile (80); hydrolysis releases the product 83 and 
regenerates the organocatalyst 82, with the chiral catalyst controlling the 
stereochemical outcome of both steps. 
Angela Kinnell, University of Leeds 
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Scheme 19: Proposed iminium-enamine mechanism of imidazolindinone 82 catalysed cascade 
reactions88 
 
Consecutive organocatalysed aldol reactions have also been previously 
reported.  The proline catalysed, one-pot, three-component assembly of lactols 88 
is an excellent example of a tandem aldol reaction (Scheme 20).89, 90  Unlike the 
previous example, this tandem process involves enamine-enamine catalysis and 
involves the self-condensation of propionaldehyde followed by the cross-
aldolisation with a second aldehyde 87.  This cascade constructs four stereogenic 
centres in one pot and is the first example of an organocatalysed one-pot 
preparation of carbohydrate derivatives. 
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Scheme 20: Proline catalysed assembly of carbohydrate derivates. 89, 90 
 
Higher enantioselectivity has been observed in the triple-cascade reaction 
which forms cyclohexene carbaldehydes 94 (Scheme 21).91  This impressive three-
component assembly involves a Michael/Michael/aldol reaction sequence and 
exhibited high levels of enantio- and diastereo-control, as well as chemo- and 
regio-selectivity.  The reaction exploited the proline-derived catalyst 93 and 
involved enamine-iminium-enamine activation to generate complex small 
molecules 94.  Further interesting examples  of organocatalysed cascade reaction 
have been reviewed recently.92 
 
 
Scheme 21: Three-component Michael/Michael/aldol organocatalysed cascade.  The cascade only 
produces two diastereoisomers where the minor diastereomer is the C5-epimer of the product 
shown.  
 
1.2.2 Combined Metal- and Organo-catalysed Cascade Reactions 
 
Despite the array of reaction cascades involving transition metal catalysts 93-
96
 the combination of organocatalysis with transition metal catalysis is an area of 
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chemistry which has, so far, received little attention.97-100  One of the finest reported 
examples is the tricatalytic triple cascade reported by MacMillan. (Scheme 22).101  
The three-step sequential cascade involves first a cross-metathesis, followed by a 
Michael addition and finally an intramolecular aldol reaction to generate a highly 
functionalised bicyclic product 97.  The three-component triple cascade operates 
as follows (Scheme 23): the initial cross-metathesis of the alkene 95 with the 
alkene 81 generates the enone intermediate 99, which then undergoes a 
subsequent Michael addition by the furan nucleophile 96, catalysed by the iminium 
catalyst 68.  The ketone 100 condenses with the enamine catalyst, L-proline, to 
produce an enamine, which undergoes an intramolecular aldol reaction.  Unlike 
previous work, where only one catalyst is used and, hence, only one stereo-
outcome can be achieved (section 1.2.1), MacMillan used two orthogonal chiral 
catalysts (68 and L-proline) which control the stereochemical outcome of the 
iminium- and enamine-catalysed steps independently and hence control the 
configuration  of the product.  By using this system to prepare the bicycle 
butenolide 97, the authors generated four contiguous stereocentres in one-pot.  
Butenolide 97 was then elaborated over a in eight further steps to give the marine 
natural product (–)-aromadendranediol. 
 
 
Scheme 22: Triple cascade involving combination of transition metal catalysis with organocatalysis 
in a sequential metathesis, Michael addition and aldol reaction 
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Scheme 23: Proposed mechanism for the triple cascade involving combination of transition-metal 
catalysis with organocatalysis in a sequential metathesis, Michael addition and aldol reaction 
 
1.2.3 Enzyme-Catalysed Cascade Reactions 
 
Although enzymatic cascade reactions have been well investigated,1, 102, 103 
tandem aldolase-catalysed reactions are relatively rare.  The rarity of such 
processes is because in order for a cascade to occur the (aldehyde) product of the 
first reaction must be an acceptor for the next.  In general, this means that at least 
one aldehyde/aldehyde coupling is needed.  One of the few reported examples is 
the tandem aldol reaction of chloroacetaldehyde 101 with acetaldehyde (Scheme 
24).104  The sequential reaction is catalysed by DERA, which produces the lactol 
103 in good yield which was converted into the lactone 104.  
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Scheme 24: DERA-catalysed tandem aldol reaction 
 
Multi-enzymatic one-pot reactions have also been developed in the 
synthesis of more complex products.  A one-pot three-enzyme system was 
developed to synthesise sialosides 108 (Scheme 25)105-107  The novel system uses 
NAL (section 1.1.1.1.1), Cytosine-5′-monophosphate-acetylneuraminate 
synthetase (CMP-NeuAc synthetase), and a silalyltransferase (Pasteurella 
multocida tPm0188Ph) and performs three sequential transformations: an aldol 
reaction, a phosphorylation and a glycosylation reaction.  The approach allowed 
the preparation of a library of sialosides.  
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Scheme 25: One-pot three-enzyme system for the synthesis of sialosides where R1 = OH, NHAc, 
NHAcN3, NHGc, NHGcOMe, or NHAlkyne; R2 = OH, N3; R = aglycon or glycosides 
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1.2.4 Enzyme- and Metal-Catalysed Cascade Reactions 
 
The combination of enzyme catalysis with metal catalysis has been 
relatively well investigated108, 109 with many examples involving dynamic kinetic 
resolutions (DKRs).  The combination of lipases with ruthenium catalysts allowed 
the DKR of secondary alcohols.  The approach used simultaneous in situ 
racemisation of the alcohol substrate 109, by the ruthenium catalyst 111 and 
kinetic resolution of the alcohol substrate 109 by the lipase.  The reaction hence 
produced the enantiomerically pure acetate 110 (Scheme 26).108-114   
 
 
Scheme 26: DKR of secondary alcohols using combination of enzyme and transition metal 
catalysis 114 
 
1.2.5 Enzyme- and Organo-catalysed Cascade Reactions 
 
The combination of enzymes with organocatalysts is relatively rare with only 
a few reported examples.115  Cordova et al. reported the first combination of 
organo- and enzyme-catalysis in 2004 with a tandem aldol/lipase resolution 
reaction (Scheme 27).  The tandem reaction involved the use of either proline 
enantiomer to catalyse the aldol reaction, which used excess acetone as reaction 
solvent.  The aldol reaction was followed by the addition of a lipase, which 
kinetically resolved the resultant aldol product.  The reaction was enantioselective 
and yielded the either the acetate 113 or the alcohol 114. 
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Scheme 27: One-pot tandem proline catalysed aldol and lipase- catalysed kinetic resolution 
reaction 
 
Organo- and enzyme-catalysis have also been combined in an 
aldol/reduction cascade (Scheme 28).116  Like the previous example, the cascade 
involved an organocatalysed aldol reaction and used catalyst 117.  The aldol 
reaction was followed by an enzymatic reduction of the resultant ketone with an 
alcohol dehydrogenase [(S)-ADH] and gave the diol 116.  The reaction was a 
sequential one-pot reaction in which the aldol reaction was performed under 
solvent-free conditions.117  In the reductive step, the NADH co-factor is recycled by 
the in situ oxidation of 2-propanol to acetone and yielded the diol 116 
enantioselectively.  The authors have also prepared the corresponding 
stereoisomers of the diol 116 by varying the enantiomer of catalyst 117 and the 
alcohol dehydrogenase used. 
 
 
Scheme 28: Enantioselective tandem aldol/reduction reaction combining organo- and enzyme-
catalysis  
 
Although the previous examples of combined organo- and enzyme catalysis 
are intriguing, they lead to the formation of only one carbon-carbon bond.  An 
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interesting area would be to develop a one-pot reaction in which both the 
organocatalyst and enzyme catalyse one carbon-carbon bond  
 
1.2.6 Summary 
 
Despite the large array of catalytic one-pot reactions reported in the 
synthetic literature, few reactions combine more than one form of catalysis.  The 
challenge of developing reactions that harnesses the usefulness of a number of 
forms of catalysis is therefore, an interesting and challenging opportunity in organic 
chemistry.   
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1.3 Project Outline 
 
The research described aims to develop of a novel three-component 
reaction, which combines organo- and enzyme-catalysis in an aldol-aldol cascade 
(Scheme 29).  The reaction aims to generate two new carbon-carbon bonds and 
up to three stereocentres in a one-pot process. 
 
 
Scheme 29 
 
The envisaged aldol cascade reaction involves two catalytic aldol reactions: 
an organocatalysed reaction and a reaction catalysed by a variant of NAL, 
discovered using directed evolution (section 1.1.1.1.4.).  The organocatalyst would 
guide a condensation reaction between glyoxylaldehyde 1 and aldehyde 2, 
generating an aldol intermediate 3.  The aldol intermediate 3 would be intercepted 
by the E192N aldolase variant and pyruvate to yield the highly functionalised small 
molecule 4 (Scheme 30). 
 
 
Scheme 30 
 
The aldolase variant E192N of NAL was known to accept a range of tertiary 
amides; however all known substrates had a hydroxyl group in the C-5 position (R3 
= OH) of the acid 3 (Scheme 30).46, 47, 118  We aim to vary the aldehyde 2 and, 
hence, generate products with alternative substituents in the C-5 position.  Before 
investing time in the development of the one-pot reaction, we proposed to prepare 
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a range of potential substrates for the E192N aldolase variant.  The data obtained 
will not only dictate whether the one-pot reaction is possible, but additionally, give 
further insights into the structural-activity relationship between the aldolase variant 
and its substrates.  The selection, preparation, assay and kinetic data of the 
potential substrates along with an investigation into the E192N-catalysed 
condensations, will be described in Chapter 2.   
 
Chapter 3 describes the development of the one-pot reaction.  Initially, the 
strategy that will be used to find common conditions under which both organo- and 
enzyme-catalysis could occur is discussed.  This strategy involves the initial 
consideration of solvent systems before careful selection of organocatalysts (based 
on reported solubility and activity).  Secondly, the organocatalysts will be prepared 
on multi-gram scales, the catalyst will be screened, and conditions optimised for 
the organocatalysed step.  Organocatalytic conditions tolerated by the E192N 
aldolase variant, will be investigated by using an appropriate enzyme assay.  The 
results from the enzyme assay will be used to select a number of potential one-pot 
reaction conditions, which will be screened and optimal conditions chosen.  With 
conditions in place, the stereoselectivity of the one-pot reaction will be investigated. 
Finally, the scope of the reaction will be explored.  Chapter 4 summarises the 
principal discoveries made in the project.   
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Chapter 2 
2 Determination of the Range of Substrates Accepted by 
the E192N Aldolase Variant 
 
A key aim of the project was to establish if the series of compounds with the 
general structure 3 were substrates for the E192N aldolase variant (Figure 5, b).  
Achieving this goal would provide information on the feasibility of the proposed 
one-pot reaction and also give further insights into the structure-activity 
relationships of substrates for the E192N aldolase variant.  Thomas Woodhall and 
Gavin Williams proved that compounds 35 were substrates for E192N by 
measuring steady-state kinetics for the substrates 36 (Figure 5, a).46, 118, 119   
a) 
 
 
b) 
 
 
Figure 5: a) E192N substrates 35 and 36; b) non-hydroxylated, potential substrates for the E192N 
variant aldolase 3 and 4 
 
We predicted that the compounds 3 and 4 (Figure 5, b), where the C-5 
hydroxyl substituent is replaced by alternative substituents, would also be 
substrates for the E192N variant aldolase.  The prediction was based on the 
following rationale.  The crystal structure of wild-type NAL (Figure 6)48 shows that 
the C-5 position of the enzyme substrate is solvent-exposed and therefore may not 
be involved in substrate recognition.  It is also known that wild-type NAL accepts 
substrates with a wide range of substituents at the C-5 position with little or no 
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deterioration in catalytic activity.25  We anticipated that the E192N variant would 
behave in a similar manner to its parent enzyme and would therefore tolerate a 
range of substituents at the C-5 position.  
a)      
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 a) 4-oxo-sialic acid (34); b) X-ray crystal structure of NAL from Haemophilus influenzae in 
complex with 4-oxo-sialic acid (34); the C-5 position is exposed to bulk solvent.48, 49 
 
2.1 Preparation of Proposed Enzyme Substrates 
 
To test the range of substrates accepted by the E192N aldolase variant, a 
range of potential substrates were prepared using synthetic chemistry.  The aim 
was to prepare a number of compounds in which the C-5 substituent is a hydrogen 
atom (X=H, Scheme 31); once prepared the compounds were screened in an 
appropriate enzyme assay. 
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The retrosynthetic analysis of the potential substrates 4 (Scheme 31) was 
adapted from the synthetic route used to prepare similar compounds and was 
developed by Thomas Woodhall.46, 118, 119  The synthetic strategy involved three 
key steps.  The Lewis acid-promoted allylation of glyoxylaldehydes 1 with 
allyltrimethylsilane 125 would yield the homoallylic alcohols 123.  Upon ozonolysis 
of the homoallylic alcohols 123, the corresponding aldehydes would be exposed to 
a diastereoselective indium-mediated coupling that would produce the diols 122.  
Ozonolysis of the diols 122, and ester hydrolysis, should give the racemic potential 
substrate 4.*   
 
 
Scheme 31: The retrosynthetic analysis of potential compounds 4.  The keto-acid functionality may 
be unmasked by the ozonolysis and hydrolysis of diols 122.  The diols 122 might be prepared from 
123 via an indium-mediated coupling where the bromoacrylate 124 is a pyruvate equivalent.  The 
homoallylic alcohols 123 might be prepared by the allylation of glyoxylaldehyde 1 with 
allyltrimethylsilane 125. 
 
2.1.1 Preparation of the Homoallylic Alcohols 123  
 
The synthesis of the homoallylic alcohols 123 was required for the 
preparation of the keto-acid potential substrates 4.  It was envisaged that the 
                                                 
*
 A racemic route was chosen for speed at this point in the project as all chiral routes towards single 
enatiomers of the alkenes 123 were unsuccessful.  It is worth noting that this impacts on the results 
obtained as the data only shows if one of the enantiomers is a substrate for the E192N aldolase 
and no information will be gained if there is any difference in enzyme kinetic between enantiomers.  
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alkenes could be prepared using a Lewis acid-promoted allylation of 
glyoxylaldehydes 1.  The glyoxylaldehydes 1 were prepared from amides 127 in a 
two-step procedure from fumaryl chloride 126 (Scheme 32 and Table 3), and were 
used directly in the next step.  Treatment of the glyoxylaldehydes 1 with 
titanium(IV) chloride and allyltrimethylsilane 125 yielded the homoallylic alcohols 
123 in 22-60% yield over two steps.† 
 
Scheme 32: Preparation of homoallylic alcohols 123 from amides 127 via a two-step 
ozonolysis/Lewis acid promoted allylation procedure (see Table 3) 
 
Entry R1 R2 Amide 127 Yield 
(%) 
Homoallylic 
Alcohol 
123 Yield c 
(%) 
1 Pr Pr 127a 69 123a 91d 
2 Bu Bu 127b 69 123b 46 
3 -(CH2)5- 127c 68 123c 30 
4 (CH2)2O(CH2)2- 127d 25 123d 60 
5 Me Pr 127e 100 123e 22 
6 Me OMe 127f 81b 123f 34 
7 Et Et 127g 100 123g 37 
8 Me Me 127h 46a 124h 30 
 
Table 3: a Reaction additive: triethylamine, b Reaction additive: pyridine,c Yield of purified product 
over two steps; d Yield from isolated glyoxylaldehyde 1a (see Scheme 32). 
 
 
 
                                                 
†
 The compounds 123e-h were not converted into the corresponding alcohols 122, but were used 
later in the project 
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2.1.2 Preparation of the Diols 122 
 
The diols 122 were prepared from the homoallylic alcohols 123 using a two-
step ozonolysis and indium-mediated coupling sequence (Scheme 33 and Table 
4).  Ozonolysis of homoallylic alcohols 123 gave the corresponding aldehydes 
which were immediately exploited in the next step.  Indium-mediated coupling with 
the bromoacrylate 124 gave the diols 122.  The allylation was moderately 
diastereoselective with the levels of diastereoselectivity determined for the isolated 
products 122.  The configuration of the products was determined by their 
subsequent conversion into the cyclic α-keto esters 134 (section 2.1.3).  In some 
cases, double bond isomerisation of the diols 122 was also observed in the 
reaction, which may explain the low yield from the two-step procedure.  
 
 
Scheme 33:  Preparation of the diols 122a-d (Table 4).  The major diastereomer is shown. 
  
Entry R1 R2 Product Yield a (%) anti:syn b 
1 Pr Pr 122a 24 70:30 
2 Bu Bu 122b 12 80:20 
3 -(CH2)5- 122c 33 68:32 
4 -(CH2)2O(CH2)2- 122d 18 74:26 
 
Table 4: Isolated yield and diastereoselectivity of the two-step ozonolysis and indium-mediated 
couplings of homoallylic alcohols 123a-d (Scheme 33).  a Isolated yield over the two step 
procedure;  b Diastereomeric ratios were determined by 1H NMR spectroscopic analysis of the 
isolated products  
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2.1.2.1 Rationalisation of the Diastereoselectivity of the Indium-
Mediated Couplings 
 
The diastereoselectivity of the indium-mediated couplings was determined 
using 500 MHz 1H NMR spectroscopy and was assigned later in the synthesis of 
the potential substrates 4.  The indium-mediated couplings are moderately anti 
diastereoselective.  This observation is  consistent with an established chelation–
control model (Figure 7).120, 121  The axial attack of the nucleophile onto the 
chelated aldehyde from the top face of chelate 131 is favoured, 120, 121 which 
results in the formation of the intermediate 132 and hence, the anti-diol 122.   
 
 
Figure 7: Chelation control model to explain the diastereoselectivity of the indium-mediated 
couplings 
2.1.3 Deprotection of the Diols 122 
 
The diols 122a-d were ozonolysed to give the corresponding α-keto esters 
134a-d.  Upon conversion to the α-keto esters 134a-d the compounds became 
enriched with the cis-diastereomer due to column chromatography.  Hydrolysis of 
diastereomeric mixtures of the α-keto esters 134a-d using barium hydroxide gave 
the corresponding barium salts which were subsequently exposed to ammonium 
sulfate to yield the potential substrates, 135a-d, as ammonium salts. 
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Scheme 34: The preparation of the potential substrates 135a-d from the diols 122a-d via ozonolysis and hydrolysis (see Table 5).  Only the 
major diastereomers of 122, 134 and 135 are shown 
 
Entry R1 R2 Diol 122  
Anti:syn a 
α-Keto 
ester 
134 
Yield 
(%) 
134  
Cis:trans b,c 
Salt 135 Yield 
(%) 
135  
Cis:trans b 
1 Pr Pr 122a 70:30 134a 59 95:5 135a >98 95:5 
2 Bu Bu 122b 80:20 134b 62 95:5 135b >98 95:5  
3 -(CH2)5- 122c 68:32 134c 27 88:12 135c >98 88:12  
4 -(CH2)2O(CH2)2- 122d 74:26 134d 49 78:22 135d 93 78:22  
 
Table 5: Isolated yields of the ozonolysis the diols 122a-d and the hydrolysis of the α -keto esters 134a-d (see Scheme 34); a 
Diastereomeric ratios were determined by 500 MHz 1H NMR spectroscopic analysis of isolated products 122a-d.  The relative configuration 
was assigned by conversion into cyclic α-keto ester 134a-d ; b Determined by 1H 500 MHz NMR spectroscopic analysis of isolated products; 
c
 Column chromatography of the α-keto esters 134a-d yielded diastereomeric mixtures enriched with the cis-diastereomer 
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2.1.4 Determination of the Diastereoselectivity of the Indium-
Mediated Couplings 
 
The diastereoselectivity of the indium-mediated couplings was determined 
by conversion of the diols 122 into the α-keto esters 134.  The relative 
configuration of the cyclic α-keto esters 134 was determined by 500 MHz 1H NMR 
spectroscopy (Figure 8).  The major product was the cis diastereomer: large 
coupling constants (J = 12.0 and12.5 Hz) observed between H-4 and the axial 
protons H-3 and H-5, and between H-6 and the axial proton H-5ax, predicted by 
Karplus,122  confirmed the configuration of the product. 
 
a)                                                       b) 
 
 
 
 
 
 
Figure 8: a) The cis diastereomer of the keto-ester 134; b) the diagnostic 500 MHz 1H NMR signals 
for axial H-3ax and H-5ax protons which exhibit large coupling J = 12.0 Hz and J =12.5 Hz 
respectively consistent with a trans-diaxial arrangement with H-4 and H-6. 
 
 
O
OH
OEt
OOH
ONR2
R1 H6
H4
H5ax H3ax
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2.2 Expression and Purification of the E192N Aldolase Variant 
 
The His-tagged E192N aldolase was over–expressed and purified by utilising 
an existing method developed within the group by Gavin Williams.  The aldolase 
was over-expressed from glycerol stocks that were kindly provided by Dr. Amanda 
Bolt.  The cells were harvested by centrifugation and lysed using a cell dispruter.  
The variant aldolase was purified using nickel affinity chromatography with elution 
with imidazole.  SDS-PAGE analysis (Figure 9) shows increased protein purity 
after the protein purification procedure. 
 
                m        Cr        L1       L2        L3        L4      L5        E1      E2        E3    
 
 
 
 
 
 
 
 
 
 
 
 
 
              
 
Figure 9: SDS-PAGE Gel depicting purification of the E192N aldolase variant using Nickel resin.  
From left to right: marker (m), the crude lysate (Cr), five sequential pre-elution washes (L1-5) and 
three sequential elution washes (E1-3). The aldolase was loaded with loading buffer (containing 
16.2 mM potassium phosphate dibasic and 3.8 mM potassium phosphate monobasic (pH 7.4), and 
300 mM NaCl and 10 mM imidazole) and eluted with elution buffer (containing 20 mM potassium 
phosphate buffer (pH 8.0), 200 mM NaCl and 200 mM imidazole). 
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2.3  Assay for Determining the Catalytic Activity of E192N Aldolase 
Variant  
 
 To determine whether the compounds 135 were substrates for the E192N 
aldolase variant, a nicotinamide adenine dinucleotide/lactate dehydrogenase 
(NADH/LDH) coupled assay was used (Figure 10).  The assay allowed the rate of 
E192N reaction to be determined.  As the substrate 137 is cleaved by the E192N 
aldolase variant pyruvic acid is produced.  The consumption of NADH and hence 
the rate of the E192N reaction can followed by a decrease in absorbance of NADH 
as it converted into NAD+. 
 
 
Figure 10 Coupled enzyme assay used to determine the activity of the aldolase variant.  The 
cleavage of compounds 137 via a reverse aldol reaction leads to the production of pyruvate, which 
is reduced in situ by lactate dehydrogenase (LDH) to L-lactate.  The decrease in the absorbance of 
NADH (A340) can be used to characterise the aldolase activity.  
 
2.4 Steady-State Kinetics for Potential Substrates 135 with the 
E192N Aldolase Variant 
 
The cleavage of the potential substrates 135, catalysed by the E192N aldolase 
variant was studied using the NADH/LDH assay (Figure 10).  The assay was 
performed in a 1 mL cuvette and the initial rate of reaction was measured by 
following the A340, using a spectrophotometer.  Reaction velocities were calculated 
using the molar extinction coefficient of NADH (6220 M-1cm-1), plotted using Origin® 
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and the kinetic parameters estimated by non-linear regression analysis.  The data 
collected for all substrates 135 is shown in Figures 11 and 13 and Table. 6.  All of 
the compounds 135 were, as predicted, substrates for the E192N aldolase variant.   
 
When the specificity constants (kcat/KM) are compared between substrates 
135a-d a general trend is observed.  The dipropylamide 135a shows the highest 
kcat/KM value and is followed by the piperidylamide 135c, the dibutylamide 135b, 
and the morpholylamide 135d.  The observation fits with the general trend shown 
for the hydroxylated substrates 36a-d (Figure 11, Table 6, Figure 14) where the 
increased hydrophobicity of the tertiary amide tallies with increased catalytic 
efficiencies,46, 118, 119  although the dibutylamide 135b bucks this trend with much 
lower specificity constant than expected.  Additionally, when the kcat/KM values are 
compared between the non-hydroxylated compounds 135a-d and their 
hydroxylated counterparts 36a-d the values are slightly elevated for the non-
hydroxylated compounds 135a-d but the values are broadly comparable.  In 
general, the activity (kcat) values are higher and the Michaelis constant (KM) are 
lower observed than the values the non-hydroxylated substrates 135a-d are 
slightly lower than the values for the hydroxylated substrates 36a-d.   
 
In conclusion, all compounds screened were indeed substrates for the E192N 
aldolase variant.‡  The presence of a hydroxyl substituent in the C-5 position is not 
crucial for E192N catalysis and has little effect on kcat/KM.  This observation fits with 
our initial rationale and also meant that it was possible to vary the groups in the C-
5 position.  
 
 
                                                 
‡
 Please note, all of the compounds 135 tested were racemic and mixtures of diastereomers.  
This means that the steady state kinetics collected is most likely average of the data for each of the 
enantiomers and diastereomers.  However, it is possible that only one or a number of the 
enantiomers and diastereomers are substrates for the E192N aldolase variant from the data 
presented here, although later in the project found not to be the case.  
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Figure 11: The E192N hydroxylated substrates 
R1 R2 Acid 
Pr Pr 36a 
Bu Bu 36b 
-(CH2)5- 36c 
-(CH2)2O(CH2)2- 36d 
Me OMe 36e 
O OH
OH
CO2HR1R2N
O
HO
36
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a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Initial rates of E192N-catalysed cleavage of the substrates 135a-d, the y axis scale is  
different on each graph. a) E192N with 135a; b) E192N with 135bX; c) E192N with 135c; d) E192N 
with 135d;  
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c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Initial rates of E192N-catalysed cleavage of the substrates 135a-d, the y axis scale is 
different on each graph. a) E192N with 135a; b) E192N with 135b; c) E192N with 135c; d) E192N 
with 135d;  
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Table 6:  Steady state kinetic parameters for the cleavage of substrates 135a-d and 36a-d with the E192N aldolase variant.  Kinetic 
parameters (± errors of the fit) were determined by fitting the data to the Michaelis–Menton equation; a Substrates prepared by Thomas 
Woodhall and steady-state kinetic data obtained by Gavin Williams.46, 118, 119 
 
 
 
 
Figure 14: Comparison of specificity constants log kcat/ KM for the cleavage substrates 135a-d and 36a-d with the E192N variant aldolase l   
Substrate kcat (min-1) KM (mM) kcat/KM (min-1mM-1) Substratea kcat (min-1) KM (mM) kcat/KM (min-1mM-1) 
135a 201.8 ± 1.6 0.103 ± 0.007 1959 36a 130 ± 3 0.39 ± 0.04 340 
135b 60.9 ± 1.9 0.105 ± 0.017 580 36b 90 ± 6 0.25 ± 0.04 359 
135c 330.8 ± 5.7 0.338 ± 0.055 853 36c 95 ± 1 0.57 ± 0.02 167 
135d 161.6 ± 8.0 0.703 ± 0.198 230 36d 72.4 ± 2.3 3.4 ± 0.2 21.3 
   135a                       135b                      135c                      135d  36a                          36b                        36c                        36d 
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2.5 E192N-Catalysed Condensation Reactions with Novel 
Enzyme Substrates  
 
Although the amides 135a-d were established as substrates for the 
E192N aldolase variant, it was not known whether the forward direction 
aldol reaction was thermodynamically favoured and hence, synthetically 
useful.  As the aldol reaction between hydroxylated substrates (35) and 
pyruvate are thermodynamically favourable processes, it was predicted 
that the non-hydroxylated substrates would also be thermodynamically 
favoured.  To investigate the thermodynamics of the aldol condensation, 
the aldehyde 141a and pyruvate were treated with the E192N aldolase 
variant (Scheme 35). 
 
 
Scheme 35 
2.5.1 Preparation of Aldehyde 141a 
 
The preparation and isolation of aldehyde 141a was attempted 
from the racemic alkene 123a (Scheme 36 and Table 7).  Various 
conditions were attempted; however the aldehyde 141a could not be 
isolated, despite the reactions going to completion as indicated by 
LCMS and TLC.  Consequently, the isolation of the aldehyde 141a was 
abandoned.  The crude aldehyde 141a, prepared by ozonolysis of the 
alkene 123a in MeOH§, was therefore used directly in the E192N 
reaction (Scheme 37).  
 
                                                 
§
 When the ozonolysis of the alkene 123a was performed in DCM the condensation 
reaction did not yield any of condensation product, acid 4a 
Angela Kinnell, University of Leeds 
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Scheme 36: The attempted routes toward aldehyde 141a from alkene 123a 
 
Entry Substrate Reaction Conditions 
1 123a 2 mol% OsO4, 2,6-Lutidine, NaIO4, dioxane/H2O 
2 123a 30 mol% OsO4, NMO, NaIO4, MeCN/H2O 
3 123a O3, MeOH, –78 °C; DMS 
4 142 Periodic acid, DCM 
5 142 NaIO4 DCM/H2O 
 
Table 7: Attempted reaction conditions in the attempted preparation of the aldehyde 
141a from the alkene 123a. 
 
2.5.2 E192N-Catalysed Condensation Reactions  
 
As anticipated, the E192N-catalysed aldol condensation between 
the aldehyde 141a and pyruvate was a thermodynamically favoured 
reaction (Scheme 37 and Table 8, entry 1).  The alkenes 123 were also 
ozonolysed and the corresponding aldehyde reacted with pyruvate to 
give the acids 4 (Scheme 37 and Table 8).  These reactions were also 
thermodynamically favoured as the reactions proceeded well with, on 
Angela Kinnell, University of Leeds 
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the whole, good yields after purification by preparative HPLC.  The 
yields observed are comparable to those observed for the hydroxylated 
derivatives 35 in the forward direction.118  The corresponding aldehyde 
of alkene 123f (R1 = Me; R2 = OMe) is not a substrate for the E192N 
aldolase variant; however there is no evidence that the hydroxylated 
version (35f) is a substrate for the E192N aldolase variant either.   
 
O
OH
OH
CO2H
R1R2N
O
N
O
OH
R1
R2
1. O3, MeOH, 78 °C
2. Me2S, RT
123
4
N
O
OH
OR1
R2
141
3. E192N, 35 °C,
sodium pyruvate (10 eq),
20 mM phosphate buffer,
pH 7.4, 67 h
 
 
Scheme 37: The preparation of the acids 4 using E192N-catalysed aldol condensation 
(see Table 8).  Only the cis diastereomer is depicted. 
 
Entry Alkene R1 R2 Aldehyde 
141 
Product 4 Yieldb 
(%) 
Cis:tran
sa 
1 123a Pr Pr 141a 4a 73 70:30 
2 123c -(CH2)5- 141c 4c 53 74:26 
3 123d -(CH2)2O(CH2)2- 141d 4d 52 83:17 
4 123e Me Pr 141e 4e 19 76:24 
5 123f Me OMe 141f 4f c - 
 
Table 8: Isolated yields of acids 4 from two-step ozonolysis and E192N catalysed aldol 
reaction sequence (see Scheme 37) a Diastereoselectivity of isolated products 
determined using  500 MHz 1H NMR spectroscopy; b All products were purified by 
preparative HPLC; c No product observed  
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The diastereoselectivity of the reactions was determined for the 
isolated products (section 2.5.3).  The reactions are moderately cis-
diastereoselective and thermodynamically controlled.  This was 
confirmed by recent work within the group by Thomas Harman, who 
determined the kinetic and thermodynamic stereoselectivities of the 
reaction with the substrate 141a.  The ratios of cis:trans observed in the 
above reactions are comparable to the ratios observed by Thomas 
Harman when the forward direction reaction of 141a is followed, using 
500 MHz 1H NMR, to completion and hence under thermodynamic 
control.  It is possible that the E192N aldolase variant is selective for 
one enantiomer of the aldehydes 141 and hence a resolution could be 
occurring in the enzyme reaction.  However, recent work by Thomas 
Harman has also confirmed that both enantiomers of the substrate 141a 
were substrates for the E192N aldolase variant and the enzyme shows 
no kinetic preference for either enantiomer of 141a.**  
 
 
2.5.3 The Sense of Diastereoselectivity of the E192N-
Catalysed Condensation Reactions  
 
The diastereoselectivity of the E192N-catalysed aldol reactions 
was determined using NMR analysis of the isolated products 4.  A 
combination of 2D NMR experiments was used to identify 
diastereoisomeric and anomeric species of the acid 4a.  NOESY 
analysis of the mixture allowed the identification of the cis-diastereomer 
with the correlations between protons H-4 and H-6 confirming the axial 
orientation of both hydrogens (Figure 14).  TOCSY analysis confirmed 
1H peak corresponding to both anomers of the trans diastereomer.  This 
was achieved by identifying cross peaks in the TOCSY spectrum which 
correspond to protons in the same spin system and hence, in this case, 
in the same species. 
                                                 
**
 personal communication 
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Figure 15 
 
The vicinal coupling constants for the H-6 signal vary between 
anomeric species and cis and trans diastereomers of the acids 4 (for 
example 4a Figure 14).  These differences can be explained by the 
likelihood that the species exist in different conformations.  It is likely 
that both the anomers of the trans diastereomer trans-4a exist in a 
mixture of chair conformations, and the coupling constants observed are 
therefore an average between the constants for each conformation.  The 
cis anomers cis-4a most likely exist in mainly one conformation (as 
depicted in Figure 14) and hence a large trans-diaxial coupling is 
observed to the axial H-5ax proton. 
 
2.5.4 E192N-Catalysed Condensation Reactions to Yield 
Products with C-5 Substituents 
 
To investigate E192N substrate specificity further, the aldehyde 
derived from alkene 146, where a methyl group is installed at the 
position corresponding to C-5, was investigated as a potential substrate 
for the E192N aldolase variant.  The aldol condensation of the 
corresponding aldehyde of the alkene was performed.  The alkene 146 
was prepared from the glyoxylaldehyde 1a and the E-crotyl boronate 
144 (Scheme 38) which gave the anti-alkene 146.  The 
Angela Kinnell, University of Leeds 
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diastereoselectivity of the allylation was high (>99:1) and may be 
explained in terms of a cyclic transition state 145.123 
 
 
 
Scheme 38: Preparation of the alkene 146. 
 
The alkene 146 was ozonolysed and treated with sodium pyruvate 
and the E192N variant aldolase (Scheme 39).  The corresponding 
aldehyde of alkene 146 was, as predicted, a substrate for the E192N 
aldolase variant.  The diastereoselectivity was determined by analysis 
by 500 MHz 1H NMR spectroscopic analysis of the isolated products.  
The diastereoselectivity at the C-4 position (85:15) is most likely, as with 
the previous examples 4, controlled by the relative thermodynamic 
stabilities of the two possible diastereomeric products.  
 
 
 
Scheme 39: Preparation of the acid 147 using E192N-catalysed aldol condensation.  
Only one anomer of the major diastereomer is depicted. 
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2.6 Chapter 2 Summary 
 
As predicted the ammonium salts 135a-d have been shown to be 
substrates for the E192N aldolase variant.  This observation fits with the 
initial hypothesis that the C-5 hydroxyl is not crucial for enzymatic 
activity.  Full steady-state kinetic data were obtained for all the 
substrates which were comparable to those of the hydroxylated 
compounds' 36a-d.  The aldol condensations were shown to be 
thermodynamically favoured, with isolated yields comparable to the 
hydroxylated variants 36.  Additionally, it was found that substituents 
other than hydrogen, can be placed in the C-5 position of the E192N 
substrate without affecting the condensation reaction.   All of these 
findings provided evidence that the proposed one-pot reaction may be 
feasible. 
Angela Kinnell, University of Leeds 
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Chapter 3 
3 The Development of a One-Pot Reaction 
 
 The next key goal of the project was to find common conditions 
under which both organo- and enzyme-catalysed steps could occur.  To 
establish these conditions, three main targets were set: to develop 
conditions for the organocatalysed step; to ascertain whether the 
optimised conditions for the organocatalysed step are compatible with 
the E192N aldolase variant; and to perform one-pot reactions combining 
organo- and enzyme-catalysis. 
 
3.1 The Development of Conditions for the 
Organocatalysed Step  
 
To establish suitable organocatalytic reaction conditions, a 
comprehensive literature search was conducted and a number of 
organocatalysts were selected as potential catalysts for the envisaged 
one-pot reaction.  The organocatalysts were chosen based on their 
reported catalytic activity in cross-aldol reactions and their solubility.78, 86, 
124
  In order to investigate the effect of different solvent systems in the 
proposed one-pot reaction, it was important to choose a range of 
organocatalysts with varying solubility in organic and aqueous solvents.  
Organocatalysts which performed well in aqueous conditions were 
attractive targets due to their potential compatibility with enzymatic 
catalysts, which usually operate in aqueous buffered conditions.  
However, organically soluble catalysts were also of interest in case 
biphasic systems or sequential reaction conditions needed to be 
explored as alternative approaches. 
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Figure 16: Selected Catalysts 
 
L-Proline is the most extensively studied organocatalyst for 
asymmetric cross aldol reactions including aldehyde-aldehyde aldol 
reactions.124  However, most of the proline-catalysed aldol reactions 
reported in the literature, are performed in DMF or DMSO.125, 126  The 
diamine 69 has been reported as an active catalyst for cross aldol 
reactions under aqueous conditions (see Introduction),86 and is therefore 
suitable for our investigation.  The tetrazole catalyst 67 has increased 
catalytic activity for cross-aldol reactions when compared to proline and 
has been reported as an effective catalyst in solvents such as 
acetonitrile.127  The imidazolidone 68 has been reported by MacMillan 
and is an active organocatalyst for various transformations including 
cross aldol reactions in ether.79 
 
As the catalysts 67-69 are not commercially available, it was 
necessary to synthesise the compounds to investigate their catalytic 
activity.  The catalysts were all synthesised on a multi-gram scale in 
order to have sufficient stocks for the planned investigations. 
 
3.1.1 Synthesis of Organocatalysts 67-69 
3.1.1.1 Synthesis of the Diamine 69 
 
The diamine 69 was synthesised in four steps from L-proline 
using a known procedure reported by Mase et al. (Scheme 40).86, 128  
Cbz protection of L-proline with benzyl chloroformate gave the 
carbamate 148 which underwent an EDC-mediated coupling with 
didecylamine to yield the amide 149.  The chemoselective reduction of 
Angela Kinnell, University of Leeds 
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the amide 149 in ethanol with borane·THF complex afforded the amine 
150.  The synthesis was completed by the deprotection of the Cbz-
group by hydrogenation which gave the free diamine 69.  The diamine 
69 was prepared in a 30% overall yield from L-proline.  
 
 
Scheme 40: Preparation of the diamine 69. 
 
3.1.1.2 Synthesis of the Tetrazole 67 
 
Preparation of the tetrazole catalyst 67 was achieved via 
literature procedures and involved four synthetic steps from Cbz-
protected L-proline 148 (Scheme 41).129  Cbz-protected L-proline 148 
was transformed into the primary amide 151 by conversion into a mixed 
anhydride and treatment with ammonium bicarbonate.  The primary 
amide 151 was dehydrated by exposure to cyanuric acid in DMF to give 
the nitrile 152.  The nitrile 152 underwent a 1,3-dipolar cycloaddition130 
with sodium azide to give the protected tetrazole 153.  The tetrazole 67 
synthesis was completed by the hydrogenolysis of the protected 
tetrazole 153, to give the deprotected tetrazole 67.  The synthesis of the 
tetrazole 67 was completed in an overall 37% yield from L-proline.  
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Scheme 41: Preparation of the tetrazole 67. 
 
3.1.1.3 Synthesis of the Imidazolidinone 68 
 
The imidazolidinone 68 was synthesised from the phenylalanine 
derivative 154 using existing synthetic methods (Scheme 42).131, 132  
Thus, D-phenylalanine methyl ester hydrochloride (154) was amidated 
with methylamine to give the secondary amide 155, which was cyclised 
with pivaldehyde to give both cis and trans imidazolidinones 68 in a 1:1 
ratio.  The diastereomers were separated by column chromatography 
and the cis product 68 was obtained in a 45% yield.  The overall yield 
from the phenylalanine derivative 154 was 43% and was comparable to 
literature reports.132 
 
Scheme 42: Preparation of imidazolidinones 68. 
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3.1.2 Preparation of the Glyoxylaldehyde 1a 
 
The glyoxylaldehyde 1a was a proposed substrate for the 
organocatalysed-aldol reactions.  The glyoxylaldehyde 1a was prepared 
by the oxidative cleavage of the diol 156a (Scheme 43).  The diol 156a 
was prepared in two steps from fumaryl chloride.  The two step 
preparation involved the reaction with dipropylamine which gave the 
intermediate amide 127a.  The amide 127a was dihydroxylated to give 
the diol 156a; oxidative cleavage of the diol 156a under biphasic 
reaction conditions yielded the glyoxylaldehyde 1a.  The 
glyoxylaldehyde 1a was not isolated at this point; instead the product 
was used directly in subsequent aldol reactions.  A lower limit for the 
yield for the periodic cleavage step was determined by the reduction of 
the glyoxylaldehyde 1a to the alcohol 157 with sodium borohydride.  In 
later work, an alternative procedure was used which allowed the 
glyoxylaldehyde 1a to be isolated (section 3.3.2.1). 
 
Cl
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Scheme 43: Synthesis of glyoxylaldehyde 1a. 
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3.1.3 Organocatalysed Aldol Reactions 
 
The organocatalysts (L-proline, 67, 68 and 69) were evaluated as 
catalysts of the aldol reaction between the glyoxylaldehyde 1a and 
propionaldehyde (Scheme 44).  Initially, attempts were focussed on the 
conditions that have been established for each catalyst that would be 
potentially compatible with the enzyme-catalysed step. Consequently, 
organic solvents (e.g. DMF) and temperatures which were unlikely to be 
tolerated by the aldolase were, when possible, avoided.133-135  The crude 
reaction products were reduced directly with sodium borohydride; the 
yields of the diols anti-158 and syn-158 allowed the success of the 
crossed aldol condensation to be observed. 
 
 
Scheme 44: Organocatalysed aldol reactions  
 
The study revealed that L-proline, the diamine 69 and the 
tetrazole 67 were the best catalysts for the crossed aldol reaction 
between glyoxylaldehyde 1a and propionaldehyde (Table 9).  The 
isolated yields of the L-proline-catalysed reactions were highest in DCM 
with one equivalent of propionaldehyde (Table 9, entry 1); no product 
was observed in DMSO (Table 9 entry 1).  The tetrazole catalyst 67 did 
not yield the diols 158 in DCM or MeCN but, in more polar solvents 
such as DMF and DMSO, the product was obtained (Table 9, entry 11 
and 12).  The imidazolidone catalyst 68 was a poor catalyst for the 
aldol reaction even with high catalyst loading and excess 
propionaldehyde (Table 9 entries 5-7); dehydration of the aldol product 
was observed by LC-MS.  In addition, L-alanine did not yield the diols 
158, under the conditions screened (Table 9, entry 4). 
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Entry Catalyst Catalyst 
loading 
(mol%) 
Propionaldehyde 
(eq) 
Additive 
 
Solvent Temp syn:anti a 158 yield b 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
L-prolineg 
L-prolineh 
L-proline 
L-alanine 
68 
68 
68 
67 
67 
67 
67h 
67h 
69i 
69i 
50 
50 
50 
30 
20 
50 
50 
5 
20 
20 
20 
20 
20 
20 
1 
82 
1 
2 
1 
10 
10 
2 
82 
82 
82 
82 
2 
2 
- 
- 
- 
 
TFAc 
TFAd 
TFAd 
- 
- 
- 
- 
- 
TFAc 
TFAc 
DCM 
DCM 
DMSO 
DMSO 
Ether 
Ether 
DCM 
MeCN 
MeCN 
DCM 
DMF 
DMSO 
H2O 
bufferf 
RT 
RT 
RT 
RT 
+ 4ºC 
RT 
RT 
RT 
RT 
RT 
+ 4ºC 
RT 
RT 
RT 
62:38 
84:16 
- 
- 
- 
- 
- 
- 
- 
- 
40:60 
78:22 
31:69 
64:36 
25% 
3% 
e 
e 
e 
e 
e 
e 
e 
e 
6% 
20% 
0.2% 
19% 
Table 9: Organocatalyst screening. a Determined by 500 MHz 1H NMR spectroscopic analysis of isolated product; b combined yield of both diastereomers; c 20 
mol% additive was used; d 50 mol% additive was used; e The diols 158 were not formed in the reaction;f pH 7.4, 20 mM potassium phosphate buffer; g 0.254 
mmol/mL concentration of glyoxylaldehyde 1a; h 0.0254 mmol/mL concentration of glyoxylaldehyde 1a; i 0.506 mmol concentration of glyoxylaldehyde 1a 
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The diamine 69 catalysed the aldol reaction in aqueous 
conditions, and interestingly, the reaction could be performed in pH 7.4 
buffer (Table 9, entry 14).  Reactions involving this catalyst further were 
further investigated (Table 10).  It was discovered that the isolated yield 
varied with the solvent used.  In water and buffer (Table 10, entries 2,3 
and 5), the reaction proceeded; in contrast, in DMSO, no diol 158 was 
isolated.  The yield was higher with TFA as an additive than with 
scandium(III) triflate (Table 10).  The highest yield of product was 
observed with 10 equivalents of propionaldehyde and 10 mol% of the 
catalyst in pH 7.4 buffer (Table 10, entry 5).   
 
The pH of the reaction was varied over the range that the wild 
type-NAL is active (between pH 6 and 9) (Table 11, entries 1-5).  The 
pH had little effect on the yield of the reaction within the range tested.  
Although the highest yield of the diols 158 was observed at pH 6 (Table 
11, entry 1), this pH may be too low for the E192N variant aldolase.  
However, a good yield of diol 158 was obtained at pH 7.5, the optimal 
pH for the wild type-NAL. 
 
The catalyst loading of the diamine-catalysed reactions was 
investigated.  At low catalyst loadings (1-5 mol% diamine, Table 11, 
entries 7-8), no reaction was observed.  With 10 mol% catalyst, the 
diamine-catalysed reaction took place (Table 11, entry 3).  All 
organocatalysed conditions screened exhibited low to medium yield of 
the diols 158.  It is possible that the low yields stemmed, in part, from 
the instability of the intermediate aldehyde. 
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Entry Catalyst loading 
(mol%) 
Propionaldehyde 
(eq) 
Additive Solvent Syn:antia  158 
yieldb 
1 
2 
3 
4 
5 
 
20 
20 
20 
20 
10 
 
2 
2 
2 
2 
10 
 
TFAc 
Sc(OTf)3c 
Sc(OTf)3c 
Sc(OTf)3c 
TFAd 
 
DMSO 
H2O 
buffer e 
DMSO 
buffere 
 
- 
12:88 
24:76 
- 
68:32 
 
f, g
 
0.2% f 
8% f 
f, g
 
45% f 
 
 
Table 10: Diamine-catalysed 69 aldol reaction. a Determined by 500 MHz 1H NMR spectroscopic analysis of isolated product; b Combined yield of both 
diastereomers; c 20 mol%; d10 mol%;e pH 7.4, 20 mM potassium phosphate buffer;f All reactions were performed at room temperature; g The diols 158 
were not formed in the reaction  
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Entry pH Cat loading 
(mol%) 
Syn: 
antia 
158 yieldb 
1 
2 
3 
4 
5 
7 
8 
9 
6.0 
6.4 
7.0 
7.4 
8.0 
7.0 
7.0 
7.0 
10 
10 
10 
10 
10 
1 
2 
5 
62:38 
82:18 
68:33 
75:25 
81:19 
- 
- 
- 
41% 
26% 
33% 
33% 
33% 
c 
c 
c
 
 
Table 11: Diamine-catalysed aldol reactions performed with phosphate buffer. All 
reactions used, 10 eq. propionaldehyde in 100mM potassium phosphate buffer for 25 
hrs at room temperature; a Determined by 500 MHz 1H NMR spectroscopic analysis of 
isolated product; b Combined yield of both diastereomers; c The diols 158 were not 
formed in the reaction 
 
3.1.3.1 Stereoselectivity of the Organocatalysed Aldol 
Reactions 
 
The diastereoselectivity of the reactions was determined by 
analysis of the isolated products by 500 MHz 1H NMR spectroscopy.  
The relative configuration of the anti- and syn-diols 158 was 
determined by conversion into cyclic derivatives (section 3.1.3.1.1).  
Most of the aldol reactions were moderately syn diastereoselective.  
The syn diastereoselectivity is unexpected as it contrasts the anti 
sense of induction observed in many other organocatalytic crossed 
aldol reactions.  However, aldehydes such as glyoxylaldehyde 1a have 
not previously been investigated as substrates for organocatalysed 
aldol reactions.   
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It is notable that the pH of the diamine-catalysed reactions 
affected the diastereoselectivity.††  At lower pH the syn 
diastereoselectivity decreases in buffer (Table 11, entries 1-5).  In 
addition, in water with TFA as an additive, the reaction is anti-
diastereoselective (Table 9, entry 14).  It can be envisaged that the 
reaction may proceed via the open chain (161) or the closed chain 
transition state (160) (Figure 17).72, 73  The pH of the reaction may 
control the population of these transition states and, hence, the 
diastereoselectivity.  It has been demonstrated that cross aldol 
reactions, catalysed by the amide 162 (Figure 17) at low pH (pH 1-4) 
proceed at slower rates but with higher anti-diastereoselectivity and 
enantioselectivity than at higher pH.136 
 
 
Figure 17 
 
3.1.3.1.1 Determining the Diastereoselectivity of the 
Organocatalysed Aldol Reactions 
 
In order to determine the diastereoselectivity of the 
organocatalysed aldol reactions, the identification of the anti- and syn-
diastereomers was necessary.  To identify the two respective 
diastereomers cyclic derivatives, acetonides 163 and 164 were prepared 
(Scheme 45).  The separable acetonides 163 and 164 were prepared 
from a diastereomeric mixture of the anti- (anti-158) and syn-diols (syn-
                                                 
††
 The enantioselectivtiy of the organocatalysed reactions was not determined at this point in 
the project.  This was despite attempts to establish the enantioselectivity of the organocatalysed 
reactions using chiral HPLC and chiral superfluid chromatography (SFC), good resolution was 
not achieved. 
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158).  The configuration of the acetonides 163 and 164 was assigned on 
the basis of the magnitude of vicinal coupling constants.  The anti 
diastereomer anti-158 yielded the acetonide 163 with large coupling (J = 
10.7 Hz, Figure 18, a) between H-4 and H-5 which is consistent with 
both protons being axial; the syn diastereomer syn-158 yielded the 
acetonide 164 exhibited a smaller coupling between H-4 and H-5 (J = 
3.0 Hz, Figure 18, b).   
 
 
 
Scheme 45: The preparation of the acetonides 163 and 164 from aldol products anti- 
and syn-diols 158 in order to determine diastereoselectivity of the organocatalysed 
aldol reaction 
 
 
The anti-diol, anti-158, was also independently prepared from the 
alkene 146 (prepared previously section 2.5.4) by ozonolysis and 
reduction using sodium borohydride.  This experiment enabled an 
independent verification of the relative configuration of the anti diol 158 
(Scheme 46). 
 
 
Scheme 46 
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a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 500 MHz 1H NMR spectrum of the acetonides 163 and 164.  The signals 
due to the H-4 and H-6ax are expanded.  a) 500 MHz 1H NMR of the acetonide 163 , 
where both the H-4 and the H-6ax shows large couplings to H-5 , J = 10.7 Hz and J = 
11.6 Hz respectively,; b) 500 MHz 1H NMR of the acetonide 164, where the H-4 shows 
coupling constant of J = 3.0 Hz, and H-6ax shows coupling constant of J = 2.2 Hz to the 
H-5. 
J 3.0 Hz J 11.2 and 2.2 Hz
J 10.7 Hz J 11.6 Hz
O
O
O
Pr2N
Me
H4
H5
H6-ax
O
O
O
Pr2N
Me
H4
H5
H6-ax
H-4
H-4 H-6ax
H-6ax
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3.2 Identification of Mutually Compatible Conditions for 
Organo- and Enzyme Catalysed Steps 
 
With organocatalytic reaction conditions established, the next goal 
of the project was determining whether the conditions were compatible 
with the E192N aldolase variant.  To do so, an enzyme assay was used 
to test whether various conditions affected the activity of the E192N 
aldolase variant.   
 
3.2.1 Development of an Assay to Identify Mutually 
Compatible Conditions for Organo- and Enzyme-
Catalysed Steps  
 
To investigate mutually compatible conditions for organo- and 
enzyme-catalysis, an enzyme assay was developed.137, 138  First 
developed for N-acetyl neuraminic acid, the literature thiobarbituric acid 
(TBA) enzyme assay is a colourimetric assay which follows the enzyme-
catalysed condensation of aldehyde 21 with pyruvate (Scheme 47).  The 
assay tests for the production of the acid 23 by its conversion into the 
highly conjugated product 168.  We envisaged that this assay would be 
useful in our system in following the E192N-cataysed reaction  which 
would instead involve the aldehyde 35a being converted to the acid 36a.  
The acid 36a would also be converted to the acid 168 when exposed to 
TBA assay conditions. 
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a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 47: a) TBA Assay enzyme assay used to determine NAL activity. The assay 
converts the NAL product 23 into the pink coloured compound 168.  The compound 
168 is a highly coloured compound and hence reactions which produce the enzyme 
product 23 can be easily detected by eye.137-140 b) TBA Assay enzyme assay used to 
determine E192N activity. 
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3.2.1.1 Preparation of the Aldehyde 35a and the Acid 36a 
 
To make use of the TBA assay, a known substrate for the E192N 
variant aldolase was prepared.  The acid 36a and corresponding 
aldehyde 35a have proved to be good substrates for the E192N variant 
(Scheme 48).  Both the aldehyde 35a and the acid 36a were prepared 
via an established synthetic route developed by Thomas Woodhall 
(Scheme 48). Thus deprotection of the acetonide 118, 119  169, kindly 
donated by Dr. Ieaun Davies, was performed under strongly acidic 
conditions and gave the alkene 170.  The alkene 170 was ozonolysed to 
give the aldehyde 35a, which was used in the TBA assay without further 
purification.  The concentrations of the aldehyde 35a, used in the TBA 
assay, were based on the assumption that the ozonolysis was a 
quantative reaction.  The acid 36a was prepared by the E192N-
catalysed aldol reaction between the aldehyde 35a and sodium 
pyruvate, which, after ion-exchange, gave the acid 36a.‡‡  The acid 36a 
was used as a standard in the TBA assay. 
Scheme 48: Synthesis of the aldehyde 35a and the acid 36a from the acetonide 169 
via acid-mediated acetonide deprotection, ozonolysis and E192N-catalysed aldol 
reaction. 
                                                 
‡‡
 Acid 36a exists as a mixture of pyraonose and furanose forms, the major product is 
the S diastereomer in one of its furanose forms. 
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3.2.1.2 Thiobarbituric Acid Assay Development 
 
To test whether the organocatalytic conditions were compatible 
with the E192N aldolase variant, the E192N-catalysed aldol reaction of 
aldehyde 35a was conducted in the presence of the components of the 
organocatalytic reaction.  Specifically, we determined the effect of the 
glyoxylaldehyde 1a, propionaldehyde and the diamine 69 at 
concentrations similar to those used in the organocatalysed reaction. 
 
 
Figure 19: Compounds screened in E192N TBA assay 
 
As expected, the literature protocol137 converted the acid 35a into 
the acid 36a and hence generated a pink colour (Figure 20, a).  
However, the diamine 69 (37 mM, corresponding to 10 mol% in the 
organocatalysed reaction) and propionaldehyde (3.77 M corresponding 
to 10 equivalents in the organocatalysed reaction) interfered with the 
TBA assay leading to the formation of a precipitate upon exposure to the 
TBA assay conditions (Figure 20 b and c).  The observation led us to 
introduce a chloroform extraction step to remove the diamine 69 and 
propionaldehyde before standard assay conditions (treatment with 
sodium periodate, sodium arsenite and thiobarbituric acid).  The 
extraction approach worked well and no interference was observed in 
positive controls with propionaldehyde, the diamine 69, the 
glyoxylaldehyde 1a and sodium pyruvate.   
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a)                                b)                                       c) 
 
 
 
 
 
 
 
 
 
Figure 20: TBA assay controls.  All of the photos show the result of standard assay 
conditions.  All  eppendorfs contained stated concentration of acid 36a,  
propionaldehyde or the diamine catalyst 69 in 100 µL 100 mM, pH 7 potassium 
phosphate buffer; a) the photo of the result of the acid 36a , and showing a positive 
result in the TBA assay containing 0.45 M acid 36a; b) the photo of the result of a 
propionaldehyde control, brown precipitate formed when assay contained 3.77 M 
propionaldehyde; c) the photo of the result of the diamine 69 control, a pink precipitate 
appeared in the sample when assayed with 37 mM diamine 69 
 
To minimise pipetting errors, it was necessary to use robotic liquid 
handling techniques to pipette the E192N-catalysed reactions into 96-
well plates.  The liquid handling robot was used to pipette the diamine 
69 and the appropriate volumes of the acid 36a (2.27-0.45 mM), 
aldehyde 35a (1.18 mM), buffer, the glyoxylaldehyde 1a and sodium 
pyruvate into a glass-based 96 deep-well plate.  Propionaldehyde and 
the E192N aldolase variant were pipetted manually.  All reactions were 
performed in triplicate and the reactions were then left overnight at room 
temperature.  The reactions were first extracted with chloroform and the 
aqueous layer treated sequentially with sodium periodate, an aqueous 
acidic sodium arsenite solution and a solution of TBA.  
 
A range of concentrations of all the reaction components were 
tested, all of which were comparable to the conditions used in the 
original diamine-catalysed aldol reaction.  Propionaldehyde was added 
at concentrations which corresponded to 1-10 equivalents; the 
concentrations of the diamine 69 screened were equivalent to 1-33 
mol%; and the glyoxylaldehyde 1a was assayed at concentrations which 
corresponded to 1-40 equivalents.  The components were also assayed 
in combination to test whether there were any additional effects when 
components were combined (Figure 21 shows a typical assay plate).   
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The activity of the variant aldolase could be assessed by eye.  
Initially we aimed to measure the effect of various conditions on the 
E192N aldolase by using absorbance spectroscopy.  This would allow 
quantification of the level of E192N activity under different conditions.  
However, upon assaying the enzyme reactions, turbidity occurred in a 
number of the samples and hence obtaining accurate absorbances was 
not achievable.  Instead, the amount of E192N activity was assessed by 
eye, by comparison to a control reaction and a scale of enzyme activity 
established (see Appendix iv). 
 
 
Figure 21 An example of thiobarbituric acid (TBA) assay plate. The pink colouring 
indicates enzyme activity under specified screening condition.   
 
 
It was observed that at the concentrations screened, 
propionaldehyde had no effect on the catalytic activity of the E192N 
aldolase variant.  This was in terms of the production of the acid 36a 
(Figure 22a), as no decrease in colour intensity was seen across the 
various concentrations.  The result was surprising as relatively high 
concentrations (4.35 mM- 4359 mM) appeared to be tolerated by the 
E192N aldolase.   
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The glyoxylaldehyde 1a did not have any noticeable effect on the 
E129N aldolase variant either (Figure 22, b).  The glyoxylaldehyde 1a 
was the limiting reagent in the diamine-catalyst reaction, however high 
concentrations were tolerated by the variant aldolase. 
 
The diamine 69 was the additive that had most effect on the 
E192N variant aldolase (Figure 22, c).  The diamine 69 was tolerated by 
the E192N aldolase at low concentrations (corresponding to 1-6 mol% 
catalyst loading) but at medium to high concentrations (corresponding to 
6-33 mol%§§ catalyst loading), the E192N aldolase was affected and 
little or no product was formed.   
 
It is interesting to note that some additional affects were observed 
when the enzyme reaction was exposed to the diamine 69, in the 
presence of either propionaldehyde or the glyoxylaldehyde 1a (Figure 
22 c)***.  When the components were combined, the E192N activity was 
higher than that observed at the same concentration of the diamine 69 
alone.  In all of the combined conditions assayed, the concentration of 
the aldehydes (propionaldehyde or glyoxylaldehyde 1a) was always 
much higher than that of the diamine 69 present.  The increase in 
E192N activity when there were two additives present can be perhaps 
be explained by the aldehyde’s ability to sequester the diamine 69, 
possibly forming an enamine species, and hence somewhat reduce the 
diamine’s 69 effect on the E192N aldolase variant. 
 
Although the E192N aldolase variant tolerated the appropriate 
concentrations of propionaldehyde and the glyoxylaldehyde 1a, the 
required catalytic loading of the diamine 69 had a severe effect on the 
                                                 
§§
 Figure 22 c) shows 1-10 mol% only, no E192N activity was seen above 10 mol% at 
the catalyst loading studied (up to 33 mol%) 
***
 Figure 22 c) shows E192N activity in presence of diamine and 5 eq. 
propionaldehyde, when the propionaldehyde concentration was varied in presence of 
the damine 69 the E192N activity was identical at equivalent diamine 69 loadings to 
that at 5 eq. propionaldehyde.  This result was mirrored with the glyoxylaldehyde 1a in 
the presence of the diamine 69. 
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enzyme activity.  However, lower levels of the diamine could be 
tolerated by the aldolase variant. 
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a) 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
 
 
 
Figure 22 Effect on E192N activity of a) propionaldehyde, b) the glyoxylaldehyde 1a 
and c) the diamine 69 and the diamine 69 with 5 eq. propionaldehyde; as determined 
by the TBA assay where +++, signifies very good E192N activity, equivalent intensity 
to E192N-catalysed reaction with no additives; ++, signifies good E192N activity; +, 
signifies little E192N activity; :, no E192N-catalysed reaction.  Concentrations of 
components are all equivalent concentration to the optimised organocatalysed 
conditions. 
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3.3 Development of an Organo- and Enzyme-Catalysed 
One-Pot Reaction  
 
The results from the TBA assay suggested that only low 
concentrations of the diamine 69 would be tolerated by the E192N 
variant aldolase.  When combining both organo- and enzyme-catalytic 
steps, the issue of diamine concentration would, therefore, have to be 
addressed.  A simple solution would be to use a dilution approach.  The 
approach would entail performing the diamine-catalysed aldol reaction 
before diluting the reaction with an appropriate volume of buffer to give a 
concentration of the diamine 69 that would be tolerated by the E192N 
aldolase variant.  The enzyme and sodium pyruvate would then be 
added to allow the enzyme reaction to proceed.   
 
The dilution approach was used in several screening reactions and 
the products were isolated by preparative HPLC (Scheme 49 and Table 
12).  All other purification methods attempted, including column 
chromatography and ion exchange chromatography, did not yield the 
acid 4a cleanly.  
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Scheme 49: One-pot reactions with dilution-step (see Table 12). Only the major diastereomer is depicted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 12: One-pot reactions.  aAll reactions were performed on a 0.0955 mmol scale of the glyoxylaldehyde 1a, in 20 mM, pH 7.4 potassium phosphate 
buffer (0.307 mL), with appropriate amount of the diamine 69 and acetaldehyde at RT.  After 18 hrs reactions were diluted with buffer (0.115 mL) and 
E192N (6.98 mg/mL in pH 7.4, 20 mM potassium phosphate buffer) and sodium pyruvate (0.955 mmol) added and reaction incubated at 35 °C for 3 days; 
b
 Relative to the volume of buffer in reaction at dilution; c All products isolated by preparative HPLC; dCis:trans ca. 80:20 and was determined using  500 
MHz 1H NMR spectroscopy ; e Enantiomeric ratio, determined by conversion of the acid 4 into the lactone 171 (section 3.3.1.2). 
Entrya Diamine 69 (mol%) Acetaldehyde eq. Dilution factorb Isolated yield 4a(%)c,d 4a E.r.e 
1 10 10 1.7 39 50:50 
2 10 10 3.23 36 26:74 
3 10 10 5.7 17 36:64 
4 10 10 11.1 35 28:72 
5 5 10 1.7 40 52:48 
6 20 10 1.7 31 52:48 
7 50 10 1.7 30 52:48 
8 10 5 1.7 37 51:49 
9 10 20 1.7 19 16:84 
10 10 50 1.7 33 49:51 
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It appeared that the dilution approach was successful, with all reaction 
conditions screened giving the acid 4a in isolated yields between 17-40% (Scheme 
49 and Table12).  The volume of buffer used to dilute the one-pot reactions was 
varied††† along with the diamine catalyst loading and acetaldehyde equivalences.  
The volume of buffer used to dilute the reactions (dilution factor) was important in 
governing reaction yield (Table 12, entries 1-4) with the optimum dilution appeared 
to be a 1.7-fold dilution.  The diamine 69 loading also affected the isolated yield of 
the one-pot reactions (Table 12, entries 1 and 5-7,) with interesting inverse 
relationship between yield and loading.  The observation fits with the findings from 
the TBA assay with the optimum catalyst loading screened being 5 mol% of the 
diamine 69.  The isolated yield also varies with the amount of acetaldehyde (Table 
12, entries 1 and 8-9) where the optimum appeared to be 10 equivalents.   
 
3.3.1 Stereochemical Outcome of the One-Pot Reactions 
 
Establishing the stereochemical outcome of the one-pot reaction was not 
trivial as two stereocentres as well as an anomeric centre were formed in the 
reaction. 
 
3.3.1.1 Diastereoselectivity of the One-Pot Reactions 
 
The diastereoselectivity observed for the isolated acid 4a was determined 
as described earlier (section 2.5.3).  The diastereoselectivity was similar to that 
observed in the E192N-catalysed aldol reactions of 123 (section 2.5.2) and is likely 
to be under thermodynamic control. 
 
 
                                                 
†††
 The concentration of E192N was kept constant across all reactions. 
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3.3.1.2 Determination of the Enantioselectivity of the One-Pot 
Reactions 
 
An essential part of the project was the determination of the 
enantioselectivity of the one-pot reaction.  In the one-pot reaction the initial 
organocatalysed reaction yields the aldol intermediate 141a as one or a mixture of 
enantiomers, both of which may be accepted by the E192N aldolase variant to give 
the acid 4a and its enantiomer ent-4a, as a mixtures of diastereomers at the C-4 
position (Scheme 50).   
 
It is a fair assessment to assume that the enantioselectivity of the initial 
organocatalysed aldol reaction, and hence the enantiomeric excess of the 
intermediate aldehyde 141a, is controlled by the chiral diamine 69.  However, one-
pot reaction conditions which produce the acid 4a with enantiomeric excess may 
result from a number of possibilities.  The organocatalysed reaction may be 
stereoselective and produce the aldehyde 141a in high enantiomeric excess and 
the E192N-catalysed aldol reaction therefore gives the acid 4a in high enantiomeric 
excess.  Alternatively, the organocatalysed reaction may not be stereoselective 
and hence, produce a mixture of the aldehyde 141a and its enantiomer ent-141a.  
In this case the aldolase may be selective for one of the enantiomers of the 
aldehyde 141a, allowing kinetic resolution to occur yielding an enantiomerically 
enriched acid 4a.  No knowledge existed on whether the E192N aldolase variant 
could differentiate between enantiomers of enzyme substrates, as all previous 
studies were performed using single enantiomers of screening compounds.46, 47, 52, 
118, 119
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Scheme 50: Possible substrate-specificity of the E192N aldolase variant in the one-pot reaction. 
 
 
The enantiomeric excess of the acid 4a, prepared in the one-pot reaction, 
was determined by conversion into a derivative.  The derivative prepared was 
lactone 171 (Scheme 51), which was synthesised from the acid 4a.  Firstly, the 
acid 4a was exposed to hydrogen peroxide under aqueous acidic conditions, which 
yielded the diol 172.  The diol 172 was treated with trifluoroacetic acid in 
acetonitrile, which, upon heating, cyclised and dehydrated to give the lactone 171.  
A chiral HPLC method was developed for the lactone 171 (Appendix i). 
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Scheme 51: Preparation of the lactone 171 from the acid 4a 
 
Upon conversion to the lactone 171, some of the products 4a from the one-
pot reactions showed low enantiomeric excesses however, most of the reactions 
were racemic (Scheme 49 and Table 12).  Given that the higher 
enantioselectivities were observed for lower yielding reactions, it was possible that 
some kinetic resolution of the aldehyde 141a and ent-141a was occurring under 
these reaction conditions. 
 
To establish whether kinetic resolution had occurred under some one-pot 
reaction conditions, the enantiomeric excess of the aldol intermediate 141a was 
determined.  If the intermediate aldehyde 141a was racemic then the enzyme must 
have processed one enantiomer of the aldehyde 141a faster than the other.  The 
enantiomeric excess of the intermediate aldehyde 141a was determined under the 
same reaction conditions which yielded the acid 4a with enantiomeric excess 
(Scheme 52).  The enantiomeric excess of the aldol intermediate 141a was 
determined by reduction using sodium borohydride to give the diol 173.  Upon 
analysis, using chiral normal phase chromatography (Appendix ii), the diol 173 was 
found to be racemic (Table 13 and Scheme 52), whereas the corresponding acid 
4a, prepared under the same one-pot conditions had low enantiomeric excess.  
This was disappointing as we had believed that the use of the chiral diamine 69 
would have led to enantiocontrol in the organocatalysed reaction.  However, it was 
concluded that the E192N aldolase variant must be performing a kinetic resolution 
under certain one-pot conditions.  Under these conditions, the enzyme-catalysed 
reactions had simply not reached completion and however under most one-pot 
conditions, in which the acid 4a was racemic the reactions must have proceeded to 
completion. 
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Scheme 52: Strategy used to determine the whether enantiomers of the aldol intermediate 141a 
were kinetically resolved under one-pot reaction conditions 
 
Reaction Conditions e.r. of diol 
173 
e.r. of lactone 
171 
10 mol% diamine 69, 10 eq. acetaldehyde dilution factor 3.23 47:53 26:74 
 
Table 13: Enantiomeric excesses determined for the diol 173 and the lactone 171 in order to 
establish the source of enantioselectivity observed under some one-pot reaction conditions 
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3.3.2 Determination of the Substrate Scope of the One-Pot 
Reaction 
 
With the conditions in place for the one-pot reaction, the scope and 
limitations of the process were investigated.  Six glyoxylaldehydes 1 (Figure 23) 
were selected as potential substrates for the one-pot reaction and prepared prior to 
screening. 
 
Figure 23: Aldehydes selected as potential substrates in the one-pot reaction 
 
3.3.2.1 Preparation of Glyoxylaldehydes 1 
 
The glyoxylaldehydes 1 were prepared from the amides 127 by ozonolysis 
or dihydroxylation and periodic cleavage (Scheme 53).  Generally, ozonolysis was 
a higher yielding route, with all yields between 62-79%.   
 
 
Scheme 53: Preparation of glyoxylaldehyde 1 from amides 127 by ozonolysis of two step 
dihydroxylation and oxidative cleavage (see Table 14) 
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Entry Amide R1 R2 Ozonolysis 
Yield  (%) 
Diol 156 
Yield 
(%) 
Periodic 
Cleavage 
Yield (%) 
Glyoxyl-
aldehyde 
1 127a Pr Pr - 156a 91 93 1a 
2 127b Bu Bu 78 - - - 1b 
3 127c -(CH2)5- 69 - - - 1c 
4 127e Me Pr 79 - - - 1e 
5 127f Me OMe a - - - 1f 
6 127g Et Et 62 - - - 1g 
7 127h Me Me 76 156h 10 26 1h 
 
Table 14: Isolated yields of the ozonolysis of amides 127, dihydroxylation of amides 127 and 
periodic cleavage of diols 156 (see Scheme 53). a The aldehyde 1f was used without purification in 
following reaction. 
 
 
3.3.2.2 Determination the Substrate Scope of the One-Pot 
Reaction with Glyoxylaldehydes 1 
 
The glyoxylaldehydes 1 were exposed to the developed one-pot reaction 
conditions (5 mol% diamine 69, 10 eq. acetaldehyde and dilution factor of 1.7).  
Five of the glyoxylaldehydes 1 were good substrates for the one-pot reaction with 
acetaldehyde, and the acids 4 were obtained in yields between 40-51% (Scheme 
54 and Table 15).  The result concurs with previous results since the aldol 
intermediates 141 had previously been shown to be substrates for the E192N 
aldolase variant (section 2.5.2).  The dibutylamide 1b and the Weinreb amide 1f 
were not substrates for the one-pot reaction.  This observation is surprising 
because the full-length dibutylamide 135b is a substrate for the E192N aldolase 
variant (section 2.5.2).  The lack of reactivity of the dibutylamide 1b is most likely 
due to its poor solubility under the aqueous conditions of the one-pot reaction.  The 
failure of the Weinreb amide 1f to react, however, fits with previous findings that 
the aldol intermediate 141f was not a substrate for the E192N aldolase variant. 
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Scheme 54 One-pot reactions with substrates 1 and acetaldehyde. 
 
Entry Glyoxylaldehyde R1 R2 Product Yield 4 (%)a Cis :trans b 
1 1a Pr Pr 4a 40 78:22 
2 1b Bu Bu 4b No product - 
3 1c -(CH2)5- 4c 48 66:34 
4 1e Me Pr 4e 48 57:43 
5 1f Me OMe 4f No product - 
6 1g Me Me 4g 43 71:29 
7 1h Et Et 4h 51 61:39 
 
Table 15 One-pot reactions with glyoxylaldehydes 1 with acetaldehyde. aAll products were isolated 
by preparative HPLC b Diastereoselectivities of isolated products were determined by  500 MHz 1H 
spectroscopy 
 
 
The diastereoselectivity of the reactions with the glyoxylaldehydes 1 
(Scheme 54 and Table 15) was comparable to that observed with the 
dipropylglyoxylaldehyde 1a (section 2.5.3).  The diastereoselectivity was 
established by 500 MHz 1H NMR spectroscopy.  When the diagnostic H-6 and H-4 
1H signals of the acids 4 were compared, the chemical shifts and coupling 
constants were consistent across the series of compounds.  The similarities 
between the 500 MHz 1H spectra of the acids 4 allowed the identification of 
diastereomers and anomers across the series (Appendix iii) 
 
The donor aldehyde can also be varied. Propionaldehyde was a good 
substrate in the one-pot reaction with the range of acceptor glyoxylaldehydes 1 
(Scheme 55 and Table 16). 
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Scheme 55: One-pot reactions with substrates 1 and propionaldehyde.  The major product 174 is 
depicted only 
 
Entry 
Glyoxylaldehy
de 
R1 R2 Product 
Yield  
4 (%)a 
Diastereoselectivity 
Maj:minor b,c 
1 1a Pr Pr 174a 70 55:45 
2 1b Bu Bu 174b No product - 
4 1e Me Pr 174e 48 56:44 
5 1f Me OMe 174f No product - 
3 1g Et Et 174g 69 74:26 
 
Table 16: One-pot reactions with glyoxylaldehydes 1 with propionaldehyde. aall products isolated by 
preparative HPLC b ratio between the major diastereomer (min), as shown in Scheme 55, and all 
other diastereomers (min); c diastereoselectivities of isolated products determined by analysis by 
500  MHz  1H NMR spectroscopy  
 
The diastereoselectivity of the one-pot reactions involving propionaldehyde 
was established by analysis of the isolated products by 500 MHz 1H NMR 
spectroscopy.  The identity of the major product 174 was achieved previously 
(Chapter 2, section 2.5.4).  The diastereoselectivities are quoted as a ratio 
between the major product 174 (as shown in Scheme 55) and all other 
diastereomers, and is comparable across the series of compounds.  The 
stereoselectivity of the one-pot reaction is likely to be controlled in the same 
manner as the one-pot reactions are with acetaldehyde.  The organocatalysed 
reaction is likely to generate a racemic aldol intermediate which is accepted by the 
E192N aldolase variant.  The enzyme-catalysed reaction is likely to be under 
thermodynamic control with the relative energies of the enzyme products 
controlling the proportion of products prepared. 
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Scheme 56: One-pot reactions with iso-butyric aldehyde 175 and phenylacetaldehyde 176 
 
When the donor aldehydes iso-butyric aldehyde (175) and 
phenylacetaldehyde (176) (Scheme 56) were exposed to the glyoxylaldehydes 1a-
h under the optimised reaction conditions, none of the acid products, 177 and 178, 
were observed.  The only product observed in these reactions was the 
intermediate aldol product.  The lack of conversion to the E192N product suggests 
that the aldol intermediates  are poor substrates for the E192N aldolase variant.   
 
The absence of E192N activity was unexpected and did not fit with our 
original model in which, the nature of the substituent in the C-5 position of the 
enzyme substrate was predicted to have little effect.  Further structural studies are 
underway within the group which may allow a more refined understanding of the 
enzyme variant’s substrate specificity. 
 
3.4 Chapter 3 Summary 
 
In this chapter, the identity of common conditions under which both organo- 
and enzyme-catalysed steps could occur was discussed.   To start with, the 
organocatalysed step was investigated. Thereafter, it was ascertained whether the 
optimised conditions for the organocatalysed step were compatible with the E192N 
aldolase variant using an enzyme assay.  The results from the assay allowed the 
development of one-pot conditions which allowed both catalytic steps to occur in a 
one-pot, sequential manner.  The reaction conditions were optimised and the 
scope of the process was investigated 
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Chapter 4 
 
4       Summary    4  
 
A novel, one-pot sequential three-component reaction was developed which 
combined organo- and enzyme-catalysis in an aldol/aldol cascade for the first time.  
The feasibility of the approach was first assessed by investigating whether the 
aldol intermediates 3 were substrates for the E192N aldolase variant.  Analysis of 
the crystal structure of the wild-type NAL enzyme suggested that the aldol 
intermediates would be substrates for the enzyme due to the solvent exposed 
nature of the substituents in the C-5 position of the substrates.  This theory was 
tested by the preparation and evaluation of the potential aldolase products 135.  It 
was concluded that the nature of the substituent at C-5 had little effect on the 
specificity constants with the E192N aldolase variant, and, crucially the aldol 
intermediates 3 were enzyme substrates.  It was shown that the corresponding 
aldol condensations were thermodynamically favourable and hence, synthetically 
useful.  
  
 
Scheme 57 
 
Once the aldol intermediates were established as substrates for the 
aldolase, the one-pot reaction was developed.  Three organocatalysts were 
prepared and together with L-proline and L-alanine, were investigated in the 
crossed aldol reaction between the glyoxylaldehyde 1a and propionaldehyde.  The 
diamine 69 catalysed the aldol reaction in buffer at a suitable pH for the aldolase; 
this catalyst was, therefore, selected as the most appropriate catalyst for the one-
pot reaction.  An assay was developed and used to assess the compatibility of the 
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diamine 69, propionaldehyde and the glyoxylaldehyde 1a with the E192N aldolase 
variant.  The diamine 69 was found to have a substantial detrimental effect on the 
activity of the enzyme and only low concentrations could be tolerated.  Accordingly, 
it was decided to conduct a one-pot sequential process: after the organocatalysed 
step, the reaction was diluted and the enzyme along with pyruvate were added; 
this allowed the acids 4 to be obtained.  Despite the use of the chiral diamine 69 in 
the organocatalytic step, the one-pot reaction was unfortunately not 
enantioselective when the one-pot reaction was run to completion.  This was found 
to be due to the lack of enantioselectivity in the organocatalysed step.  Some 
kinetic resolution was observed between aldol intermediates 141a under some 
one-pot conditions, however this was at the expense of yield.  To circumvent this 
problem of enantioselectivity, further screening of organocatalysts, (including 
perhaps polymer supported catalysts) would possibly yield an enantioselective 
one-pot reaction.  This approach would possibly avoid incompatibility with the 
enzyme catalyst and may allow the reaction be performed non-sequentially.  The 
scope of the one-pot reaction was determined using a range of aldehyde acceptors 
(glyoxylaldehydes 1) and aldehyde donors (acetaldehyde and propionaldehyde) 
demonstrating the degree of diversity that can be generated using these systems. 
 
In summary, a novel aldol-aldol sequential cascade reaction, with broad 
scope, has been developed.  The reaction generates molecular complexity rapidly 
and hence may find synthetic applications such as natural product synthesis or in 
diversity oriented chemistry.  
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Chapter 5 
5 Experimental  5  
General Experimental 
 
All non-aqueous reactions were carried out under an atmosphere of nitrogen.  
Water-sensitive reactions were performed in oven- or flame-dried glassware cooled 
under nitrogen before use.  Solvents were removed under reduced pressure using 
either a Büchi rotary evaporator and a Vacuubrand PC2001 Vario diaphragm pump, 
or a Genevac HT-4 evaporation system.  Solvents were distilled before use when 
necessary.   
 
Solvents  
Tetrahydrofuran was freshly distilled from sodium, using benzophenone as a self-
indicator.   
Dichloromethane, and toluene were freshly distilled from calcium hydride.  
Anhydrous N,N-dimethylformamide was obtained from Sigma–Aldrich.  Ether refers 
to diethyl ether and petrol refers to petroleum spirit (b.p. 40-60 °C) unless otherwise 
stated.   
 
Reagents  
Commercially available starting materials were obtained from Sigma–Aldrich, Fluka, 
Lancaster, Alfa Aesar, or Novabiochem  
 
Flash Chromatography 
Flash column chromatography was carried out using silica (35-70 µm particles).  
Thin layer chromatography was carried out on commercially available pre-coated 
glass or aluminium plates (Merck silica 2 8 8 0 Kieselgel 60F254).   
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Ozonolysis 
Ozone was generated using a Welsbach generator (0.4-0.6 psi), and the reaction 
mixture was purged with oxygen gas (0.4-0.6 psi) for a minimum of 15 minutes 
before and after ozonolysis. 
 
LCMS 
Analytical LC-MS was performed using a Waters X-Terra chiral column (MS 
C18, 5 µm, 50 × 4.6 mm) with a Waters 2525 pump, Waters 2996 photodiode 
array detector and a Waters Micromass ZQ mass spectrometer as the detector. 
or 
 
Analytical LC-MS was performed using an Agilent 1200 series LC system 
comprising of a Bruker HCT Ultra ion trap mass spectrometer, a high vacuum 
degasser, a binary pump, a high performance autosampler and micro well plate 
autosampler, an autosampler thermostat, a thermostated column compartment 
and a diode array detector.  The system used two solvent systems: MeCN/H2O 
+ 0.1% formic acid with a Phenomenex Luna C18 50 × 2mm 5 micron column 
or MeCN/H2O with a Phenomenex Luna C18 50 × 2mm 5 micron column. 
 
Analytical HPLC and normal phase chromatography 
Analytical HPLC was performed using a Daicel Chemical Industries LTD chiral 
column AS-RH Chiralpak, 5 µm, 150 × 4.6 mm or a Daicel Chemical Industries 
LTD chiral column AD-RH Chiralpak and 5 µm, 150 × 4.6 mm eluting with 
Linear gradients of 0.1% TFA in MeCN/ H2O.  Normal phase liquid 
chromatography was performed using a Daicel Chemical Industries LTD chiral 
column AD-H Chiralpak, 5 µm, 250 × 4.6 mm chiral column with isocratic 5% 
IPA in hexane.  Both were run with a Dionex Analytical HPLC system and diode 
array detector 
 
Prep HPLC 
Preparative HPLC was performed using a Phenomenex Hyperclone column 
(ODS (C18), 120 A, 5 µm, 250 × 21.2 mm) with a Gilson 333/334 Binary pump, 
a Gilson 402 syringe pump, a Gilson UV/Vis- 151 single wavelength detector 
and a Gilson FC 204 fraction collector. 
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Semi-prep HPLC 
Semi preparative HPLC was performed using a Gilson semi-prep HPLC system 
comprising of 1 ×  Gilson 215 liquid handler; 1× 811c dynamic mixer; 1 ×  806 
manometric module; 2 × 306 pumps with 25cc pump heads; 1 ×  119 UV/VIS 
detector.  Linear gradients of 0.1% TFA in MeCN/ H2O and Zorbax-SB-C18 21.2 × 
100mm 5uM column. 
 
Semi-prep mass-directed HPLC 
Semi-preparative HPLC was performed using a Phenomenex Hyperclone 
column (ODS (C18), 120 A, 5 µm, 250 × 10 mm) with a Dionex P580 Binary 
pump, a STH 585 Column oven, a Gynkotek sampler, a Gynktotek UVD340U 
Detector Dionex semi-preparative HPLC system or a Gilson preparative HPLC 
system . 
 
NMR 
Proton and carbon NMR spectra were recorded on a Bruker Advance DPX 300, 
Advance 500 or DRX500 spectrophotometer using an internal deuterium lock.  
Carbon NMR spectra were recorded with composite pulse decoupling using the 
waltz 16 pulse sequence.  DEPT, COSY, HMQC and HMBC pulse sequences were 
routinely used to aid the assignment of spectra.  Chemical shifts are quoted in parts 
per million downfield of tetramethylsilane, and coupling constants (J) are given in Hz.  
NMR spectra were recorded at 300 K unless otherwise stated.  
 
Melting point 
Melting points were determined on a Reichert hot stage microscope and are 
uncorrected.   
 
IR 
Infrared spectra were recorded on a Perkin Elmer spectrum One FT-IR 
spectrophotometer.   
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Mass Spectrometry  
Nominal mass spectrometry was routinely performed on a Waters-Micromass ZMD 
spectrometer using electrospray (+) ionization.  Isotopic distributions were as 
expected.   Nominal and accurate mass spectrometry using electrospray ionisation 
was carried out by staff in the School of Chemistry at the University of Leeds, using 
either a Micromass LCT-KA111 or Bruker MicroTOF mass spectrometer and 
reserpine as the lock mass and sodium iodide as the standard..  Field Desorption 
Ionisation mass spectra were acquired on a Waters-Micromass GCT premier 
spectrometer equipped with a Linden LIFDI probe.  All mass spectra quoted to four 
decimal places are high resolution spectra 
 
Microanalysis 
Microanalyses were carried out by staff in the School of Chemistry at the University 
of Leeds using a Carlo Erba 1108 automatic analyser.  
 
[α]D 
Optical activity measurements were recorded at room temperature on an AA-1000 
polarimeter; units for [α]D are 10–1 deg cm2 g–1 and are omitted. 
 
Fractional hydrogens in mixtures 
For compounds that exist as inseparable mixtures or as mixtures of species in 
slow exchange (eg anomers, hydrates and rotamers), fractional protons are 
assigned to 1H NMR signals.  The fractional protons reflect the proportion of the 
species in the mixture: for example, “5.16 (0.04H, d, J 10.3, 6-Htrans(maj))” 
indicates that the major anomer of the trans diastereomer forms 4% of the total 
mixture of species present.  The total number of hydrogens in all species sum to 
1H for each specified proton signal. 
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General Procedures 
 
General Procedure A – Aldol reactions  
 
The organocatalyst was added to the glyoxylaldehyde 1a and propionaldehyde 
in the given solvent and reaction stirred at the given temperature until judged 
complete, NaBH4 was added and stirred at the given temperature for the given 
time.  Reaction was quenched with aqueous 2M NH4Cl solution and extracted 
with EtOAc.  Column chromatography yielded the diols 158. 
 
General Procedure B – Aldol reactions with tetrazole 67  
 
Propionaldehyde was added to a mixture of the glyoxylaldehyde 1a and 
tetrazole catalyst 67 in the given solvent and reaction stirred at the given 
temperature until judged complete, NaBH4 was added and stirred at the given 
temperature until judged complete. Reaction was quenched with a 2M aqueous 
NH4Cl solution and extracted with EtOAc. Column chromatography yielded the 
diols 158. 
 
General Procedure C – Aldol reactions with diamine catalyst 69  
 
Additive was added to a mixture of diamine 69 and stated solvent and stirred for 
5 min in a sealed system under air.  This mixture was then added to the 
glyoxylaldehyde 1a followed by propionaldehyde and reaction stirred for the 
stated time in a sealed vessel under air atmosphere at room temperature until 
judged complete. NaBH4 was added reaction stirred until judged complete.  
Reaction was quenched with aqueous NH4Cl solution and extracted with 
EtOAc. Column chromatography yielded the diols 158. 
 
General Procedure D – Aldol reactions with diamine catalyst 69 in buffer 
 
Glyoxylaldehyde 1a, the diamine 69 and stated solvent and stirred for 5 min  
propionaldehyde was added and reaction stirred for the stated time at room 
temperature until judged complete . NaBH4 was added, reaction stirred until 
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judged complete. Reaction was quenched with a 2M aqueous NH4Cl solution 
and extracted with EtOAc. Column chromatography yielded the diols 158. 
 
General Procedure E; Dihydroxylation with Potassium Osmate 
 
4-methyl-morpholine-N-oxide in water was added to a suspension of diamide, 
citric acid and K2OsO2(OH)4 in 1:1 tBuOH–water which upon addition turned 
from green to yellow.  The reaction was stirred at the given temperature for the 
given time, and tBuOH removed by rotary evaporator.  The mixture was diluted 
with 1 M aqueous HCl solution and extracted with EtOAc, dried (MgSO4) and 
evaporated under reduced pressure to give the crude product as a colourless 
oil. 
 
General Procedure F; Ozonolysis 
 
Oxygen (15 min, 0.5 psi), ozone (0.5 psi, until reaction mixture turned blue), and 
oxygen (15 min, 0.5 psi), were bubbled sequentially through a stirred solution of 
alkene in the given solvent at −78 °C.  Dimethyl sulfide was added, and the 
mixture was allowed to warm to room temperature, stirred until reaction was 
quenched, as established by testing with starch-iodide paper, and evaporated 
under reduced pressure to give the aldehyde. 
 
General Procedure G; Allylation with allytrimethylsilane 
 
The aldehyde was dissolved in DCM and TiCl4 added at 0 °C.  The reaction was 
stirred for 15 minutes at this temperature then allyltrimethylsilane added.  The 
reaction was warmed to room temperature and stirred for the allotted time and 
quenched at 0 °C with a saturated aqueous sodium bicarbonate solution.  The 
phases were separated and the aqueous phase washed with DCM twice, the 
combined organic layers were dried (MgSO4) and concentrated to give the 
crude product. 
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General Procedure H; Indium coupling 
 
Ethyl (bromomethyl)acylate and indium metal were added  
to the aldehyde in the given solvent, and the reaction stirred for 61 h at room 
temperature.  The reaction was filtered through Celite, washed with EtOAc and 
the combined organics washed with a saturated aqueous solution of sodium 
bicarbonate.  The organic layer was dried (MgSO4), and concentrated to give 
the crude product. 
 
 
General Procedure I; Barium hydroxide hydrolysis 
 
The ester was dissolved in MeOH and was added to a solution of barium 
hydroxide monohydrate in water and stirred for 18 h at room temperature.  The 
reaction mixture was concentrated under reduced pressure, dissolved in water, 
ammonium sulphate added and reaction stirred at room temperature for 2 h.  
The reaction mixture was filtered through Celite and 0.2 µm Whatman syringe 
filter and the filtrate concentrated under reduced pressure to give the 
ammonium salt . 
 
General Procedure J; One-pot reactions 
 
The glyoxylaldehyde was dissolved in buffer and was added to the diamine 69. 
Acetaldehyde or propionaldehyde was added to a mixture and reaction was 
stirred at room temperature for 20 h then diluted with a pH adjusted solution (pH 
7.4) of sodium pyruvate in buffer (pH 7.4, 20 mM potassium phosphate) and 
E192N (in pH 7.4, 20 mM potassium phosphate) and reaction incubated at 35 
ºC for 70h then reaction pH lowered to pH 2 with an aqueous solution of 2M 
formic acid for 5 minutes then pH raised to pH 7 with an aqueous solution of 2M 
NH4OH solution.  The reaction mixture was filtered through Celite and reaction 
purified using preparative HPLC. 
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General Procedure K; E192N catalysed aldol reactions with sodium 
pyruvate 
 
The alkene was ozonolysed following General Procedure F in MeOH.  The 
resultant residue was dissolved in an aqueous potassium phosphate buffer (20 
mM, pH 7.4), sodium pyruvate added and pH adjusted to 7.4 using and 
aqueous solution of 2M NH4OH.  E192N was added in potassium phosphate 
buffer (20 mM, pH 7.4) and reaction incubated at 35 ºC.  After reaction reached 
completion the pH was lowered to pH 2 with an aqueous solution of 2M formic 
acid for 5 minutes then pH raised to pH 7 with an aqueous solution of 2M 
NH4OH solution and filtered through Celite and reaction purified using 
preparative HPLC.  
 
 
N1,N1,N4,N4-Tetrapropylfumaramide 127a  
 
 
 
Dipropylamine (6.62 g, 65.4 mmol) was added dropwise to a vigorously stirred 
solution of fumaryl chloride (1.77 mL, 16.3 mmol) in ether (200 mL) at 0 °C.  
After addition the reaction was allowed to warm to room temperature and stirred 
for further 2 h.  The reaction was filtered to remove precipitate and filtrate was 
washed with ether (100 mL).  The mother liquor was concentrated under 
reduced pressure to give the crude product. Column chromatography, eluting 
with 3:7 EtOAc–Petrol, afforded the title compound 127a (3.16 g, 69%) as pale 
yellow oil, Rf: 0.20 (3:7 EtOAc–Petrol);  (Found: C, 60.7; H, 10.25, N, 9.0%; 
C16H32N2O4 requires C, 60.7; H, 10.2, N, 8.9%); max/cm–1 (film) 3534, 2964, 
2875, 1723, 1625, 1463 and 1380;δH (500 MHz, CDCl3) 7.33-7.31(1H, m, CH), 
3.31 (2H, t, J 7.7, N(CH2)A), 3.27 (2H, t, J 7.7, N(CH2)B), 1.62-1.49 (4H, m, 
(NCH2CH2)A,B), 0.87-0.83 (6H, m, (CH2CH3)A, B); δC (75 MHz, CDCl3) 165.3 
(CO), 131.7 (CH), 50.2 ((NCH2)A), 48.9 ((NCH2)B), 23.4 ((NCH2CH2)A ), 21.4 
((NCH2CH2)B), 11.8 ((CH2CH3)A), 11.5 ((CH2CH3)B); m/z (ES+) 305.2 (60%, 
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MNa+) 283.2 (40%, MH+); HRMS Found MNa+ 305.2198. C16H30N2O2 requires 
MNa+ 305.2205. 
 
 
N1,N1,N4,N4-Tetrabutylfumaramide142 127b 
 
 
 
Dibutylamine (13.2 mL, 78.4 mmol) was added slowly to a solution of fumaryl 
chloride (2.12 mL, 19.6 mmol) in dry ether (200 mL) at 0 °C.  The reaction was 
allowed to warm to room temperature and after 17 h reaction was filtered 
mother liquor evaporated under reduced pressure to give the title compound142 
127b (3.32 g, 68%) as pale brown oil; Rf: 0.23 (1:9 EtOAc–petrol); νmax/cm−1 
(film) 3463, 2957 1624 and 1443; δH (300 MHz, CDCl3) 7.37 (1H, s, CH), 3.39 
(2H, t, J 7.7, (NCH2)A), 3.35 (2H, t, J 7.9, (NCH2)B), 1.65-1.48 (4H, m, 
(NCH2CH2)A,B), 1.33 (4H, sextet, J 7.5, (NCH2CH2CH2)A,B), 0.94 (6H, t, J 7.5, 
(CH3) A,B); δC (75 MHz, CDCl3) 165.2 (CO), 131.6 (CH), 48.5 and 47.5((NCH2) 
A,B), 32.4 and 30.3 ((NCH2CH2) A,B), 20.7 and 20.4 ((NCH2CH2CH2) A,B), 14.2 
and 14.2 ((CH3) A,B); m/z (EI+) 339.3 (100%, MH+); HRMS Found:MH+: 
339.2991, C20H39N2O2 requires MH+ 339.3006.   
 
 
(E)-1,4-Di(piperidin-1-yl)but-2-ene-1,4-dione144 127c 
 
 
 
Piperidine (7.75 mL, 78.4 mmol) was added slowly to a solution of fumaryl 
chloride (2.12 mL, 19.6 mmol) in dry ether (200 mL) at 0 °C.  The reaction was 
allowed to warm to room temperature, after 17 h the reaction was filtered and 
mother liquor evaporated under reduced pressure to give the title compound144 
127c (3.32 g, 68%) as colourless needles, m.p. 100-103 °C (DCM–petrol) [lit.144 
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m.p. 104 °C]; Rf: 0.20 (1:1 EtOAc–petrol); νmax/cm−1 (solid) 3493, 2929, 1627 
and 1441; δH (300 MHz, CDCl3) 7.14 (1H, s, CH), 3.44 (2H, t, J 5.6, (NCH2)A), 
3.36 (2H, t, J 5.6, (NCH2)B), 1.54-1.33 (6H, m, CH2); δC (75 MHz, CDCl3) 164.1 
(1-C), 131.4 (CH), 47.3 and 43.5 (NCH2)A,B), 26.9, 26.9 and 24.7 (CH2); m/z 
(ES+) 251.2 (100%, MH+); HRMS Found MH+: 251.1759, C14H23N2O2 requires 
MH+ 251.1759. 
 
 
(E)-1,4-Dimorpholinobut-2-ene-1,4-dione145127d 
 
 
 
Morpholine (5.74 mL, 65.2 mmol) was added slowly to a solution of fumaryl 
chloride (1.77 mL, 163. mmol) in dry ether (100 mL) at 0 °C.  Reaction was 
allowed to warm to room temperature and after 45 minutes reaction diluted with 
water (100 mL).  The reaction was washed with 1-butanol (3× 100 mL) and the 
combined organics dried (MgSO4) and evaporated under reduced pressure to 
give the title compound145 127d (1.04g, 25%) as colourless needles, m.p. 
188.8-192.2 °C (DCM–petrol) [lit. 145 m.p. 195-200 °C]; Rf: 0.38 (9:1 EtOAc–
MeOH);  νmax/cm−1 (solid) 3484, 2871, 1626 and 1288; δH (500 MHz, CDCl3) 7.4 
(1H, s, CH), 3.76-3.58 (8H, m, (NCH2)A,B and (NCH2CH2)A,B); δC (75 MHz, 
CDCl3) 164.1 (CO), 131.4 (CH), 67.0, 42.8 and 42.1 ((NCH2)A,B and 
(NCH2CH2)A,B); m/z (ES+) 255.1 (60%, MH+), 277.1 (40%, MNa+); HRMS Found 
MNa+: 277.1154, C12H18N2O4 requires MNa+ 277.1159.  
 
 
N1,N4-Dimethyl-N1,N4-dipropylfumaramide 127e 
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N-Methylpropylamine (12.6 mL, 136 mmol) was added slowly to a solution of 
fumaryl chloride (3.67 mL, 34.2 mmol) in dry ether (100 mL) at 0 °C.  Reaction 
was allowed to warm to room temperature and after 1 h reaction was filtered 
and mother liquor evaporated under reduced pressure to give the title 
compound 127e (7.90 g, 100%) as pale yellow oil; Rf: 0.30 (EtOAc); νmax/cm−1 
(film); 3501. 2964, 1620, 1455 and 1143; δH (400 MHz, CDCl3) 7.39 (2H, s, CH), 
3.46-3.34 (4H, m, (NCH2)), 3.12 (3H, s, NCH3), 3.03 (3H, s, NCH3), 1.70-1.53 
(4H, m, NCH2CH2), 0.92 (6H, t, J 7.4, NCH2CH2CH3); δC (100 MHz, CDCl3) 
167.6 and 165.7 (CO), 132.3 and 131.5 (CH), 52.1 and 50.2 (NCH2), 35.9 and 
34.5 (NCH3), 22.6 and 20.7 (NCH2CH2), 11.6 and 11.3 (CH3); m/z  (ES+) 227.2 
(100%, MH+); HRMS Found MH+: 227.1750, C12H22N2O2 requires MH+ 
227.1754. 
 
 
N1, N4-Dimethoxy- N1, N4-dimethylfumaramide143 127f 
 
 
 
Dry pyridine (42 mL) was added at dropwise to a suspension of N,O-
dimethylhydroxylamine hydrochloride (3.37g, 34.4 mmol) and fumaryl chloride 
(931 µL, 8.6 mmol) and DCM (20 mL) at 0°C.  The reaction was then warmed to 
room temperature and stirred for 17 h.  The reaction was cooled to 0°C and 
diluted and with aqueous saturated of NH4Cl (50 mL), washed with DCM 
(3 × 75 mL) and the combined organic layers dried (MgSO4) and evaporated 
under reduced pressure to give the title compound143 127f (1.40 g, 81%) as 
colourless needles; m.p. 120.9-123.6 °C (DCM–petrol) [lit.143 m.p. 129.5-
134.5 °C]; Rf: 0.63 (9:1 EtOAc–MeOH); νmax/cm−1 (solid) 2971, 1642, 1463 and 
1390; δH (300 MHz, CDCl3) 7.49 (1H, s, CH), 3.76 (3H, s, CH3), 3.30 (3H, s, 
CH3); m/z (ES+) 203.1 (70%, MH+), 225.1 (30%, MNa+); HRMS Found MH+: 
203.1027, C8H15N2O4 requires MH+ 203.1026. 
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N1,N1,N4,N4-Tetraethylfumaramide141 127g 
 
 
 
Diethylamine (27 mL, 263 mmol) was added slowly to a solution of fumaryl 
chloride (7.08 mL, 65.8 mmol) in dry ether (200 mL) at 0 °C.  Reaction was 
allowed to warm to room temperature and after 2h the reaction was filtered and 
the mother liquor evaporated under reduced pressure to give the title 
compound141 127g (14.9 g, 100%) as colourless needles m.p. 88-90 °C, [lit.141 
m.p. 90.5°C];  Rf: 0.19 (EtOAc); νmax/cm−1 (solid); 3436, 1978, 1614, 1463 and 
1314; δH (500 MHz, CDCl3) 6.91 (1H, s, CH), 3.08-2.95 (4H, m, (NCH2)A,B), 0.78 
(3H, t, J 7.2, (CH3)A), 0.71 (3H, t, J 7.2, (CH3)B); δC (75 MHz, CDCl3) 166.2 
(CO), 131.4 (CH), 42.4 and 40.9 ((NCH2)A,B), 15.2 and 12.9 ((CH3)A,B); m/z  
(ES+) 227.2 (100%, MH+); HRMS Found MH+: 227.1761, C12H22N2O2 requires 
MH+ 227.1754. 
 
 
N1,N1,N4,N4-Tetramethylfumaramide141 127h 
 
 
 
Dry triethylamine (10 mL) was added in two portions to a mixture of 
dimethylamine. hydrogen chloride (5.32 g, 65.2 mmol) and fumaryl chloride 
(1.77 mL, 16.3 mmol) and DCM (25 mL) at 0 °C.  After 1 h further dry 
triethylamine (10 mL) was added followed by DCM (25 mL) and reaction 
allowed to warm to room temperature.  The reaction was diluted with NH4Cl (50 
mL) after 22 h, washed with EtOAc (3 × 75 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the title compound 141 127h (1.77 g, 46%) as 
colourless needles; m.p. 120.3-122.9 °C (DCM–petrol)   [lit.141 m.p. 135°C ]; Rf: 
0.38 (8:2 EtOAc–MeOH); νmax/cm−1 (solid) 2938, 1621, 1503, 1397 and 1271; 
δH (300 MHz, CDCl3) 7.39 (1H, s, CH), 3.15 (3H, (NCH3)A), 3.05 (3H, (NCH3)B); 
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δC (75 MHz, CDCl3) 165.6 (CO), 131.4 (CH), 37.7 and 36.1 ((NCH3)A and 
(NCH3)B); m/z (EI+) 170.1 (30%, M+), 127.1 (70%, [M–N(CH3)2] +), 98.1 (100%, 
[M–CON(CH3)2] +), 72 (30%, [M– (CH)2CON(CH3)2] +); HRMS Found M+: 
170.1056, C8H14N2O2 requires M+170.1055.  
 
 
2-Hydroxy-N,N-dipropylpent-4-enamide 123a 
 
 
 
Titanium (IV) chloride (4.91 mL, 44.5 mmol) was added to a solution of the 
glyoxylaldehyde 1a (3.5 g, 22.3 mmol) in DCM (100 mL) at 0 ºC and stirred at 
for 15 minutes. Allyltrimethylsilane (17.7 mL, 111 mmol) was added the reaction 
warmed to room temperature.  After 17 h the reaction was cooled to 0 ºC and 
diluted with a saturated aqueous solution of sodium bicarbonate (50 mL) and 
phases separated.  The aqueous layer was washed with DCM (2 x 75 mL) and 
the combined organic layers were dried (MgSO4), and concentrated to give the 
crude product.  Column chromatography, eluting with 7:3 isohexanes–EtOAc, 
afforded the title compound 123a (4.04 g, 91%) as a colourless oil; Rf: 0.3 (19:1, 
CHCl3–EtOAc); νmax/cm−1 (film) 3411, 2965, 1639 and 1466; δH (500 MHz, 
CDCl3) 5.88-5.76 (1H, m, 4-H), 5.10 (1H, d, J 5.1, 5-HA), 5.07 (1H, br s, 5-HB), 
4.37-4.32 (1H, m, 2-H), 3.70 (1H, d, J 8.12, OH), 3.62-6.54 (1H, m, (NCHA)A), 
3.24-3.16 (1H, m, (NCHB)A), 3.06-2.96 (2H, m, (NCHA,B)B), 2.42-2.34 (1H, m, 3-
HA), 2.29-2.20 (1H, m, 3-HB), 1.65-1.46 (4H, m, (NCH2CH2)A,B), 0.89 (3H, t, J 
7.3, (CH3)A), 0.86 (3H, t, J 7.3, (CH3)B); δC (75 MHz, CDCl3) 176.1 (1-C), 135.9 
(4-C), 120.7 (5-C), 70.4 (2-C), 51.1 and 50.2 ((NCH2)A,B), 42.3 (3-C), 24.7 and 
23.5 ((NCH2CH2) A,B), 14.1 and 13.9 ((CH3)A,B); m/z (ES+) 222.1 (30%, MNa+), 
200.0 (5%, MH+), 186.2 (65%, M-H2O+); HRMS Found MNa+: 222.1465, 
C11H21NO2 requires MNa+ 222.1457. 
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2-Hydroxy- N,N-dibutylpent-4-enamide 123b 
 
 
 
The amide 127b (276 mg, 0.814 mmol) was ozonolysed following General 
Procedure F in DCM (5 mL) quenching with DMS (5 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (2 mL), with 
TiCl4 (1M in DCM, 3.26 mL, 3.26 mmol) and allyltrimethylsilane (1.29 mL, 8.15 
mmol) for 18 h.  Column chromatography, eluting with 1:9 EtOAc–petrol, 
afforded the title compound 123b (170 mg, 46%) as a colourless oil; Rf: 0.15 
(1:9 EtOAc–petrol); νmax/cm−1 (film) 3412, 2959, 1639 and 1467; δH (300 MHz, 
CDCl3) 5.87 (1H, ddt, J 17.4, 9.7 and 6.91, 4-H), 5.17-5.12 (1H, m, 5-HA), 5.11-
5.08 (1H, m, 5-HB), 4.36 (1H, ddd, J 7.9, 7.1 and 3.8, 2-H), 3.72 (1H, d, J 7.9, 
OH), 3.64 (1H, dt, J 14.4 and 7.7, (NCHA)A), 3.27 (1H, dt, J 13.8 and 7.7, 
(NCHB)A), 3.14-3.01 (2H, m, (NCHA,B)B), 2.47-2.36 (1H, m, 3-HA), 2.33-2.22 (1H, 
m, 3-HB), 1.64-1.49 (4H, m, (NCH2CH2)A,B), 1.40-1.24 (4H, m, 
(NCH2CH2CH2)A,B), 0.95 (3H, t, J 6.7, (CH3)A), 0.93 (3H, t, J 6.7, (CH3)B); δC (75 
MHz, CDCl3) 173.6 (1-C), 133.7 (4-C), 118.3 (5-C), 68.9 (2-C), 47.0 and 46.0 
((NCH2)A,B), 40.5 (3-C), 31.3 and 30.1 ((NCH2CH2)A,B), 20.6 and 20.4 
((NCH2CH2CH2)A,B), 14.2 and 14.1 ((CH3)A,B); m/z (EI+) 227 (15%, M+), 156 
(100%, [M-C4H8O]+); HRMS Found M+: 227.1891, C13H25NO2 requires  M+ 
227.1885. 
 
 
2-Hydroxy-1-(piperidin-1-yl)pent-4-en-1-one 123c 
 
 
 
The amide 127c (279 mg, 1.11 mmol) was ozonolysed following General 
Procedure F in DCM (5 mL) quenching with DMS (5 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (2 mL), with 
TiCl4 (1M in DCM, 4.44 mL, 4.44 mmol) and allyltrimethylsilane (1.76 mL, 11.1 
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mmol) for 18 h.  Column chromatography, eluting with 3:7 EtOAc–petrol, 
afforded the title compound 123c (122 mg, 30%) as a colourless oil; Rf: 0.24 
(3:7 EtOAc–petrol); νmax/cm−1 (film) 3410, 1938, 2938, 1638, 1445, 1339 and 
1257; δH (300 MHz, CDCl3) 5.87 (1H, ddt, J 17.4, 9.3 and 7.6, 4-H), 5.17-5.13 
(1H, m, 5-HA), 5.12-5.08 (1H, m, 5-HB), 4.47-4.38 (1H, m, 2-H), 3.89 (1H, d, J 
6.9, OH), 3.59 (4H, t, J 5.4, ((NCH2)A), 3.34 (4H, t, J 5.4, (NCH2)B), 2.47-2.37 
(1H, m, 3-HA), 2.32-2.19 (1H, m, 3-HB), 1.74-1.56 (6H, m, (NCH2CH2)A,B and 
NCH2CH2CH2); δC (75 MHz, CDCl3) 173.2 (1-C), 133.6 (4-C), 118.3 (5-C), 67.8 
(2-C), 46.3 and 44.1 ((NCH2)A,B), 40.1 (3-C), 26.6 and 25.9 ((NCH2CH2) A,B), 
24.8 (NCH2CH2CH2); m/z (ES+) 184.1 (100%, MH+); HRMS Found MH+: 
184.1339, C10H18NO2 requires MH+184.1332.  
 
 
2-Hydroxy-1-morpholinopent-4-en-1-one 123d 
 
 
 
The amide 127d (207 mg, 0.815 mmol) was ozonolysed following General 
Procedure F in MeOH (2 mL) and DCM (4 mL) quenching with DMS (5 mL).  
The resultant aldehyde was allylated following General Procedure G in DCM (5 
mL), with TiCl4 (1M in DCM, 1.63 mL, 1.63 mmol) and allyltrimethylsilane (647 
µL, 707 mmol) for 18 h.  Column chromatography, eluting with 1:1 EtOAc–
petrol, afforded the title compound 123d (180 mg, 60%) as a colourless oil; Rf: 
0.17 (7:3 EtOAc–petrol); νmax/cm−1 (film); 3418, 2919, 1642, 1439 and 1273; δH 
(500 MHz, CDCl3) 5.86-5.76 (1H, m, 4-H), 5.11 (1H, br s, 5-HA), 5.09-5.07 (1H, 
m, 5-HB), 4.41-4.35 (1H, m, 2-H), 3.75-3.33 (9H, m, (NCH2)A,B, (NCH2CH2)A,B, 
and OH), 2.42-2.34 (1H, m, 3-HA), 2.29-2.20 (1H, m, 3-HB); δC (75 MHz, CDCl3) 
75.1 (1-C), 135.7 (4-C), 121 (5-C), 70.3 (2-C), 69.6, 69.2, 48.3 and 45.6 
((NCH2)A,B and (NCH2CH2)A,B, ), 42.4 (3-C); m/z  (EI+) 185.1 (20%, M+), 144.1 
(100%, [M-CH2CHCH2]+); HRMS Found M+: 185.1053, C9H15NO3 requires M+ 
185.1052.  
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2-hydroxy-N-methyl-N-propylpent-4-enamide 123e 
 
 
 
The amide 127e (3.00 g, 13.3 mmol) was ozonolysed following General 
Procedure F in DCM (75 mL) quenching with DMS (75 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (40 mL), with 
TiCl4 (11.7 mL, 106 mmol) and allyltrimethylsilane (21.1 mL, 133 mmol) for 17 
h.  Column chromatography, eluting with 7:3 EtOAc–petrol, afforded the title 
compound 123e (1.00 g, 22%, ca. 6:5 mixture of rotomers) as a colourless oil; 
Rf:  0.42 (7:3 EtOAc–petrol); νmax/cm−1 (film) 3414, 2965, 1639 and 1388; δH 
(500 MHz, CDCl3) 5.95-5.75 (1H, m, 4-H), 5.19-5.12 (1H, m, 5-HA), 5.10 (1H, br 
s, 5-HB), 4.44 (1H, td, J 7.2 and 3.6, 2-H), 3.58-3.08 (2H, m, NCH2), 2.95 (3H, s, 
NCH3rotA), 2.93 (s, NCH3 rotB), 2.51-2.37 (1H, m, 3-HA), 2.37-2.23 (1H, m, 3-HB), 
1.73-1.48 (2H, m, NCH2CH2), 0.98-0.85 (3H, m, NCH2CH2CH3); δC (75 MHz, 
CDCl3) 174.0 (1-C rotA), 173.8 (1-C rotB), 133.6 (4-C rotA), 133.5 (4- C rotB), 118.5 
(5-C), 68.1 (2-C), 50.7 (NCH2rotA), 50.5 (NCH2rotB), 40.3 (NCH3rotA), 39.6 (NCH3 
rotB), 35.0 (3-C rotA), 33.9 (3-C rotB), 21.8 (NCH2CH2 rotA), 30.6 (NCH2CH2 rotB), 11.6 
(NCH2CH2CH3 rotA) and 11.4 (NCH2CH2CH3 rotB); m/z  (ES+) 172.1 (100%, MH+); 
HRMS Found MH+: 172.1336, C9H17NO2 requires MH+ 171.1332. 
 
 
2-Hydroxy-N-methoxy-N-methylpent-4-enamide 123f 
 
 
 
The amide 127f (156 mg, 0.772 mmol) was ozonolysed following General 
Procedure F in DCM (5 mL) quenching with DMS (5 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (5 mL), with 
TiCl4 (1M in DCM, 3.08 mL, 3.08 mmol) and allyltrimethylsilane (1.22 mL, 7.72 
mmol) for 16 h.  Column chromatography, eluting with 6:4 EtOAc–petrol, 
afforded the title compound 123f (82 mg, 34%) as a colourless oil; Rf:  0.33 (1:1 
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EtOAc–petrol);  νmax/cm−1 (film) 3435, 1941 and 1658; δH (500 MHz, CDCl3) 
5.91-5.80 (1H, m, 4-H), 5.14 (1H, d, J 7.69, 5-HA), 5.11 (1H, br s, 5-HB), 4.48 
(1H, br s, 2-H), 4.73 (3H, s, CH3), 3.33 (1H, d, J 8.12, OH), 3.25 (3H, s, CH3), 
2.56-2.48 (1H, m, 3-HA), 2.36 (1H, dt, J 14.5 and 6.4, 3-HB); δC (75 MHz, CDCl3) 
171.6 (1-C), 133.7 (4-C), 118.4 (5-C), 68.7 (2-C), 61.7 (CH3), 39.4 (CH3), 32.9 
(3-C); m/z (EI+) 160.1 (20%, M+), 118 (80%, [M-CH2CHCH2]+); HRMS Found 
M+, 160.0970, C7H14NO3 requires M+ 160.097. 
 
 
2-Hydroxy-N,N-diethylpent-4-enamide 123g 
 
 
 
The amide 127g (5.00 g, 22.1mmol) was ozonolysed following General 
Procedure F in DCM (100 mL) quenching with DMS (100 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (50 mL), with 
TiCl4 (19.5 mL, 177 mmol) and allyltrimethylsilane (35.1 mL, 221 mmol) for 
three days.  Column chromatography, eluting with a gradient elution of 1:1 to 
7:3 EtOAc–petrol, afforded the title compound 123g (1.66 g, 37%) as a 
colourless oil; Rf: 0.36 (1: 1 EtOAc–petrol); νmax/cm−1 (film) 3409, 2977, 1634, 
1435 and 1310; δH (300 MHz, CDCl3) 5.95-5.75 (1H, m, 4-H), 5.15 (1H, d, J 4.1, 
5-HA), 5.10 (1H, br s, 5-HB), 4.74 (1H, br s, 2-H), 3.81 (1H, br s, OH), 3.68-3.64 
(4H, m, (NCH2)A,B), 2.49-2.36 (1H, m, 3-HA), 2.29 (1H, dt, J 14.3 and 7.2, 3-HB), 
1.21 (3H, t, J 7.2, (NCH2CH3)A), 1.14 (3H, t, J 8.2, (NCH2CH3)B);δC (75 MHz, 
CDCl3) 173.2 (1-C), 133.6 (4-C), 118.4 (5-C), 68.0 (2-C), 41.4 and 40.4 
((NCH2)A,B), 40.6 (3-C), 14.6 and 13.3 ((NCH2CH3)A,B); m/z (ES+) 172.1 (50%, 
MH+), 194.1 (50%, MNa+); HRMS Found MH+: 172.1335, C9H17NO2 requires 
MH+ 172.1332. 
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2-Hydroxy-N,N-dimethylpent-4-enamide 123h 
 
 
 
The amide 127h (171 mg, 1.01 mmol) was ozonolysed following General 
Procedure F in DCM (5 mL) quenching with DMS (5 mL).  The resultant 
aldehyde was allylated following General Procedure G in DCM (5 mL), with 
TiCl4 (1M in DCM, 2.02 mL, 2.02 mmol) and allyltrimethylsilane (799 µL, 5.03 
mmol) for 18 h.  Column chromatography, eluting with 7:3 EtOAc–petrol, 
afforded the title compound 123h (86 mg, 30%) as a colourless oil; Rf: 0.17 (7:3 
EtOAc–petrol); νmax/cm−1 (film) 3412, 2937, 1642 and 1381; δH (300 MHz, 
CDCl3) 5.93-5.74 (1H, m, 4-H), 5.16-5.18 (1H, m, 5-HA), 5.06 (1H, br s, 5-HB), 
4.46-4.35 (1H, m, 2-H), 4.73 (1H, d, J 7.4, OH), 2.98 (6H, s, (CH3)A,B), 2.48-2.33 
(1H, m, 3-HA), 2.26 (1H, dt, J 14.8 and 7.4, 3-HB); δC (75 MHz, CDCl3) 174 (1-
C), 133.6 (4-C), 118.3 (5-C), 68.1 (2-C), 39.6 (3-C), 36.8 and 36.3 ((CH3)A,B); 
m/z (EI+) 43.1 (30%, M+), 102 (100%, [M-CH2CHCH2]+); HRMS Found M+: 
143.0939, C7H13NO2 requires M+ 143.0946. 
 
 
(4S*,6R*)-Ethyl 7-(dipropylamino)-4,6-dihydroxy-2-methylene-7-
oxoheptanoate and (4R*,6R*)-ethyl 7-(dipropylamino)-4,6-dihydroxy-2-
methylene-7-oxoheptanoate 122a 
 
 
 
The alkene 123a (2.1 g, 10.6 mmol) was ozonolysed following General 
Procedure F in DCM (25 mL) and was quenched with DMS (25 mL).  The crude 
aldehyde was alkylated following General Procedure H in 1:1 THF–water (160 
mL), with ethyl (bromomethyl) acrylate (1.91 mL, 13.3 mmol), THF (40 mL) and 
indium metal (1.40 g, 12.2 mmol), washed with EtOAc (4 × 125 mL) and 
saturated aqueous solution of sodium bicarbonate (3 × 100 mL).  Column 
chromatography, eluting with 8:2 to 1:1 EtOAc–petrol, afforded the title 
Angela Kinnell, University of Leeds 
 107 
compound 122a (811 mg, 24%, 70:30 anti:syn) as a colourless oil; Rf: 0.37 (7:3 
EtOAc–petrol); νmax/cm−1 (film) 3413, 2965, 1714, 1632 and 1466 ; δH (500 
MHz, CDCl3) 6.25 (1H, s, 2-C-CHA), 5.68 (1H, s, 2-C-CHB), 4.61 (0.70 H, td, J 
9.2 and 2.8, 6-Hanti), 4.52 (0.30 H, td, J 8.5 and 2.7, 6-Hsyn),4.21 (2H, q, J 7.0, 
OCH2), 4.12 (1H, br s, 4-H), 3.85 (1H, d, J 7.7, OH), 3.64-3.46 (1H, m, 
(NCHA)A), 3.39-3.00 (3H, m, (NCHB)A and (NCHA,B)B ), 2.77-2.37 (2H, m, 3-H), 
1.70-1.46 (6H, m, (NCH2CH2)A,B and 5-H), 1.30 (3H, t, J 7.0, OCH2CH3), 0.91 
(3H, t, J 6.8, N(CH2CH2CH3)A), 0.89 (3H, t, J 7.2, N(CH2CH2CH3)B); δC (75 MHz, 
CDCl3, anti isomer only) 174.7 and 168.2 (1-C and 7-C), 137.8 and 129.3 (2-C 
and 2-C-CH2), 67.1 and 65.8 (4-C and 6-C), 61.5 (OCH2), 48.8 and 48.0 
((NCH2)A,B), 42.9 and 40.8 (3-C and 5-C), 22.3 and 21.0 ((NCH2CH2)A,B), 14.5 
(OCH2CH3), 11.6 and 11.4 ((NCH2CH2CH3)A,B); m/z (ES+) 338.2 (100%, MNa+); 
HRMS Found MNa+: 338.1933, C16H29NO5 requires MNa+338.1938.  The ratio 
of the anti and syn diastereomers were determined by the integration of the 
signals at 4.61 ppm (anti), 4.52 ppm (syn). 
 
 
(4S*,6R*)-Ethyl 7-(dibutylamino)-4,6-dihydroxy-2-methylene-7-
oxoheptanoate and (4R*,6R*)-ethyl 7-(dibutylamino)-4,6-dihydroxy-2-
methylene-7-oxoheptanoate 122b 
 
 
 
The alkene 123b (6.26 g, 24.3 mmol) was ozonolysed following General 
Procedure F in DCM (150 mL) and was quenched with DMS (150 mL). The 
crude aldehyde was alkylated following General Procedure H in 1:1 water–THF 
(200 mL), with ethyl (bromomethyl) acrylate (4.74 mL, 33.1 mmol) and indium 
metal (3.49 g, 30.4 mmol), washed with EtOAc (4 × 250 mL) and saturated 
aqueous solution of sodium bicarbonate (3 × 100 mL).  Column 
chromatography, eluting with 8:2 to 4:6 petrol–EtOAc afforded the title 
compound 122b (275 mg, 12%, 80:20 anti:syn) as a colourless oil; Rf: 0.58 (3:7 
EtOAc–petrol); δH (500 MHz, CDCl3) 6.26 (1H, s, 2-C-CHA), 5.67 (1H, s, 2-C-
CHB), 4.60 (0.80 H, td, J 9.3 and 2.4, 6-Hanti), 4.54-4.49 (0.20 H, m, 6-Hsyn), 4.22 
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(2H, t, J 7.7, OCH2), 4.15-4.07 (1H, m, 4-H), 3.76 (1H, d, J 7.7, OH), 3.66-3.54 
(1H, m, (NCHA)A), 3.37-3.01 (3H, m, (NCHB)A, (NCHA)B and (NCHB)B), 2.96-2.89 
(1H, m, OH), 2.73-2.37 (2H, m, 3-H), 1.84-1.26 (12H, m, 5-H, (NCH2CH2,)A,B, 
(NCH2CH2CH2)A,B and OCH2CH3), 1.35-1.27 (6H, m, (NCH2CH2CH2CH3)A,B); δC 
(75 MHz, CDCl3, anti isomer only) 174.6 and 169.1(7-C and 1-C), 137.8 and 
128.2  (2-C-CH2 and 2-C), 67.9 (4-C), 65.8 (6-C), 61.5 (OCH2), 46.7 and 46.2 
((NCH2)A,B), 43.1 and 40.8 (5-C and 3-C), 31.2 and 30.0 ((NCH2CH2)A,B), 20.5 
and 20.3 ((NCH2CH2CH2) A,B), 14.6 (OCH2CH3), 14.3 and 14.2 
((NCH2CH2CH2CH3)A,B); m/z (ES+) 344.2 (70%, MH+), 366.2 (30%, MNa+); 
HRMS Found MH+: 344.2433, C18H33NO5 requires MH+ 344.2431.  The ratio of 
the anti and syn diastereomers were determined by the integration of the 
signals at 4.60 ppm (anti), 4.54-4.49ppm (syn). 
 
 
(4S*,6R*)-Ethyl 4,6-dihydroxy-2-methylene-7-oxo-7-(piperidin-1-
yl)heptanoate and (4R*,6R*)-ethyl 4,6-dihydroxy-2-methylene-7-oxo-7-
(piperidin-1-yl)heptanoate 122c 
 
 
 
The alkene 123c (857 mg, 4.68 mmol) was ozonolysed following General 
Procedure F in DCM (25 mL) and was quenched with DMS (15 mL).  The crude 
aldehyde was alkylated following General Procedure H in water (72 mL), with 
ethyl (bromomethyl) acrylate (0.775 mL, 5.61 mmol) and indium metal (592 mg, 
5.15 mmol), washed with EtOAc (4 × 100 mL) and saturated aqueous solution 
of sodium bicarbonate (3 × 75 mL).  Column chromatography, eluting with 8:2 to 
5:95 petrol–EtOAc, afforded the title compound 122c (565 mg, 33%, 68:32 
anti:syn) as a colourless oil; Rf: 0.19 (7:3 EtOAc–petrol); νmax/cm−1 (film) 3401, 
2938, 1712, 1631 and 1446; δH (400 MHz, CDCl3) 6.25 (1H, s, 2-C-CHA), 5.66 
(1H, s, 2-C-CHB), 4.67-4.61 (0.68 H, m, 6-Hanti), 4.67-4.61 (0.32 H, m, 6-Hsyn), 
4.25-4.18 (2H, m, OCH2), 4.15-4.08 (1H, m, 4-H), 3.89 (1H, d, J 7.8, 6-OH), 
3.71-3.59 (1H, m, (NCHA)A), 3.57-3.41 (1H, m, (NCHB)A), 3.42-3.36 (2H, m, 
(NCHA,B)B), 2.90 (1H, d, J 4.7, 4-OH), 2.62-2.41 (2H, m, 3-H), 1.72-1.49 (8H, m, 
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(NCH2CH2)A,B, NCH2 CH2CH2, and 5-H ), 1.30 (3H, t, J 7.2, CH3); δC (100 MHz, 
CDCl3, anti isomer only) 172.7 (C=O), 172.0 (C=O), 137.3 and 127.6 (2-C-CH2 
and 2-C), 67.3 (4-C), 65.2 (6-C), 60.9 (OCH2), 45.7 and 43.8 ((NCH2)A,B), 42.2 
and 40.2 (5-C and 3-C), 26.2 and 25.5 ((NCH2CH2) A,B), 25.4 (NCH2CH2CH2), 
14.2 (CH3); m/z (ES+) 322.2 (100%, MNa+); HRMS Found MNa+: 322.1625, 
C15H25NO5 requires MNa+ 322.1625.  The ratio of the anti and syn 
diastereomers  were determined by the integration of the signals at 4.67-4.61 
ppm (anti), 4.67-4.61 ppm (syn). 
 
 
(4S*,6R*)-Ethyl 4,6-dihydroxy-2-methylene-7-morpholino-7-oxoheptanoate 
and (4R*,6R*)-ethyl 4,6-dihydroxy-2-methylene-7-morpholino-7-
oxoheptanoate 122d 
 
 
 
The alkene 123d (4.50 g, 24.3 mmol, ) was ozonolysed following General 
Procedure F in DCM (100 mL) and was quenched with DMS (100 mL).  The 
crude aldehyde was alkylated following General Procedure H in 1:1 water–THF 
(200 mL), with ethyl (bromomethyl) acrylate (4.17 mL, 29.2 mmol) and indium 
metal (3.07 g, 26.7 mmol), washed with EtOAc (4 × 200 mL) and saturated 
aqueous solution of sodium bicarbonate (3 × 100 mL).  Column 
chromatography, eluting with 1:1 petrol–EtOAc to 6% MeOH in EtOAc, afforded 
the title compound 122d (3.75 g, 18%, 74:26 anti:syn) as a colourless oil; Rf: 
0.18 (3% MeOH in EtOAc); νmax/cm−1 (film) 3413, 2978, 1712, 1634 and 1442; 
δH (500 MHz, CDCl3, anti isomer only) 6.26 (1H, s, 2-C-CHA), 5.67 (1H, s, 2-C-
CHB), 4.64 (0.74 H, br s, 6-Hanti), 4.59 (0.24 H, br s, 6-Hsyn), 4.22 (2H, q, J 7.3, 
OCH2), 4.15-4.06 (1H, m, 4-H), 3.80-3.41 (8H, m, (NCH2)A,B and (NCH2CH2) 
A,B), 3.09 (1H, br s, OH), 2.55 (1H, dd, J 13.3 and 4.3, 3-HA), 2.44 (1H, dd, J 
14.1 and 8.1, 3-HB), 1.61-1.55 (2H, m, 5-H), 1.31 (3H, t, J 7.3, OCH2CH3); δC 
(100 MHz, CDCl3, anti isomer only) 173.3 and 167.8 (1-C and 7-C), 137.4 and 
127.8  (2-C-CH2 and 2-C), 69.8 (4-C), 66.7 and 66.4 ((NCH2)A,B), 67.8 (6-C), 
61.2 (OCH2CH3), 45.5 and 42.7 ((NCH2CH2)A,B), 42.8 (5-C), 40.9 (3-C), 14.2 
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(CH3); m/z (ES+) 324.1 (100%, MNa+); HRMS Found MNa+: 324.1402, 
C14H23NO6 requires MNa+ 324.1418.  The ratio of the anti and syn 
diastereomers  were determined by the integration of the signals at  4.64 ppm 
(anti), 4.59 ppm (syn). 
 
 
(4R*,6R*)-ethyl 6-(dipropylcarbamoyl)-2,4-dihydroxytetrahydro-2H-pyran-2-
carboxylate and (4S*,6R*)-ethyl 6-(dipropylcarbamoyl)-2,4-
dihydroxytetrahydro-2H-pyran-2-carboxylate 134a 
 
 
 
 
The alkene 122a (710 mg, 2.25 mmol, 70:30 anti:syn) was ozonolysed following 
General Procedure F in DCM (15 mL) and was quenched with DMS (15 mL). 
Column chromatography eluting with 9:1 to 7:3 DCM–acetone followed by 95:5 
EtOAc–MeOH, afforded the title compound 134a (418 mg, 59%, 95:5 cis:trans) 
as a colourless oil; Rf: 0.18 (8:2 DCM–acetone); νmax/cm−1 (film) 3368, 2966, 
1743, 1634 and 1466; δH (500 MHz, CDCl3) 4.72 (1H, dd, J 12.0 and 2.4, 6-H), 
4.60 (1H, d, J 9.4, 6-H), 4.37-4.10 (4H, m, 4-H, OCH2 and OH), 3.37-3.00 (4H, 
m, (NCH2)A,B), 2.19-2.09 (2H, m, 5-HA and 3-HA), 1.99-1.85 (1H, m, 3-HB and 5-
HB), 1.67-1.47 (4H, m, (NCH2CH2)A,B), 1.32 (3H, t, J 7.3, OCH2CH3), 0.94-0.83 
(6H, m, (NCH2CH2CH3)A,B); δC (75 MHz, CDCl3, major isomer only) 170.4 and 
168.8 (amide and 1-C), 96.2 (2-C), 68.5 and 64.5 (6-C and 4-C), 63.4 (OCH2), 
49.6 and 48.1 (NCH2)A,B), 39.9 and 37.0 (5-C and 3-C), 22.7 and 21.0 
(NCH2CH2)A,B), 14.3 (OCH2CH3), 11.7 and 11.6 (NCH2CH2CH3)A,B); m/z (ES+) 
318.2 (60%, MH+), 340.2 (40%, MNa+); HRMS Found MH+: 318.1904, 
C15H28NO6 requires MH+ 318.1911. 
 
Full interpretation of the anomeric species of the cis and trans diastereomers 
was not achieved by analysis by 500 MHz 1H NMR of the esters 134a-d but 
was achieved for the corresponding ammonium salts 135a-d. 
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(4R*,6R*)-ethyl 6-(dibutylcarbamoyl)-2,4-dihydroxytetrahydro-2H-pyran-2-
carboxylate and (4S*,6R*)-ethyl 6-(dibutylcarbamoyl)-2,4-
dihydroxytetrahydro-2H-pyran-2-carboxylate 134b 
 
 
 
The alkene 122b (1.00 g, 2.91 mmol, 80:20 anti:syn) was ozonolysed following 
General Procedure F in DCM (20 mL) and was quenched with DMS (25 mL). 
The crude product was purified with column chromatography, eluting with 1:1 
ether–DCM, to give the title compound 134b (620 mg, 62%, 95:5 cis:trans) as a 
colourless film; Rf: 0.14 (1:1 ether–DCM); νmax/cm−1 (film) 3368, 2959, 1744, 
1633, 1467, 1370 and 1274; δH (400 MHz, CDCl3) 4.72 (1H, d, J 11.2, 6-H), 
4.37-4.13 (4H, m, 6-H, 4-H and OCH2), 3.40-2.97 (4H, m, (NCH2)A,B), 2.17-1.78 
(4H, m, 5-H and 3-H), 1.63-1.43 (4H, m, (NCH2CH2)A,B), 1.38-1.23 (7H, m, 
(NCH2CH2CH2)A,B and OCH2CH3), 0.93 (3H, t, J 7.0, (NCH2CH2CH2CH3)A), 0.90 
(3H, t, J 7.4, (NCH2CH2CH2CH3)B); δC (75 MHz, CDCl3, major isomer only); 
170.4 and 169.5 (amide and 1-C), 96.3 (2-C), 68.5 (6-C), 62.6 (4-C), 62.4 
(OCH2), 46.3 and 45.9 ((NCH2)A,B), 39.9 and 36.4 (5-C and 3-C), 31.3  and 31.0 
((NCH2CH2)A,B), 20.6 and 20.3 ((NCH2CH2CH2)A,B), 14.5 and 14.1 
((NCH2CH2CH2CH3 )A,B and OCH2CH3); m/z (ES+) 346.2 (70%, MH+), 368.2 
(30%, MNa+); HRMS Found MH+: 346.2233, C17H31NO6 requires MH+ 346.2224. 
 
Full interpretation of the anomeric species of the cis and trans diastereomers 
was not achieved by analysis by 500 MHz 1H NMR of the esters 134a-d but 
was achieved for the corresponding ammonium salts 135a-d. 
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(4R*,6R*)-ethyl 2,4-dihydroxy-6-(piperidine-1-carbonyl)tetrahydro-2H-
pyran-2-carboxylate and (4S*,6R*)-ethyl 2,4-dihydroxy-6-(piperidine-1-
carbonyl)tetrahydro-2H-pyran-2-carboxylate 134c 
 
 
 
The alkene 122c (410 mg, 1.37 mmol, 68:32 anti:syn) was ozonolysed following 
General Procedure F in DCM (10mL) and was quenched with DMS (10 mL). 
The crude product was purified with column chromatography, eluting with 9:1 
EtOAc–toluene, to give the title compound 134c (112 mg, 27%, 88:12 cis:trans) 
as a colourless film; Rf: 0.18 (9:1 EtOAc–toluene); νmax/cm−1 (film) 3368, 2936, 
1742, 1630 and 1447; δH (500 MHz, CDCl3) 5.07 (1H, dd, J 12.9 and 2.5, 6-H), 
4.71 (1H, dd, J 11.8 and 2.3, 6-H), 4.73-4.13 (3H, m, 4-H and OCH2), 3.83-3.27 
(4H, m, (NCH2)A,B), 2.20-2.01 (1H, m, 5-HA), 1.87 (1H, m, 3-HA), 1.70-1.48 (8H, 
m, 5-HB, 3-HB, (NCH2CH2)A,B and NCH2CH2CH2), 1.31 (3H, t, J 7.6, CH3); δC (75 
MHz, CDCl3, major isomer only) 170.3 and 167.7 (1-C and amide), 96.4 (2-C), 
69.3 ,64.2 and 62.5 (6-C, 4-C and OCH2), 46.1 and 44.1 ((NCH2)A,B), 39.0 and 
36.7 (5-C and 3-C), 26.8 and 25.9 ((NCH2CH2)A,B), 24.7 (NCH2CH2CH2), 14.3 
(CH3); m/z (ES+) 302.2 (60%, MH+), 324.1 (50%, MNa+); HRMS Found MNa+: 
324.1413, C14H23NO6 requires MNa+ 324.1418. 
 
Full interpretation of the anomeric species of the cis and trans diastereomers 
was not achieved by analysis by 500 MHz 1H NMR of the esters 134a-d but 
was achieved for the corresponding ammonium salts 135a-d. 
 
(4R*,6R*)-ethyl 2,4-dihydroxy-6-(morpholine-4-carbonyl)tetrahydro-2H-
pyran-2-carboxylate and (4S*,6R*)-ethyl 2,4-dihydroxy-6-(morpholine-4-
carbonyl)tetrahydro-2H-pyran-2-carboxylate 134d 
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The alkene 122d (1.20 g, 3.99 mmol, 74:26 cis:trans) was ozonolysed following 
General Procedure F in DCM (20 mL) and was quenched with DMS (25 mL). 
The crude product was purified with column chromatography, eluting with 2% 
MeOH in EtOAc, to give the title compound 134d (598 mg, 49%, 78:22 
cis:trans) as a colourless film; Rf: 0.17 (2% MeOH in EtOAc); νmax/cm−1 (film) 
3400, 2978, 1740, 1643, 1471 and 1274; δH (500 MHz, CDCl3)  5.05 (1H, d, J 
11.5, 6-H), 4.71 (1H, d, J 12.0, 6-H), 4.35-4.08 (3H, m, 4-H and OCH2CH3), 
3.81-3.24 (8H, m, (NCH2)A,B and (NCH2CH2)A,B), 2.12-1.60 (4H, m, 5-H and 3-
H), 1.31 (3H, t, J 7.3, CH3); δC (75 MHz, CDCl3, major isomer only) 170.5 and 
169.1 (amide and 1-C), 96.5 (2-C), 67.1 and 62.9 (6-C and 4-C), 67.2 and 67.0 
((NCH2CH2)A,B), 60.8 (OCH2CH3), 43.1, 39.0, 34.0 and 34.3 (5-C, 3-C and 
(NCH2)A,B), 14.5 (CH3); m/z (ES+) 326.1 (70%, MNa+), 304.1 (30%, MH+); 
HRMS Found MNa+: 326.1214, C13H21NO7 requires MNa+326.1210. 
 
Full interpretation of the anomeric species of the cis and trans diastereomers 
was not achieved by analysis by 500 MHz 1H NMR of the esters 134a-d but 
was achieved for the corresponding ammonium salts 135a-d. 
 
 
Ammonium (4R*,6R*)-6-(dipropylcarbamoyl)-2,4-dihydroxytetrahydro-2H-
pyran-2-carboxylate and ammonium and (4S*,6R*)-6-(dipropylcarbamoyl)-
2,4-dihydroxytetrahydro-2H-pyran-2-carboxylate 135a 
 
 
 
The ammonium salt 135a was prepared following General Procedure I from 
ester 134a (258 mg, 0.813 mmol, 95:5 cis:trans) in MeOH (4 mL) with barium 
hydroxide monohydrate (77.0 mg, 0.406 mmol) in water (20 mL).  The reaction 
was stirred for 16.5 h at room temperature then further barium hydroxide 
monohydrate (35.0 mg, 0.203 mmol) and stirred for further 8 h and reaction 
mixture concentrated and was dissolved in water (5 mL), ammonium sulphate 
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(122 mg, 0.591 mmol) added giving the ammonium salt 135a (218 mg, 100%, 
95:5 cis:trans) as an amorphous solid;  νmax/cm−1 (solid) 3233, 2964, 1764, 1625 
and 1458; δH (500 MHz, D2O) 5.18 (0.04H, d, J 11.5, 6-Htrans(maj)), 5.18 (0.02H, 
d, J 11.2, 6-Htrans(min)), 4.81 (0.84H, d, J 11.5, 6-Hcis(maj)), 4.65-4.57 (0.13H, m, 6-
Hcis(min) and 4-Htrans(min)), 4.33-4.22 (0.04H, m, 4-Htrans(maj)), 4.15-4.05 (0.84H, m, 
4-Hcis(maj)), 4.03-3.94 (0.11H, m, 4-Hcis(min)), 3.45-2.95 (4H, m, (NCH2)A,B), 2.11-
2.00 (2H, m, 5-Heq and 3-Heq), 1.64 (1H, t, J 12.0, 3-Hax), 1.59-1.40 (5H, m, 5-
Hax and (NCH2CH2)A,B), 0.81 (3H, t, J 7.3, (CH3)A), 0.77 (3H, t, J 7.7, (CH3)B); δC 
(75 MHz, D2O,cis(maj) only) 175.5 and 172.2 (amide and 1-C), 97.9 (2-C), 69.3 
and 63.7 (6-C and 4-C), 49.7 and 48.4 ((NCH2)A,B), 41.9 and 38.2 (5-C and 3-
C), 22.0 and 20.5 ((NCH2CH2)A,B), 11.0 and 10.7 ((CH3)A,B)); m/z (ES─) 288.1 
(100%, [M–NH4]─); HRMS Found [M–NH4] ─: 288.1456, C13H26N2O6 requires 
[M–NH4] ─ 288.1453.  Correlation with the acid 4a allowed the identification the 
cis and trans isomers and the maj and min anomers of each of the isomers.  
The ratio of the species were determined by the integration of the signals at   
5.18 ppm (trans(maj)), 5.18  ppm (trans(min)), 4.14-4.04 ppm (cis(maj)), 4.03-
3.94 ppm (cis(min)).  Analysis by 500 MHz 1H NMR revealed that a 95:5 mixture 
of cis  and trans diastereomers was present and  that the cis isomer exists as a 
88:12 mixture of anomers; the trans isomer exists as a 70:30 mixture of 
anomers. 
 
 
Ammonium (4R*,6R*)-6-(dibutylcarbamoyl)-2,4-dihydroxytetrahydro-2H-
pyran-2-carboxylate and ammonium and (4S*,6R*)-6-(dibutylcarbamoyl)-
2,4-dihydroxytetrahydro-2H-pyran-2-carboxylate 135b 
 
 
 
The ester 134b (211 mg, 0.612 mmol, 95:5 cis trans ) was hydrolysed following 
General Procedure I in MeOH (2 mL) with barium hydroxide monohydrate (74.1 
mg, 0.391 mmol) in water (5 mL).  The reaction was concentrated and dissolved 
in water (3 mL) and ammonium sulphate (59.5 mg, 0.391 mmol) added and 
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gave the title compound 135b (234 mg, 100%, 95:5 cis trans) as an amorphous 
solid; νmax/cm−1 (solid) 3326, 2958, 1632, 1455 and 1005; δH (500 MHz, D2O) 
5.16 (0.04H, d, J 10.3, 6-Htrans(maj)), 4.92 (0.02H, d, J 10.7, 6-Htrans(min)), 4.78 
(0.86H, d, J 11.5, 6-Hcis(maj)), 4.65-4.56 (0.11H, m, 6-Hcis(min) and 4-Htrans(min)), 
4.32-4.26 (0.04H, m, 4-Htrans (maj)), 4.16-4.05 (0.86H, m, 4-Hcis(maj), 4.02-3.94 
(0.09H, m, 4-Hcis(min)), 3.51-3.00 (4H, m, (NCH2)A,B), 2.09-1.59 (4H, m, 5-H and 
3-H), 1.57-1.37 (4H, m, (NCH2CH2)A,B), 1.29-1.14 (4H, m, (NCH2CH2CH2)A,B), 
0.87-0.78 (6H, m, (CH3)A,B); δC (75 MHz, D2O, cis(maj) only) 176.5 and 171.4 
(amide and 1-C), 97.8 (2-C), 67.7and 63.8 (6-C and 4-C), 48.1 and 46.4 
((NCH2)A,B), 40.1 and 36.2 (5-C and 3-C), 31.0 and 29.4 ((NCH2CH2)A,B), 20.0 
and 19.8 ((NCH2CH2CH2)A,B), 13.6 and 13.6 ((CH3)A,B); m/z (ES─) 316.2 (100%, 
[M–NH4]─); HRMS Found [M–NH4] ─: 316.1757, C15H30N2O6 requires [M–NH4] ─ 
316.1766.  Correlation with the acid 4a allowed the identification the cis and 
trans isomers and the maj and min anomers of each of the isomers.  The ratio 
of the species were determined by the integration of the signals at 5.16 ppm 
(trans(maj)), 4.92 ppm (trans(min)), 4.16-4.05 ppm (cis(maj)), 4.02-3.94 ppm 
(cis(min)).  Analysis by 500 MHz 1H NMR revealed that a 95:5 mixture of cis  
and trans diastereomers was present and  the cis isomer exists as a 91:9 
mixture of anomers; the trans isomer exists as a 67:33 mixture of anomers. 
 
 
 
Ammonium (4R*,6R*)-2,4-dihydroxy-6-(piperidine-1-carbonyl)tetrahydro-
2H-pyran-2-carboxylate and ammonium (4S*,6R*)-2,4-dihydroxy-6-
(piperidine-1-carbonyl)tetrahydro-2H-pyran-2-carboxylate and 135c 
 
 
 
The ester 134c (108 mg, 0.358 mmol, 88:12 cis trans) was hydrolysed following 
General Procedure I in MeOH (2 mL) with barium hydroxide monohydrate (35.0 
mg, 0.185 mmol) in water (5 mL).  The reaction was concentrated and dissolved 
in water (3 mL) and ammonium sulphate (24.5 mg, 0. 185 mmol) added and 
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gave the title compound 135c (104 mg, 100%, 88:12 cis :trans) as a yellow film; 
νmax/cm−1 (film) 3226, 2506, 1759, 1600 and 1447, δH (500 MHz, D2O) 5.31-5.20 
(0.12H, m, 6-Htrans(maj) and 6-Htrans(min)), 4.87 (0.77H, d, J 12.0, 6-Hcis(maj)), 4.70-
4.61 (0.14H, m, 6-Hcis(min) and 4-Htrans(min)), 4.33-4.25 (0.09H, m, 4-Htrans (maj)), 
4.18-4.06 (0.77H, m, 4-Hcis(maj)), 4.02-3.93 (0.11H, m, 4-Hcis(min)), 3.54-3.30 (4H, 
m, (NCH2)A,B), 2.15-1.98 and 1.68-1.36 (10H, m, 5-H, 3-H, (NCH2CH2)A,B and 
NCH2CH2CH2); δC (75 MHz, D2O, cis(maj) only) 180.6 and 174.5 ( amide and 1-
C), 101.9 (2-C), 71.9 and 68.0 (6-C and 4-C), 51.2 and 48.3 ((NCH2)A,B), 44.0 
and 39.8 (5-C and 3-C), 30.2, 29.6 and 28.1 ((NCH2CH2) A,B and NCH2CH2CH2); 
m/z (ES─) 272.1 (100%,[M–NH4]─); HRMS Found [M–NH4] ─: 272.1129, 
C12H22N2O6 requires [M–NH4] ─  272.1140.  Correlation with the acid 4a allowed 
the identification the cis and trans isomers and the maj and min anomers of 
each of the isomers.  The ratio of the species were determined by the 
integration of the signals at 5.31-5.20 (trans(maj) and trans(min)), 4.61 
(trans(min) and (cis(min)) and  4.18-4.06  ppm (cis(maj)), 4.02-3.93  ppm 
(cis(min)).  Analysis by 500 MHz 1H NMR revealed that a 88:12 mixture of cis  
and trans diastereomers was present and the cis isomer exists as a 88:12 
mixture of anomers; the trans isomer exists as a 78:22 mixture of anomers. 
 
 
Ammonium (4R*,6R*)-2,4-dihydroxy-6-(morpholine-4-carbonyl)tetrahydro-
2H-pyran-2-carboxylate and ammonium (4S*,6R*)-2,4-dihydroxy-6-
(morpholine-4-carbonyl)tetrahydro-2H-pyran-2-carboxylate 135d  
 
 
 
The ester 134d (299 mg, 0.970 mmol, 78:22 cis:trans) was hydrolysed following 
General Procedure I in MeOH (2 mL) with barium hydroxide monohydrate (91.0 
mg, 0.485 mmol) in water (10 mL).  The reaction was concentrated and re-
dissolved in water (3 mL) and ammonium sulphate (73.8 mg, 0.485 mmol) 
added and gave the title compound 135d (264 mg, 93%, 78:22 cis:trans) as a 
colourless solid; νmax/cm−1 (solid) 3392, 2524, 2159, 1627 and 1444; δH (500 
Angela Kinnell, University of Leeds 
 117 
MHz, D2O) 5.22 (0.14H, d, J 9.8, 6-Htrans(maj)), 5.04 (0.08H, d, J 11.5, 6-
Htrans(min)), 4.85 (0.67H, d, J 11.5, 6-Hcis(maj)), 4.65-4.57 (0.19H, m, 6-Hcis(min) and 
4-Htrans(min)), 4.27-4.19 (0.14H, m, 4-Htrans (maj)), 4.13-4.03 (0.67H, m, 4-Hcis(maj), 
4.01-3.94 (0.11H, m, 4-Hcis(min)), 3.67-3.14 (8H, m, (NCH2)A,B and 
(NCH2CH2)A,B), 2.11-1.37 (4H, m, 5-H and 3-H); δC (75 MHz, D2O, cis(maj) only) 
176.7 and 171.5 (amide and 1-C), 98.2 (2-C), 68.2 and 63.5 (6-C and 4-C), 
66.7, 66.5, 46.1, 42.7, 40.3 and 36.0 (5-C, 3-C, (NCH2)A,B and (NCH2CH2)A,B); 
m/z (ES─) 274.1 (100%,[M–NH4]─); HRMS Found [M–NH4] ─: 274.0931, 
C11H20N2O7 requires [M–NH4] ─ 274.0961.  Correlation with the acid 4a allowed 
the identification the cis and trans isomers and the maj and min anomers of 
each of the isomers.  The ratio of the species were determined by the 
integration of the signals at 5.22 ppm (trans(maj)), 5.04 ppm (trans(min)), 4.13-
4.03 ppm (cis(maj)), 4.01-3.94 ppm (cis(min)).  Analysis by 500 MHz 1H NMR 
revealed that a 78:22 mixture of cis  and trans diastereomers was present and  
that the cis isomer exists as a 86:14 mixture of anomers; the trans isomer exists 
as a 65:35 mixture of anomers. 
 
 
2,4,5-Trihydroxy-N,N-dipropylpentanamide 142  
 
 
 
Following General Procedure E a spatula tip of K2OsO2(OH)4, citric acid (2.01 
mmol, 386 mg), the amide 123a (200 mg, 1.00 mmol) and NMO (150 mg, 1.10 
mmol) in tBuOH (2 ml) and water (2.4 ml) were stirred at room temperature for 
21 h extracted with EtOAc (3 × 25 mL).  Column chromatography, eluting with 
3:97 MeOH–EtOAc afforded the title compound 142 (180 mg, 77%, 3:2 mixture 
of diastereomers) as a colourless oil; Rf: 0.33 (5% MeOH–EtOAc); νmax/cm−1 
(film) 3391, 2965, 2877, 1632, 1463 and 1098; δH (400 MHz, CDCl3) 4.62 (1H, 
dd, J 9.7 and 2.1, 2-Hmaj) and 4.60 (1H, dd , J 9.3 and 2.6, 2-Hmin), 4.09-4.02 
(1H, m, 4-H), 3.71-3.48 (3H, m, 5-H and (NCHA)A), 3.33-3.20 (1H, m, NCHB)A), 
3.13-3.02 (2H, m, (NCHA,B)B), 1.86-1.50 (6H, m, (NCH2 CH2)A,B and 3-H), 0.96-
0.87 (6H, m, (NCH2CH2 CH3)A,B); δC (100 MHz, CDCl3) 174.5 and 174.0 (1-C), 
70.5 and 69.4 (2-C), 67.2 and 66.6 (5-C), 67.1 and 65.8 (4-C), 48.8 and 48.7 
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and 47.8 and 47.8 ((NCH2)A,B), 38.8 and 38.6 (3-C), 22.4 and 22.3 and 21.1 and 
21.0 ((NCH2CH2)A,B), 11.7 and 11.5 ((NCH2CH2CH3)A,B); m/z  (ES+) 256.2 (80%, 
MNa+), 234.2 (20%, MH+); HRMS Found MNa+: 256.1512, C11H23NONa 
requires MNa+ 256.1519. 
 
2-(Benzyloxy)-N,N-dipropylpent-4-enamide 143 
 
 
 
The alkene 123a (0.502 mmol, 100 mg) in THF (12.0 mL) was added via a 
cannula to a suspension of NaH (60% in mineral oil, 36.1 mg, 1.51 mmol) in 
DMF (12 ml) at 0 °C.  The mixture was stirred at this temperature for 10 minutes 
then cooled to –10 °C and benzyl bromide (60 µL, 0.502 mmol) added, the 
reaction was stirred at this temperature for 30 minutes then allowed to warm to 
room temperature.  The reaction was stirred overnight for 17 hthen cooled to 0 
°C and saturated aqueous sodium bicarbonate solution added and the reaction 
mixture was washed with DCM (3 × 75 mL).  The combined the organic layers 
were washed with water (3 × 50 mL), dried (MgSO4) and concentrated to give 
the crude product.  Column chromatography, eluting with 3:1 EtOAc–isohexane, 
afforded the title compound 143 (112 mg, 79%) as a colourless oil; Rf: 0.37 (1:1 
EtOAc–heptane); νmax/cm−1 (film) 1650, 1454 and 1098; δH (400 MHz, CDCl3) 
7.34-7.27 (5H, m, Ar-H), 5.92-5.82 (1H, m, 4-H), 5.16-5.12 (1H, m, 5-HA), 5.10-
5.08 (1H, m, 5-HB), 5.64 (1H, d, J 11.8, CHAPh), 4.39 (1H, d, J 11.8, CHBPh), 
4.24 (1H, dd, J 7.9 and 5.5, 2-H), 3.39-3.34 (1H, m, (NCHA)A), 3.27-3.18 (3H, m, 
(NCHB)A and (NCHA,B)B), 2.64-2.57 (1H, m, 3-HA), 2.52-2.45 (1H, m, 3-HB), 1.67-
1.46 (4H, m, (NCH2 CH2)A,B), 0.90 (3H, t, J 7.4, (CH3)A), 0.82 (3H, t, J 7.4, 
(CH3)B); δC (100 MHz, CDCl3) 170.4 (1-C), 137.8, 128.4, 127.8 and 127.7 (Ar-
C), 133.9 (4-C); 117.6 (5-C), 76.4 (2-C), 70.5 (CH2Ph), 48.6 and 47.7 
((NCH2)A,B), 36.9 (3-C), 22.4 and 20.8 ((NCH2CH2)A,B), 11.4 and 11.1 ((CH3)A,B); 
m/z (ES+) 290.2 (80%, MH+), 312.2 (20%, MNa+); HRMS Found MH+: 290.2116, 
C18H28NO2 requires MH+ 290.2115.  
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(4R*,6R*)-6-(Dipropylcarbamoyl)-2,4-dihydroxytetrahydro-2H-pyran-2-
carboxylic acid and (4S*,6R*)-6-(dipropylcarbamoyl)-2,4-
dihydroxytetrahydro-2H-pyran-2-carboxylic acid 4a 
 
 
 
 
The title compound 4a can be prepared from the alkene 123a (60.0 mg, 0.301 
mmol) following General Procedure K in MeOH (5 mL) quenching with DMS (5 
mL).  Sodium pyruvate (331 mg, 3.01 mmol) was added to residue in potassium 
phosphate buffer (1 mL, 20 mM, pH 7.4) followed by E192N (6.98 mg/mL in 20 
mM, pH 7.4 potassium phosphate buffer (1 mL)  incubating at 35 ºC for 16 h.  
The product was purified using preparative HPLC eluting with 15-30% (1% TFA 
in H2O–1% TFA in MeCN) over 23 minutes.  The reaction gave the title 
compound 4a (63.4 mg, 73%, 70:30 cis:trans) as a colourless film;  
 
The title compound 4a can also be prepared using the one-pot reaction 
 
10 mol% diamine, 10 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 1  
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a(10.8 mg, 39%; ca. 80:20 cis:trans) as a 
colourless film; 
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10 mol% diamine, 10 eq. acetaldehyde, dilution factor 3.23, Table 12, entry 2  
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (877 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (9.9 mg, 36%; ca 80:20 cis:trans) as a 
colourless film; 
 
10 mol% diamine, 10 eq. acetaldehyde, dilution factor 5.7, Table 12, entry 3  
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (1626 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (4.7 mg, 17%; ca 80:20 cis:trans) as a 
colourless film; 
 
10 mol% diamine, 10 eq. acetaldehyde, dilution factor 11.1, Table 12, entry 4  
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (3300 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
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reaction gave the title compound 4a (9.7 mg, 35%; ca 80:20 cis:trans) as a 
colourless film; 
 
5 mol% diamine, 10 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 5 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (1.81mg, 4.76 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (11.1 mg, 40%; ca 80:20 cis:trans) as a 
colourless film 
 
20 mol% diamine, 10 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 6 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (7.24mg, 19.0 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (8.6 mg, 31%; ca 80:20 cis:trans) as a 
colourless film; 
 
50 mol% diamine, 10 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 7 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (18.1mg, 47.5 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
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eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (8.3 mg, 30%; ca 80:20 cis:trans) as a 
colourless film; 
 
10 mol% diamine, 5 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 8 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (27µL, 0.478 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (10.3 mg, 37%; ca 80:20 cis:trans) as a 
colourless film; 
 
10 mol% diamine,20 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 9 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (108µL, 1.91 mmol), diamine 69 (3.62 mg, 9.55 µmol), diluted 
with sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (5.3 mg, 19%; ca 80:20 cis:trans) as a 
colourless film; 
 
10 mol% diamine, 50 eq. acetaldehyde, dilution factor 1.7, Table 12, entry 10 
 
Glyoxylaldehyde 1a (15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (270µL, 4.78 mmol), diamine 69 (3.62mg, 9.55 µmol), diluted with 
sodium pyruvate (105 mg, 1.91 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
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potassium phosphate).  The product was purified using preparative HPLC 
eluting with 15-30% (1% TFA in H2O–1% TFA in MeCN) over 23 minutes.  The 
reaction gave the title compound 4a (9.2 mg, 33%; ca 80:20 cis:trans) as a 
colourless film; 
 
νmax/cm−1 (film) 3233, 2964, 1764, 1625 and 1458; δH (500 MHz, D2O) 5.18 ( 
0.15H, dd, J 9.5 and 3.3, 6-Htrans(maj)), 5.10 (0.05H, dd, J 6.7 and 4.9, 6-
Htrans(min)), 4.83 (0.74H, d, J 10.5, 6-Hcis(maj)), 4.69-4.63 (0.11H, m, 6-Hcis(min) and 
4-Htrans(min)), 4.30 (0.15H, br s, 4-Htrans (maj)), 4.17-4.08 (0.74H, m, 4-Hcis(maj)), 
4.01-3.93 (0.06H, m, 4-Hcis(min)), 3.64-2.85 (4H, m, NCH2), 2.16-1.58 (4H, m, H-
5 and H-3), 1.58-1.35 (4H, m, NCH2CH2), 0.78 (3H, t, J 6.4, CH3), 0.76 (3H, t, J 
7.3, CH3);δC (125 MHz, D2O, cis(maj) only); 173 and 171 (amide and 1-C), 67.2 
(6-C), 62.8 (4-C), 49.4 and 48.1 (NCH2), 39.1 and 35.5 (5-C and 3-C), 21.6 and 
20.0 (NCH2CH2), 10.4 and 10.2 (CH3); m/z (ES─) 288.1 (100%, [M–H]─); HRMS 
Found [M–H]─: 288.1456, C13H23NO6 requires [M–H]─ 288.1453.  TOCSY and 
NOESY analysis allowed the identification of the major (maj) and minor (min) 
anomers of the cis and trans diastereoisomers.  The ratio of the species was 
determined by the integration of the signals at 5.18 ppm (trans(maj)), 5.10ppm 
(trans(min)), 4.17-4.08 ppm (cis(maj)) and 4.01-3.93 ppm (cis(min)).  Analysis 
by 500 MHz 1H NMR revealed that a 70:30 mixture of cis  and trans 
diastereomers was present and that the cis isomer existed as a 92:8 mixture of 
anomers and the trans isomer existed as a 75:25 mixture of anomers. 
 
(4R*,6R*)-2,4-dihydroxy-6-(piperidine-1-carbonyl)tetrahydro-2H-pyran-2-
carboxylic acid and (4S*,6R*)-2,4-dihydroxy-6-(piperidine-1-
carbonyl)tetrahydro-2H-pyran-2-carboxylic acid 4c 
 
 
 
The title compound 4c can be prepared following General Procedure K with 
alkene 123c (11.6 mg, 0.0633 mmol) in MeOH(1 mL) quenching with DMS (1 
mL).  Sodium pyruvate (70 mg, 0.633 mmol) was added to residue in potassium 
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phosphate buffer (0.250 mL, 20 mM, pH 7.4) followed by E192N (6.98 mg/mL in 
potassium phosphate buffer (0.250 mL, 20 mM, pH 7.4)) incubating for 66 h.  
The product was purified using preparative HPLC eluting with 0-30% (1% TFA 
in H2O–1% TFA in MeCN) over 30 minutes..  The reaction gave the title 
compound 4c (9.1 mg, 53%, 74:26 cis:trans) as a colourless film. 
 
The title compound 4c can also be prepared using the one-pot reaction 
Glyoxylaldehyde 1c (12.3 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol) diamine 69 (1.81mg, 4.76 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 0-30% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
reaction gave the title compound 4c (11.9 mg, 48%, 66:34 cis:trans) as a 
colourless film. 
 
The data presented is for the product prepared using general procedure K and 
subsequent E192N-catalysed aldol reaction.  
νmax/cm−1 (film)3247, 2941, 1755, 1675, 1632, 1447 and 1202; δH (500 MHz, 
D2O) 5.13 (0.16H, dd, J 9.2 and 3.4, 6-Htrans(maj)), 5.07 (0.07H, dd, J 6.4 and 4.2, 
6-Htrans(min)), 4.84 (0.63H, dd, J 11.7 and 1.6, 6-H cis(maj)), 4.56-4.51 (0.18H, m, 6-
Hcis(min) and 4-Htrans(min)), 4.48-4.38 (0.16H, m, 4-Htrans (maj),4.14-4.04 (0.63H, m, 
4-Hcis(maj)), 3.94-3.84 (0.11H, m, 4-Hcis(min)), 3.50-3.23 and (3H, m, NCH), 3.01 
(1H, t, J 6.0, NCH), 2.25-1.66 (2H, m, H-5 and H-3), 1.65-1.33 (6H, m, 
NCH2CH2 and NCH2CH2CH2); δC (125 MHz, D2O, cis(maj) only) 175.8 and 
172.1 (amide and 1-C), 70.1 and 65.8 (6-C and 4-C), 49.9, 49.5, 47.4, 46.8, 
40.7 and 38.2 (5-C, 3-C and NCH2), 28.8, 28.0 and 26.5 (NCH2CH2 and 
NCH2CH2CH2);  m/z  (ES─) 272.1 (100%, [M–H]─); HRMS Found [M–H]─: 
272.1142, C12H19NO6 requires [M–H]─ 272.1140.  Correlation of the 1H NMR 
spectrum with that of the acid 4a allowed the identification of the anomers of the 
cis and trans diastereoisomers.  The ratio of the species was determined by the 
integration of the signals at 5.13 ppm (trans(maj)), 5.07 ppm (trans(min)), 4.14-
4.04 ppm (cis(maj)), 3.94-3.84 ppm (cis(min)).  Analysis by 500 MHz 1H NMR 
revealed that a 74:26 mixture of cis  and trans diastereomers was present and 
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that the cis isomer existed as an 85:15 mixture of anomers and the trans isomer 
existed as a 63:27 mixture of anomers. 
 
 (4R*,6R*)-2,4-dihydroxy-6-(methyl(propyl)carbamoyl)tetrahydro-2H-pyran-
2-carboxylic acid and (4S*,6R*)-2,4-dihydroxy-6-
(methyl(propyl)carbamoyl)tetrahydro-2H-pyran-2-carboxylic acid 4e 
 
 
 
 
The title compound 4e can be prepared following general procedure K with 
alkene 123e (30mg, 0.175 mmol) in MeOH (1 mL) quenching with DMS (2 mL).  
Sodium pyruvate (193 mg, 1.75 mmol) was added to residue in potassium 
phosphate buffer (0.580 mL, 20 mM, pH 7.4) followed by E192N (6.98 mg/mL in 
potassium phosphate buffer (0.580 mL, 20 mM, pH 7.4)) incubating for 66 h.  
The product was purified using preparative HPLC eluting with 0-30% (1% TFA 
in H2O–1% TFA in MeCN) over 30 minutes. The reaction gave the title 
compound 4e (4.75 mg, 19%, 76:24 cis:trans) as a colourless film.  
 
The title compound 4e can also be prepared using the one-pot reaction 
Glyoxylaldehyde 1e (12.3 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol), diamine 69 (1.81mg, 4.76 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 0-30% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
reaction gave the title compound 4e (11.9 mg, 48%, 57:43 cis:trans) as a 
colourless film. 
The data presented is for the product prepared using general procedure K and 
subsequent E192N-catalysed aldol reaction  
Angela Kinnell, University of Leeds 
 126 
νmax/cm−1 (film) 3368, 2968, 1744, 1635, 1632, 1439, 1201 and 1142;δH (500 
MHz, D2O) 5.23-5.02 (0.26H, m, 6-Htrans(maj) and 6-Htrans(min)), 4.85 (0.65H, br d, 
J 12.0, 6-Hcis(maj)),  4.62-4.53  (0.20H, m, 6-Hcis(min) and 4-Htrans(min)), 4.33-4.26 
(0.17H, m, 4-Htrans (maj)), 4.17-4.08 (0.65H, m, 4-Hcis(maj)), 4.00-3.90 (0.11H, m, 4-
Hcis(min)), 3.36-3.11 (2H, m, NCH2), 3.05-2.96 (3H, m, NCH3rotA), 2.85-2.81 (4H, 
m, NCH3rotB), 2.25-1.59 (4H, m, 5-H and 3-H), 1.59-1.41 (2H, m, NCH2CH2), 
0.89-0.72 (3H, m, CH3); δC (100 MHz, D2O, cis(maj) only) 171.5, 163.2 and 
163.1 (amide and 1-C), 67.7, 67.4, 63.2 and 63.1 (6-C and 4-C), 51.0 and 50.4 
(NCH2), 39.4, 35.6, 35.4, 35.2, 34.1 and 32.8 (3-C, 5-C and NCH3), 19.7 and 
19.3 (NCH2CH2), 10.6 and 10.4 (NCH2CH2CH3);  m/z (ES+) 284.1 (80%, MH+), 
306.1 (20%, MNa+); HRMS Found MH+: 284.1111, C11H19NO6 requires MH+ 
284.1105.  Correlation of the 1H NMR spectrum with that of the acid 4a allowed 
the identification of the anomers of the cis and trans diastereoisomers.  The 
ratio of the species were determined by the integration of the signals at  5.23-
5.02 ppm  (trans(maj) and (trans(min)), 4.62-4.53  ppm (trans(min) and cis(min) 
), 4.17-4.08 ppm (cis(maj)), 4.00-3.90  ppm (cis(min)).  Analysis by 500 MHz 1H 
NMR revealed that a 76:24 mixture of cis and trans diastereomers was present  
and that the cis isomer exists as a 88:12 mixture of anomeris and as a and as a 
ca. 1:1 mixture of rotomers ; the trans isomer exists as a 67:33 mixture of 
anomers. 
 
 
 (2S*,3S*)-2-Hydroxy-3-methyl-N,N-dipropylpent-4-enamide 146 
 
 
 
Trans-crotylboronic acid pinacol ester (721 µl, 3.50 mmol) in DCM (5 mL) was 
added to the glyoxylaldehyde 1a (500mg, 3.18 mmol) in DCM (15 mL)at –78 °C.  
The reaction was stirred overnight at –78 °C.  After 23 hrs the reaction was 
diluted with water (5 mL) and the aqueous layer was washed with DCM(3 x 20 
mL) and the combined the organiclayers was dried (MgSO4) and concentrated 
to give the crude product.  Column chromatography, eluting with 8:2 petrol–
EtOAc, afforded the title compound 146 (468 mg, 70%) as a colourless oil; Rf: 
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0.29 (1:1, EtOAc–Heptane); νmax/cm−1 (film)  2966, 1637, 1450; δH (500 MHz, 
CDCl3) 5.81-5.72 (1H, m, 4-H), 5.04 (1H, d, J 10.4, 5-HA), 4.99 (1H, d, J 17.2, 5-
HB), 4.26 (1H, dd, J 7.7 and 3.0, 2-H), 3.74-3.61 (2H, m, OH and (NCHA)A), 
3.34-3.22 (1H, (NCHA)B), 3.16-3.07 (1H, m, (NCHB)A), 3.00-2.90 (1H, m, 
(NCHB)B), 2.46-2.38 (1H, m, 3-H), 1.67-1.52 (4H, m, (NCH2 (CHA,B))A,B), 1.9 (3H, 
d, J 6.9, 3-CH3), 0.93 (3H, t, J 7.4, (NCH2 CH2 CH3)A), 0.90 (3H, t, J 7.4, (NCH2 
CH2 CH3)B); δC (75 MHz, CDCl3) 173.3 (1-C), 138.0 (4-C), 116.4 (5-C), 72.1 (2-
C), 49.0 and 47.9 (NCH2), 42.4 (3-C), 22.4 and 21.3 (NCH2 CH2), 17.6 (3-CH3), 
11.8 and 11.6 (NCH2 CH2 CH3); m/z (ES+) 236.2 (60%, MNa+), 214.2 (40%, 
MH+); HRMS Found MNa+: 236.1618, requires C12H23NNaO2 MNa+ 236.1621. 
 
 
(2S*,3R*)-2-hydroxy-3-methyl-N,N-dipropylpent-4-enamide  
 
 
 
Prepared in an identical manner the alkene 146 (shown above) using cis-
crotylboronic acid pinacol ester (721 µl, 3.50 mmol) and column 
chromatography, eluting with 8:2 petrol–EtOAc, afforded the title compound 
(394 mg, 59%) as a colourless oil; Rf: 0.29 (1:1 EtOAc–heptane); νmax/cm–1 
(film) 3100, 2966, 1636 and 1461; δH (400 MHz CDCl3) 5.93 (1H, ddd, J 17.4, 
10.6 and 7.6, 4-H), 5.10 (1H, d, J 17.6, 5-HA), 5.07 (1H, d, J 10.6, 5-HB), 4.31 
(1H, dd, J 7.9 and 3.4, 2-H), 3.69-3.64 (2H, m, (NCHA)A and OH), 3.27 (1H, dt, J 
14.6 and 7.0, (NCHA)B), 3.10-2.96 (2H, m, (NCHB)A,B), 2.41-2.36 (1H, m, 3-H), 
1.66-1.56 (4H, m, (NCH2 (CHA,B))A,B), 0.97 (3H, d, J 6.8, 3-CH3), 0.92 (3H, t, J 
7.5, NCH2 CH2 CH3)A), 0.90 (3H, t, J 7.5, NCH2 CH2 CH3)A ) δC (100 MHz, 
CDCl3) 173.5 (1-C), 141.1 (4-C), 115.1 (5-C), 71.5 (2-C), 49.0 and 47.9 (NCH2), 
42.4 (3-C), 22.4 and 21.2 (NCH2 CH2), 13.3 (3-CH3), 11.8 and 11.5 (NCH2 CH2 
CH3); m/z (ES+) 236.2 (75%, MNa+), 214.2 (25%, MH+); HRMS Found MNa+: 
236.1216, requires C12H23NNaO2 MNa+ 236.1621. 
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(4S*,5R*,6R*)-6-(dipropylcarbamoyl)-2,4-dihydroxy-5-methyltetrahydro-2H-
pyran-2-carboxylic acid and (4R*,5R*,6R*)-6-(dipropylcarbamoyl)-2,4-
dihydroxy-5-methyltetrahydro-2H-pyran-2-carboxylic acid 147 
 
 
 
Alkene 146 (50 mg, 0.235 mmol) was reacted following General Procedure K in 
MeOH (10 mL) quenching with DMS (10 mL).  Sodium pyruvate (258 mg, 2.35 
mmol) was added to residue in potassium phosphate buffer (0.778 mL, 20 mM, 
pH 7.4) followed by E192N (6.98 mg/mL in 20 mM, pH 7.4 potassium 
phosphate buffer (0.778 mL)  incubating at 35 ºC for 3 days.  The product was 
purified using preparative HPLC eluting with 0-30% (1% TFA in H2O–1% TFA in 
MeCN) over 30 minutes.  The reaction gave the title compound 147(53 mg, 
74%, 85:15, 4S:4R) as a colourless film; νmax/cm−1 (film) 3391, 2966, 1743, 
1632 and 1458; δH (500 MHz, D2O) 4.95(0.06H, d, J 8.55, 6-H4Rmin), 
4.86(0.09H, d, J 10.6, 6-H4Rmaj), 4.53 (0.71H, d, J 10.5, 6-H4Smaj), 4.22 (0.14H, 
d, J 10.4, 6-H4Smin), 4.06-4.01 (0.15H, m, 4-H4Rmin and 4-H4Rmaj), 3.72 (0.71H, td, 
J 11.5 and 4.6, 4-H4Smaj), 3.55 (0.14H, td, J 11.5 and 4.4, 4-H4Smin), 3.49-2.85 
(4H, m, (NCHA,B)A,B) 2.17-2.10 (1H, m, 3-HA), 1.82-1.70 (2H, m, 3-HB and 5-
H)1.65-1.41 (4H, m, (NCH2CH2)A,B), 0.86 (1H, d, J 6.5, 5-C-CH3), 0.83-0.72 (6H, 
m, (NCH2CH2CH3)A,B) δC (125MHz, CD3OD) 171.6 (C=O), 170.6 (C=O), 97.8 (2-
C), 73.6 (6-C), 69.9 (4-C), 50.7 and 49.5 (NCH2), 41.5 (3-C), 41.3 (5-C), 23.9 
and 21.8 (NCH2CH2), 13.3 (5-C-CH3), 11.8 and 11.5 (NCH2CH2CH3); m/z (ES+) 
302.2 (100%, MH+); HRMS Found MH+: 302.1620, C14H24NO6 requires MH+ 
302.1609.  TOCSY and NOESY analysis allowed the identification of the 
anomers of the 4S and 4R diastereomers.  The ratio of the species were 
determined by the integration of the signals at: 4.95 ppm (4R-min), 4.86 ppm 
(4R-maj), 3.72 ppm (4S-maj), 3.55 ppm (4S-min).  Analysis by 500 MHz 1H 
NMR revealed that a 85:15 mixture of 4S  and 4R diastereomers was present 
and that the 4S isomer existed as an 83:17 mixture of anomers and the 4R 
isomer existed as a 63:27 mixture of anomers. 
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1-[(Benzyloxy)carbonyl]-L-proline128 148  
 
N
OH
O
O O
 
 
L -Proline (11.6 g, 0.10 mol) was added to a vigorously stirred solution of 2M 
NaOH (50 mL) at −5 °C followed by addition of benzyl chloroformate (20.5 g, 
0.120 mol) and aqueous 4M NaOH (35 mL) simultaneously over 1 h with 
temperature maintained between −5 °C and 0 °C. The reaction was stirred for 1 
h, warmed to room temperature and washed with diethyl ether (2 × 20 mL).  
The organic layer was then re-extracted with aqueous 2M NaOH solution (3 × 
20 mL) and the aqueous phase acidified to pH 2, saturated with NaCl and 
extracted with EtOAc (3 × 20 mL).  The aqueous phase was acidified to pH 2 
with aqueous 6M HCl, saturated with NaCl and extracted with EtOAc (3 × 50 
mL) and combined with other organic fractions, dried (MgSO4) and evaporated 
under reduced pressure to give the crude product as a colourless oil.  
Crystallisation afforded the title compound128 148 (16.79 g, 67%) as colourless 
needles (from EtOAc–Petrol), m.p. 55-57 °C (lit. m.p. 69-74 °C 128); Rf: 0.57 
(EtOAc); [α]D23 –55.2 (c =1.0, MeOH) [lit. 128 [α]D22  –39.9 (c = 1.0, EtOH)]; 
max/cm–1 (solid) 3478, 3023, 2629, 1758, 1657, 1437 and 1337; δH (500 MHz, 
CDCl3, ca. 3:2 mixture of rotomers) 9.50 (1H, br s, COOH) 7.43-7.22 (5H, m, 
Ar-H), 5.25-5.07 (2H, m, Ar-CHA,B), 4.48-4.33 (1H, m, 2-H), 3.68-3.42 (2H, m, 5-
HA,B), 2.34-1.85 (4H, m, 3-HA,B and 4-HA,B); δC (75 MHz, CDCl3, mixture of 
rotomers) 178.7 and 177.1 (COOH), 156.2 and 154.9 (carbamate CO) 136.9 
and 136.7 (Ar), 128.9 and 128.8 (Ar), 128.6 and 128.4 (Ar), 128.3 and 128.1 
(Ar), 67.9 and 67.6 (ArCH2), 59.7 and 59.1 (2-C), 47.3 and 47.1 (5-C), 31.3 and 
29.8 (3-C), 24.7 and 23.9 (4-C); m/z (ES+) 250.2 (100%, MH+). 
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Benzyl (2S)-2-(didecylcarbamoyl)pyrrolidine-1-carboxylate 86 149 
 
 
 
Didecylamine (8.36 g, 28.1 mmol) was added in one portion to a mixture of the 
acid 148 (7.00 g, 28.1 mmol), 1-[3-(dimethylaminopropyl]-3-ethylcarbodiimide 
hydrogen chloride (5.30 g, 28.1 mmol) and 4-(dimethylamino)pyridine (3.43 g, 
28.1 mmol) in DCM (100 mL) and reaction stirred at room temperature for 23 h.  
The reaction was washed with 1 M aqueous HCl solution (3 × 30 mL) followed 
by saturated NaHCO3 solution (3 × 30 mL) the organic phase was then was 
dried (MgSO4) and concentrated under reduced pressure to give the crude 
product.  Column chromatography, eluting with 2:98 MeOH−DCM, afforded the 
title compound86 149 (11.3 g, 76%) as a colourless oil; Rf: 0.17 (2:98 
MeOH−DCM); [α]D23  –17.6 (c = 1.0, CHCl3) [lit. 86 [α]D24  −32.5 (c =1.0, EtOH)]; 
max/cm–1 (film) 2925, 2854, 1712, 1652, 1422, 1415 and 1352; δH (500 MHz, 
CDCl3 ca.1:1 mixture of rotomers) 7.38-7.25 (5H, m, Ar-H), 5.18 (2H, d, J 13.3, 
ArCH2 rotA) and 5.07 (2H, d, J 16.2, ArCH2 rotB) 4.65-4.61(1H, m, 2-H rotA) and 
4.48(1H, dd, J 5.1 and 3.4, 2-H
 
rotB), 3.75-3.00 (6H, m, 5-HA,B  and 2 × NCH2), 
2.21-2.08 (2H, m, 3-HA,B), 1.92-1.83 (2H, m, 4-HA,B ), 1.55 (32H, m, 16 × CH2) 
0.92-0.84 (6H, m, 2 × CH3); δC (75 MHz, CDCl3, ca.1:1 mixture of rotomers) 
172.4 ((C10H21)2NCOrotA ), 172.3 ((C10H21)2NCOrotB), 155.2 (pyrro-CO rotA), 154.6 
(pyrro-COrotB),137.3 (Ar
 
rotA), 137.0 (Ar
 
rotB) 129.0, 128.8, 128.7, 128.5, 128.4, 
128.2, 128.1 (Ar), 67.6 and 67.2 (ArCH2) 57.5 and 56.8 (2-C rotB), 48.3, and 48.0 
(5-C), 47.8 and 47.2(CH2), 47.1 and 47.0(CH2), 32.3, 31.6, 31.3, 31.0, 30.1, 
30.0, 29.9, 29.8, 29.8, 29.7, 29.7, 29.4, 28.1, 28.1, 27.4, 27.2, 24.7, 23.9, 23.1, 
22.4, 14.6 (2 ×CH3); m/z (ES+) 551.4 (60%, MNa+) 529.4 (40%, MH+).  
Full assignment of the carbon spectrum was not possible due to rotomers. 
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Benzyl (2S)-2-[(didecylamino)methyl]pyrrolidine-1-carboxylate 86 150 
 
 
 
1 M Borane.THF complex in THF (37.8 mL, 37.6 mmol) was added dropwise to 
the amide 149 (10.0 g, 18.1 mmol) at 0 °C and allowed to return to room 
temperature slowly before heating to reflux under argon for 4 h.  The reaction 
was quenched at 0 °C with 1 M aqueous HCl solution (5 mL), neutralised with 
2M aqueous NaOH solution and extracted with ether (3 × 70 mL).  The 
combined organic fractions were dried (MgSO4) and concentrated under 
reduced pressure to give the crude product.  Column chromatography, eluting 
with 10:90 raising to 30:70 EtOAc–Petrol, afforded the title compound 86 150 
(7.76 g, 80%) as a colourless oil; Rf: 0.54 (70:30 EtOAc–Petrol);  [α]D23 –71.2 (c 
= 1.0, CHCl3) [lit. 86[α]D24 –5.17 (c = 1.0, EtOH)]; max/cm–1 (film) 2924, 2854, 
2388, 2313, 1704, 1455, 1408 and 1355; δH(500 MHz, CDCl37.39-7.29 (5H, m 
Ar-H) 5.24-5.07 (2H, m, Ar-CH2) 4.31-4.24 (1H, m, 2-H) 3.48-3.33 (2H, m, 5-
HA,B) 3.06-2.05 (8H, m, 3-HA,B and 3 × NCH2) 1.90-1.79 (2H, m, 4-HA,B) 1.75-
1.13 (32H, m, 16 × CH2) 0.88 (6H, t, J 6.8, 2 × CH3);  δC (75 MHz, CDCl3, ca. 3:2 
mixture of rotomers) 155.3 (COrotA), 155.0 (COrotB) 137.1 (Ar) 128.9 (Ar) 128.4 
(Ar) 128.2 (Ar) 67.2 (ArCH2 rotA), 65.2 (ArCH2 rotB) 64.1 (CH2 rotA) 62.0 (CH2 rotB) 
58.6, 54.3 (2-C rotA), 53.8 (2-C rotB), 46.7, 33.6, 32.9, 32.3, 30.0, 29.9, 29.8, 27.8, 
24.2, 23.5, 23.3, 23.1, 14.6 (2 × CH3); m/z (ES+) 515.5 (70%, MH+) 551.5 (30%, 
MNa+); HRMS Found MH+, 515.4583. C13H15N5O2 requires MH+ 515.4571. 
Full assignment of the carbon spectrum was not possible due to rotomers. 
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N-decyl-N-[(2S)-Pyrrolidin-2-ylmethyl]decan-1-amine 86 69 
 
 
 
The amine 150 (7.40 g, 4.38 mmol) in ethanol (100 mL) with 5% Pd/C (0.75 g) 
was hydrogenated for 29 h, filtered through a bed of Celite and concentrated 
under reduced pressure.  Column chromatography, eluting with 10:90 EtOAc–
hexanes raising to 10:90 NEt3–EtOAc, afforded the title compound86 69 (4.04 g, 
73%) as a pale yellow oil; Rf 0.1 (9:1 EtOAc─ hexanes); [α]D23  + 15.25 (c =  1.0, 
CHCl3) [lit. 86[α]D24  +17.22 (c = 1.0, CHCl3)]; max/cm–1 (film) 2924, 2853, 1465 
and 1403; δH (500 MHz, CDCl3) 3.22-3.15 (1H, m, 2-H) 2.98-2.92 (1H, m, 
NHCHCHAHN) 2.87-2.81 (1H, m, NHCHCHBN) 2.48-2.45 (2H, m, 5-HA,B) 2.38-
2.25 (4H, m, 2 × NCH2) 1.90-1.69 (4H, m, 3-HA,B and 4-HA,B) 1.44-1.20 (32H, m, 
16 × CH2) 0.88 (6H, t, J 6.8, 2 × CH3) δC (75 MHz, CDCl3) 60.1 (NCH2CH), 
56.8 (2-C), 55.0 (CH2) 46.0 (CH2), 32.3 (CH2), 30.1 (CH2), 30.1 (CH2), 30.0 
(CH2), 29.9 (CH2), 29.8 (CH2), 28.0 (CH2), 27.6 (CH2), 25.2 (CH2), 23.1 (CH2), 
14.6 (2 × CH3); m/z (ES+) 381.4 (100%, MH+); HRMS Found MH+: 381.4204. 
C25H52N2 requires MH+ 381.4203. 
 
 
Benzyl (2S)-2-carbamoylpyrrolidine-1-carboxylate129 151  
 
N
OO
O
NH2
 
 
The acid 148 (5.00 g, 20.1 mmol) was added to a solution of 
ditertbutyldicarbonate (5.70 g, 26.1 mmol) and ammonium bicarbonate (1.91 g, 
24.1 mmol) in MeCN (20 mL).  Anhydrous pyridine (0.953 g, 12.0 mmol) was 
added and stirred for 5 h at room temperature and the reaction concentrated to 
approximately 5% of volume.  The reaction was diluted with water (50 mL), 
extracted with EtOAc (3 × 50 mL), dried (MgSO4) and concentration to gave the 
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crude product.  Column chromatography eluting with EtOAc afforded the title 
compound129 151 (4.25 g, 85%) as a colourless oil; Rf: 0.23 (EtOAc); [α]D23  –
75.7 (c =1.4, CHCl3) [lit. 129[α]D25  –82.8 (c = 0.5, CHCl3)]; max/cm–1 (film) 3390, 
3196, 2955, 1692, 1682, 1498, 1417, and 1358;δH (500 MHz, CDCl3, ca. 4:1 
mixture of rotomers) 7.43-7.25 (5H, app s, Ar-H), 6.70 (app s), 6.02 (app s), 
5.89-5.64 (2H, m, NH2), 5.20-5.08 (2H, m, Ar-CH2), 4.39-4.25 (1H, m, 2-H), 
3.60-3.38 (2H, m, 5-HA,B), 2.39-1.83 (4H, m, 3-HA,B and 4-HA,B); δC (75 MHz, 
CDCl3 mixture of rotomers) 175.8 and 175.0 (CONH2), 156.5 and 156.3 
(COOCH2) 136.7 and 136.4 (Ar), 129.0 and 128.7 (Ar), 128.6 and 128.3 (Ar), 
128.3 and 128.1 (Ar), 68.1 and 67.8 (ArCH2), 61.1 and 60.8 (NCH), 47.9 and 
47.4 (NCH) 47.3 (NCH2), 31.5 and 29.0 (NCHCH2), 24.9 and 24.1 (NCH2CH2); 
m/z (ES+) 271.1 (100%, MNa+); HRMS Found MNa+: 271.1055. C13H16N2O3 
requires MNa+271.1053.  
 
 
Benzyl (2S)-2-cyanopyrrolidine-1-carboxylate 129 152 
 
N
OO
CN
 
 
The amide 151 (4.26 g, 17.2 mmol) was stirred in dry DMF (45 mL) at 0 °C for 
30 min and cyanuric acid (2.06 g, 11.2 mmol) was added in one portion.  The 
reaction was stirred for 1 h and allowed to warm to room temperature and 
stirred for further 17 h. The reaction mixture was diluted with water (60 mL), 
ether (60 mL) added and the phases separated, and the aqueous layer 
extracted with EtOAc (4 × 50 mL).  The combined organic fractions were 
washed with brine (3 × 50 mL), dried (MgSO4) and concentrated under reduced 
pressure to give the crude product.  Column chromatography, eluting with DCM 
to give the title compound129 152 (3.67 g, 92%) as a yellow oil; Rf 0.44 (DCM); 
[α]D23 –108.4 (c = 1, CDCl3) [lit. 129[α]D25  –89.0 (c = 1, CHCl3)]; max/cm–1 (film) 
2958, 2889, 2240, 1708, 1411 and 1358; δH (500 MHz, CDCl3, ca. 1:1 mixture 
of rotomers) 7.44-7.30 (5H, m, Ar-H), 5.25-5.13 (2H, m, Ar-CH2), 4.59 (1H, d, J  
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6.0, 2-HrotA) and 4.53 (1H, d, J  6.0, 2-HrotA), 3.66-3.53 (1H, m, 5-HA), 3.50-3.36 
(1H, m, 5-HB), 2.34-2.00 (4H, m, 3-HA,B and 4-HA,B); δC (75 MHz, CDCl3 mixture 
of rotomers) 154.7 and 154.0 (CON), 136.5 and 136.4 (Ar), 129.0 (Ar), 128.7 
(Ar) 128.6 (Ar), 119.3 and 119.2 (NCHCN) 68.2 and 68.1 (ArCH2), 47.9 and 
47.4 (2-C), 46.8 and 46.4 (5-C), 32.1 and 31.2 (3-C) 25.1 and 24.2 (4-C); m/z 
(ES+) 253.1 (100%, MNa+); HRMS Found MNa+: 253.0950 C13H16N2O2 
requires, MNa+ 253.0947. 
 
 
Benzyl (2S)-2-(1′H-tetrazol-5′-yl)pyrrolidine-1-carboxylate 129 153 
 
N
OO
HN N
N
N
 
 
Sodium azide (757 mg, 11.7 mmol) was added in one portion to a suspension of 
the nitrile 152 (2.00 g, 8.69 mmol) and triethylamine hydrogen chloride (1.49 g, 
10.8 mmol) in toluene (15 mL) and heated to 90 °C for 3 days.  The reaction 
was cooled to room temperature and diluted with water (20 mL) and the phases 
separated.  The aqueous phase was cooled to 0°C and quenched with a 20% 
w/w aqueous solution of sodium nitrate (7 mL) followed by 20% w/w aqueous 
solution of sulfuric acid (6 mL), extracted with EtOAc (3 × 20 mL), dried 
(MgSO4) and concentrated under reduced pressure to give the title 
compound129 153 (1.95g, 83%) as a colourless oil, which was used in the next 
step without purification; Rf: 0.54 (EtOAc); [α]D23 –137.6 (c = 1, CHCl3) [lit. 
129[α]D25 –91.3 (c = 1.27, CHCl3)]; max/cm–1 (film) 3000, 2400, 1703, 1418 and 
1358; δH (500 MHz, CDCl3) 7.41-7.20 (5H, m, Ar-H), 5.38-4.98 (3H, m, Ar-CH2 
and 2-H), 3.66-3.48 (2H, m, 5-HA,B), 2.86-2.74 (1H, m, 3-HA), 2.50-1.84 (3H, m, 
3-HB and 4-HA,B); δC (75 MHz, CDCl3 ca. 5:1 mixture of rotomers) 156.8 (CO and 
5′-C
 
), 136.0 (Ar), 129.0 (Ar), 128.8 (Ar), 128.3 and 128.2 (Ar), 68.5 and 68.3 
(ArCH2), 53.1 and 51.8 (2-C), 47.7 and 47.5 (5-C), 33.4 and 29.9 (3-C), 25.0 
and 23.9 (4-C); m/z (ES+) 296.1 (100%, MNa+); HRMS Found MNa+: 296.1121. 
C13H15N5O2 requires, MNa+ 296.1118.  
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5′-[(2S)-pyrrolidin-2-yl]-1′H-tetrazole 129 67 
 
 
 
A solution of the tetrazole 153 (2.87 g, 10.5 mmol) and 10% Pd/C in AcOH–
water (9:1, 140 mL) was hydrogenated at 1 atm for 84 h.  The reaction mixture 
was filtered through a bed of Celite and the solvent removed azetropically with 
toluene to give the crude product which was crystallised from MeOH–toluene to 
afford the title compound129 67 (1.23 g, 85%) as an off-white solid; Rf: 0.57 
(3:3:1 tBuOH–H2O–AcOH); [α]D23  −12.1 (c = 0.63, CHCl3) [lit. 129 [α]D25  −10.5 (c 
= 0.63, CHCl3)]; δH (500 MHz, DMSO-d6) 9.17 (1H, br s, NH), 4.75 (1H, t, J 7.7, 
2-H), 3.33-3.20 (2H, m, 5-H), 2.39-2.30 (1H, m, 3-HA), 2.21-2.12 (1H, m, 3-HB), 
2.10-1.97 (2H, m, 4-HA,B);  δC (75 MHz, DMSO-d6) 158.2 (5′-C), 55.4 (2-C), 45.0 
(5-C), 30.3 (3-C), 23.5 (4-C); max/cm–1 (solid) 3054, 2446, 2159, 2023, 1977 
and 1636; m/z (ES+) 139.1 (100%, M+); HRMS Found M+, 139.0852. C5H9N5 
requires, M+ 139.0858. 
 
 
D-Phenylalanine N-methyl amide131 155 
 
Ph N
H
O
NH2
 
 
Triethylamine (6.06 mL, 43.9 mmol) was added dropwise to a suspension of D-
phenylalanine methyl ester hydrogen chloride (9.46 g, 43.9 mmol) in THF (100 
mL) and reaction stirred at room temperature for 1 h.  The reaction was filtered 
and the mother liquor concentrated under reduced pressure.  8M Ethanolic 
methylamine solution (150 mL) was added immediately and reaction stirred for 
24 h at room temperature and concentrated under reduced pressure to give the 
crude product as a yellow oil.  Crystallisation from DCM–pentane afforded the 
title compound 155131 (7.44 g, 95%) as pale yellow needles; m.p. 60-63 °C; Rf: 
0.14 (EtOAc); [α]D23  –24.3 (c = 1.2, MeOH); max/cm–1 (solid) 3294, 2944, 2530, 
2154, 2029, 1976, 1644 and 1400; δH (500 MHz, CDCl3) 7.34-7.18 (5H, m, Ar-
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H), 3.61 (1H, dd, J 9.5 and 3.9, PhCHA ), 3.29 (1H, dd, J 13.7 and 3.9, PhCHB), 
2.82 (3H, d, J 4.7, CH3), 2.68 (1H, dd, J 13.7 and 9.5, CH(NH2) ), 1.44 (2H, br s, 
NH2) δC (75 MHz, CDCl3) 175.3 (CO), 138.4 (Ar-C), 129.7 (Ar-CH), 129.1 (Ar-
CH), 127.2 (Ar-CH), 56.9 (NH2CH), 41.4 (ArCH2), 26.3 (CH3); m/z (ES+) 179.1 
(60%, MH+) 201.1 (40%, MNa+); HRMS Found MH+, 179.1184. C10H14N2O 
requires, MH+179.1179. 
 
 
(2R,5R)-5-Benzyl-2-tert-butyl-3-methylimidazolidin-4-one 79, 132 68  
 
 
 
Method A 
A mixture of trimethylacetaldehyde (73 µL, 0.67 mmol) and amide 155 (124 mg, 
0.674 mmol) in toluene (4 mL) was added via a cannular to a dry flask fitted with 
Dean─Stark apparatus containing FeCl3 (22 mg, 0.14 mmol) and reaction 
refluxed for 26 h.  The mixture was cooled to room temperature, diluted with 
brine (10 mL) and extracted with EtOAc (2 × 50 mL) and organic phase was 
dried (MgSO4) and concentrated under reduced pressure to give the crude cis 
and trans products in 1:1 ratio.  Column chromatography, eluting with 7:3 
Petrol–EtOAc gave the title compound 132 68 (75 mg, 45%) as a pale yellow 
film. 
 
Method B 
The trans product can be recycled as follows  
(2R,5S)-5-Benzyl-2-tert-butyl-3-methylimidazolidin-4-one hydrogen chloride 
(10.4 g, 48.5 mmol) in ether (150 mL) was washed with saturated NaHCO3 
solution (150 mL) then concentrated under reduced pressure and dissolved in 
THF (75 mL) and FeCl3 (1.57 g, 9.70 mmol) and reaction stirred at room 
temperature for 5 days. The reaction was diluted with DCM (200 mL) and 
washed with brine (200 mL) followed by H2O (3 × 200 mL) and organic layer 
was dried (MgSO4) and concentrated under reduced pressure Column 
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chromatography, eluting with 3:7 EtOAc–Petrol, afforded the title compound132 
68 (949 mg, 8%) as pale yellow needles (from DCM–Petrol),  
 
m.p. 76-80 °C; Rf: 0.06 (3:7 EtOAc–Petrol);  [α]D27  ─12.2 (c =1.0 , CH2Cl2) [lit. 
132[α]D25  –10.1 (c = 1.0, CH2Cl2)]; max/cm–1 (film) 2962, 1745, 1701, 1454, 1397 
and 1365; δH (300 MHz, CDCl3,) 7.33-7.18 (5H, m, ArH), 4.06 (1H, s, 2-H), 
3.75-3.65 (1H, m, 5-H), 3.16 (1H, dd, J 13.8 and 4.1, PhCHA), 2.94 (1H, dd, 
J 13.8 and .7.4, PhCHB), 2.91 (3H, m, NCH3), 0.83 (9H, s, C(CH3)3; δC (75 MHz, 
CDCl3) 175.3(4-C) , 137.9, 129.6, 128.6, 126.7 (Ar), 82.5, 59.4, 38.2, 35.1, 30.7 
and 25.0; m/z (ES+) 247.1 (100%, MH+). 
 
 
(2R*,3R*)-Dihydroxy-N1,N1,N4,N4-tetrapropyl-succinamide 156a 
 
 
 
The amide 127a (3.27 g, 11.5 mmol) was reacted following General Procedure 
E with NMO in water (1.48 g, 12.7 mmol in 1.5 mL), citric acid (4.42 g, 23.0 
mmol), K2OsO2(OH)4 (9 mg, 0.023 mmol), in 1:1 tBuOH–water (14 mL) for 25 h.  
Column chromatography eluting with 1:1 EtOAc–DCM gave the title compound 
156a (3.32 g, 91%) as a colourless plates; m.p. 108-113°C (from IPA); Rf: 0.30 
(1:1 EtOAc–DCM); max/cm–1 (solid) 3390, 2969, 2874, 1632, 1472 and 1408; δH 
(500 MHz, CDCl3) 4.59 (2H, s, CH), 4.21 (2H, br s, OH) 3.59-3.43 (4H, m, 
N(CH2)A), 3.28-3.11 (4H, m, N(CH2)B), 1.69-1.53 (8H, m, (NCH2CH2) A, B), 0.93 
(6H, t, J 7.7, (CH3)A), 0.91 (6H, t, J 7.7, (CH3)B); δC (75 MHz, CDCl3) 171.0 
(CO), 70.5 (CH), 49.5 (N(CH2)A) 48.5 (N(CH2)B), 22.5 ((NCH2CH2)A), 21.1 
((NCH2CH2)B), 11.8 ((CH3)A), 11.6 ((CH3)B); m/z (ES+) 339.2 (80%, MNa+) 317.2 
(20%, MH+); HRMS Found MNa+: 339.2257. C16H32N2O4 requires MNa+ 
339.2254. 
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2-oxo-N,N-dipropylacetamide 1a 
 
 
 
Water (2.8mL) was added dropwise to a vigorously stirred suspension of 
sodium periodate (948 mg, 4.42mmol) and diol 156a (700 mg, 2.21 mmol) in 
DCM (11.2 mL) and reaction stirred for 3 h at room temperature.  Sodium 
sulphate was added to the mixture and the reaction filtered and evaporated 
under reduced pressure to give the crude title compound as a colourless film 
which was used in all organocatalysed aldol reaction without any further 
purification. 
 
In all one-pot chemistry the title compound was prepared using an alternative 
method 
 
Water (25mL, 20% by volume) was added dropwise to a vigorously stirred 
suspension of sodium periodate (6.76 g, 31.6mmol) and diol 156a (5.00 g, 15.8 
mmol) in DCM (100 mL) and reaction stirred for 20 h at room temperature.  The 
reaction was filtered through a hydrophobic frit, silica added and evaporated 
under reduced pressure.  Column chromatography, eluting with 6:4 EtOAc–
hexane, afforded the title compound 1a (4.62 mg, 93%) as colourless oil; Rf: 
0.33 (4:6 EtOAc–petrol).  
 
the title compound 1a was characterised as the hydrate; νmax/cm−1 (film) 3370, 
2965, 1654, 1466, and 1412; δH (300 MHz, D2O) 5.56 (1H, s, hydrate), 3.32 
(2H, t, J 7.2, (NCH2)A), 3.27 (2H, t, J 7.0, (NCH2)B), 1.65-1.45 (4H, m, 
(NCH2CH2)A,B), 0.85-0.79 (6H, m, (CH3)A,B); δC (75 MHz, D2O) 170.5 (amide), 
84.1 (hydrate), 49.1 and 48.2 ((NCH2)A,B), 21.8 and 20.4 ((NCH2CH2)A,B), 10.9 
and 10.6 ((CH3)A,B); m/z (ES+) 158.1 (100% MH+); HRMS Found MH+: 
158.1177, C8H15NO2 requires MH+158.1176. 
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2-Hydroxy-N,N-dipropylacetamide146 157  
 
 
 
The glyoxylaldehyde 1a (115 mg, 0.737 mmol) was dissolved in DCM (5 mL) 
and NaBH4 (279 mg, 7.37 mmol) added and reaction stirred at room 
temperature for17 h.  The reaction was cooled to 0 ºC and quenched with a 2M 
aqueous solution of  NH4Cl.  The reaction was extracted with EtOAc (3 ×50 mL) 
and organic layer was dried (MgSO4) and concentrated under reduced pressure 
to afforded the title compound 157 (83 mg, 70%) as a colourless film.  
 
Alternatively the title compound can be prepared as follows  
 
Sodium methoxide  0.162 g, 2.44 mmol) was added in one portion to a solution 
of 2-(dipropylamino)-2oxoethyl acetate (2.48 g, 12.2 mmol) in MeOH (20 mL) 
and reaction stirred at room temperature for 17 h. The reaction mixture was 
then diluted with water (10 mL), extracted with EtOAc (3 × 20 mL) and the 
combined organic fractions were dried (MgSO4) and concentrated under 
reduced pressure to give the alcohol146 157 (1.90 g, 98%) as a colourless oil; Rf: 
0.52 (1:1 EtOAc–Petrol); (Found: C, 60.4; H, 10.85, N 8.6%; C8H17NO2 requires 
C, 60.4; H, 10.76, N 8.8.%); max/cm–1 (film) 3409, 2965, 2876, 1645, 1465 and 
1404; δH (500 MHz, CDCl3, mixture of rotomers, ca. 1:1) 4.15 (2H, s, CH2O), 
3.72-3.68 (1H, m, OH), 3.35 (2H, t, J 7.7, N(CH2)A), 3.04 (2H, t, J 7.7, N(CH2)B), 
1.64-1.54 (4H, m, (NCH2CH2)A, B), 0.91 (3H, t, J 7.7, (CH2CH3) A), 0.89 (3H, t, 
J 7.3, (CH2CH3) B); δC (75 MHz, CDCl3) 171.2 (CO), 60.1, (CH2OH), 48.0 
(NCH2) A), 47.8 ((NCH2) B), 22.1 ((NCH2CH2) A), 21.1 ((NCH2CH2)B), 11.8 
((CH2CH3)A), 11.6 ((CH2CH3)B); m/z (EI+) 159.1 (100%, M+); HRMS Found M+, 
159.1252. C8H17NO2 requires, M+ 159.1259. 
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(2R*,3R*)-2,4-dihydroxy-3-methyl-N,N-dipropylbutanamide anti-158 and 
(2R*3S*)-2,4-dihydroxy-3-methyl-N,N-dipropylbutanamide syn-158 
 
 
 
 
L-proline-catalysed aldol reactions  
50 mol% L-proline; 1 eq propionaldehyde; DCM; Table 9 entry 1 
 
Following General Procedure A, with L-proline (72 mg, 0.63 mmol) the 
glyoxylaldehyde 1a (199 mg, 1.27 mmol), propionaldehyde (92 µL, 1.27 mmol), 
in DCM (5 mL) the reaction was performed at room temperature for 68 h. 
NaBH4  (232 mg, 6.13 mmol) was added and the reaction stirred for 1 h 45 min 
at room temperature.  Column chromatography eluting with 1:1 DCM–Ether 
gave the title compound 158 as a colourless film (66 mg, 25%, 62:38 syn:anti) 
 
50 mol% L-proline; 82 eq propionaldehyde; DCM ; Table 9 entry 2 
 
Following General Procedure A, with L-proline (36 mg, 0.316 mmol) the 
glyoxylaldehyde 1a (99 mg, 0.632 mmol), propionaldehyde (4 mL, 55.4 mmol), 
in DCM (25 mL) the reaction was performed at room temperature for 98 h.  
NaBH4  (1.20 g, 31.6  mmol) was added and the reaction stirred for 1 h 45 min 
at room temperature.  Column chromatography eluting with 9:1 EtOAc–Tol 
gave the title compound 158 as a colourless film (4 mg, 3%, 84:16 syn:anti) 
 
Tetrazole 67-catalysed aldol reactions 
20 mol% tetrazole 67; 82 eq propionaldehyde; DMF; Table 9 entry 12 
 
Following General Procedure B propionaldehyde (4 mL, 55.4 mmol), the 
glyoxylaldehyde 1a (99 mg, 0.632 mmol), and tetrazole 67 (18 mg, 0.13 mmol) 
were reacted in DMF (25 mL) for 145 h at +4 ºC.  NaBH4 (1.06 g, 27.7 mmol) 
was added and reaction stirred for 21 h at room temperature.  Column 
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chromatography eluting solvent with 9:1 EtOAc–Tol gave the title compound 
158 as a colourless film (8 mg, 6%, 40:60 syn:anti) 
 
20 mol% tetrazole 67; 82 eq propionaldehyde; DMSO; Table 9 entry 13 
 
Following General Procedure B propionaldehyde (4 mL, 55.4 mmol), the 
glyoxylaldehyde 1a (99 mg, 0.632 mmol), and tetrazole 67 (18 mg, 0.13 mmol) 
were reacted in DMSO (25 mL) for 74 h at RT.  NaBH4 (1.20 g, 31.6 mmol) was 
added and reaction stirred for 21 h at room temperature.  Column 
chromatography with 7:3 EtOAc–Tol gave the title compound 158 as a 
colourless film (27 mg, 20%, 78:22 syn:anti) 
 
Diamine 69-catalysed aldol reactions 
20 mol% diamine 69; 2eq propionaldehyde; TFA additive; H2O; Table 9 entry 14 
 
Following General Procedure C, TFA (5 µL, 0.06 mmol) as an additive with the 
diamine 69 (24 mg, 0.063 mmol), glyoxylaldehyde 1a (99 mg, 0.63 mmol) and 
propionaldehyde (91 µL, 1.3 mmol) in H2O (1.25 mL) the reaction was stirred at 
room temperature for 142 h. NaBH4 (481 mg, 6.32 mmol) was added and stirred 
at room temperature for 7.5 h.  Column chromatography eluting with 7:3 
EtOAc–Tol gave the title compound 158 as colourless film (3 mg, 0.2%, 31:69 
syn:anti)). 
 
20 mol% diamine 69; 2eq propionaldehyde; TFA additive; Phosphate buffer pH 
7.4; Table 9 entry 15 
 
Following General Procedure C, TFA (5 µL, 0.06 mmol) as an additive with the 
diamine 69 (24 mg, 0.063 mmol), glyoxylaldehyde 1a (99 mg, 0.63 mmol) and 
propionaldehyde (91 µL, 1.3 mmol) in 20 mM Phosphate buffer pH 7.4 (1.25 
mL) the reaction was stirred at room temperature for 142 h. NaBH4 (481 mg, 
6.32 mmol) was added and stirred at room temperature for 7.5 h.  Column 
chromatography eluting with 7:3 EtOAc–Tol gave the title compound as 
colourless film (16 mg, 19%, 64:36 syn:anti). 
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20 mol% diamine 69; 2eq propionaldehyde; Sc(OTf)3 additive; H2O; Table 10 
entry 2 
 
Following General Procedure C, Sc(OTf)3 (31 mg, 0.063 mmol) as an additive 
with the diamine 69 (24 mg, 0.063 mmol), glyoxylaldehyde 1a (99 mg, 0.63 
mmol) and propionaldehyde (91 µL, 1.3 mmol) in H2O (1.25 mL) the reaction 
was stirred at room temperature for 158 h. NaBH4 (481 mg, 6.32 mmol) was 
added and stirred at room temperature for 20h.  Column chromatography 
eluting with 6:4 Ether–DCM gave the title compound 158 as colourless film (2 
mg, 0.2%, 12:88 syn:anti). 
 
20 mol% diamine 69; 2eq propionaldehyde; Sc(OTf)3 additive; Phosphate buffer 
pH 7.4; Table 10 entry 3 
 
Following General Procedure C, Sc(OTf)3 (31 mg, 0.063 mmol) as an additive 
with the diamine 69 (24 mg, 0.063 mmol), glyoxylaldehyde 1a (99 mg, 0.63 
mmol) and propionaldehyde (91 µL, 1.3 mmol) in 20 mM Phosphate buffer pH 
7.4 (1.25 mL) the reaction was stirred at room temperature for 206h. NaBH4 
(481 mg, 6.32 mmol) was added and stirred at room temperature for 20h.  
Column chromatography eluting with 7:3 EtOAc–Tol gave the title 
compound158 as colourless film (11 mg, 8%.24:76:syn:anti). 
 
 
10 mol% diamine 69; 10eq propionaldehyde TFA additive; Phosphate buffer pH 
7.4; Table 10 entry 5 
 
 Following General Procedure C, TFA (5 µL, 0.063 mmol) as an additive with 
the diamine 69 (24 mg, 0.063 mmol), glyoxylaldehyde 1a (99 mg, 0.63 mmol) 
and propionaldehyde (91 µL, 6.3 mmol) in 20 mM Phosphate buffer pH 7.4 
(1.25 mL) the reaction was stirred at room temperature for 26h. NaBH4 (1.20 g, 
31.6 mmol) was added and stirred at room temperature for 20h.  Column 
chromatography eluting with 3% MeOH in DCM gave the title compound 158 as 
colourless film (62 mg, 45%, 68:32 syn:anti). 
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10 mol% diamine 69; 10eq propionaldehyde; 100 mM Phosphate buffer pH 6.0; 
Table 11 entry 1 
 
Following General Procedure D, the glyoxylaldehyde 1a (115 mg, 0.737 mmol) 
and propionaldehyde (531µL, 7.37 mmol) diamine 69 (28mg, 0.0737 mmol), in 
100 mM Phosphate buffer pH 6 (1.53 mL) the reaction was stirred at room 
temperature for 25h. NaBH4 (1.20 g, 31.6 mmol) was added and stirred at room 
temperature for 137h.  Column chromatography eluting with 7:3 EtOAc–Tol 
gave the title compound 158 as colourless film (47 mg, 41%, 62:38 syn:anti). 
 
10 mol% diamine 69; 10eq propionaldehyde; 100 mM Phosphate buffer pH 6.4; 
Table 11 entry 2 
 
Following General Procedure D, the glyoxylaldehyde 1a (115 mg, 0.737 mmol) 
and propionaldehyde (531µL, 7.37 mmol) diamine 69 (28 mg, 0.0737 mmol), in 
100 mM Phosphate buffer pH 6.4 (1.53 mL) the reaction was stirred at room 
temperature for 25h. NaBH4 (1.20 g, 31.6 mmol) was added and stirred at room 
temperature for 137h.  Column chromatography eluting with 7:3 EtOAc–Tol 
gave the title compound 158 as colourless film (28 mg, 26%, 82:18 syn:anti). 
 
10 mol% diamine 69; 10eq propionaldehyde; 100 mM Phosphate buffer pH 7.0; 
Table 11 entry 3 
 
Following General Procedure D, the glyoxylaldehyde 1a (115 mg, 0.737 mmol) 
and propionaldehyde (531µL, 7.37 mmol) diamine 69 (28mg, 0.0737 mmol), in 
100 mM Phosphate buffer pH 7.0 (1.53 mL) the reaction was stirred at room 
temperature for 25h. NaBH4 (1.20 g, 31.6 mmol) was added and stirred at room 
temperature for 137h.  Column chromatography eluting with 7:3 EtOAc–Tol 
gave the title compound 158 as colourless film (37 mg, 33%, 68:33 syn:anti). 
 
10 mol% diamine 69; 10eq propionaldehyde; 100 mM Phosphate buffer pH 7.4; 
Table 11 entry 4 
 
Following General Procedure D, the glyoxylaldehyde 1a (115 mg, 0.737 mmol) 
and propionaldehyde (531µL, 7.37 mmol) diamine 69 (28mg, 0.0737 mmol), in 
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100 mM Phosphate buffer pH 7.4 (1.53 mL) the reaction was stirred at room 
temperature for 25h. NaBH4 (1.20 g, 31.6 mmol) was added and stirred at room 
temperature for 137h.  Colum chromatography eluting with 7:3 EtOAc–Tol gave 
the title compound 158 as colourless film (37 mg, 33%,75:25 syn:anti). 
 
 
10 mol% diamine 69; 10eq propionaldehyde; 100 mM Phosphate buffer pH 8.0; 
Table 11 entry 5 
 
Following General Procedure D, the glyoxylaldehyde 1a (115 mg, 0.737 mmol) 
and propionaldehyde (531µL, 7.37 mmol) diamine 69 (28mg, 0.0737 mmol), in 
100 mM Phosphate buffer pH 8.0 (1.53 mL) the reaction was stirred at room 
temperature for 25h. NaBH4 (1.20 g, 31.6 mmol) was added and stirred at room 
temperature for 137h.  Column chromatography eluting with 7:3 EtOAc–Tol 
gave the title compound 158 as colourless film (37 mg, 33%, 81:19 syn:anti). 
 
The anti diastereomer can also be prepared from the alkene 146 
 
The alkene 146 (40 mg, 0.186 mmol) was ozonolysed following General 
Procedure F in MeOH (5 mL) with DMS( 5 mL).  The residue was dissolved in 
EtOH (5 mL) and NaBH4 added (282 mg, 7.44 mmol) and stirred at room 
temperature for 2h 45 min the reaction was cooled to 0ºC and 1 M aqueous 
hydrochloric acid added.  The reaction mixture was extracted with EtOAc (3 × 
20 mL) and the combined organics were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Column chromatography, eluting 
with 9:1 EtOAc–Petrol, afforded the title compound anti-158 (4 mg, 13%) as 
colourless film. 
 
Syn diastereomer 158 
Colourless film; Rf: 0.37 (1:1 DCM–Ether); δH (300 MHz, CDCl3,) 4.66 (1H, dd, 
J 7.4 and 2.1, 2-H), 3.85 (1H, d, J 7.4, 2-OH), 3.72-3.61 (3H, m, N(CH
 A)A and 4-
H ), 3.32 (1H, dt, J 14.5 and 7.9, (NCH
 A)B), 3.13-2.95 (2H, m, (NCH B)A and 
(NCH
 B)B), 2.21 (1H, br s, 4-OH),  1.97-1.87 (1H, m, 3-H), 1.69-1.50 (4H, m, 
(CH2CH2)A, B), 0.93 (3H, t, J 7.4 , (CH2CH3)A,), 0.90 (3H, t, J 7.4 , (CH2CH3)B), 
0.78 (3H, t, J 6.9 , (CHCH3)); δH (75 MHz, CDCl3) 173.3 (CO), 68.2 (2-C), 65.6 
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(4-C) 48.2 ((NCH2)A), 47.3 ((NCH2)B), 38.3 (3-C), 21.9 ((NCH2CH2)A), 20.7 
((NCH2CH2)B), 11.3 ((CH2CH3)A), 11.1 ((CH2CH3)B) 9.1 (CHCH3); max/cm–1 
(film) 3400, 2965, 2935, 2876, 1632, 1466 and 1401; m/z (EI+) 240.2 (80%, 
MNa+) 218.2 (20%, MH+); HRMS Found MH+, 218.15757,. C11H23NO3 requires, 
MH+ 218.1751. 
 
Anti diastereomer 158 
Colourless film; Rf: 0.30 (1:1 DCM–Ether); max/cm–1 (film) 3391, 2964, 2932, 
2876, 1626, 1458 and 1381; δH (500 MHz, CDCl3,) 4.53 (1H, dd, J 7.3, 3.5, 2-
H), 3.76-3.70 (1H, m, 4-H), 3.69-3.59 (2H, m, 2-OH and (NCH
 A)A), 3.54-3.47 
(1H, m, 4-H), 3.35-3.21 (1H, m, (NCH
 A)B), 3.15-3.00 (2H, m, (NCHB)A and 
(NCHB)B), 2.01-1.92 (1H, m, 3-H), 1.69-1.53 (4H, m, (CH2CH2)A, B), 1.04 (3H, d, 
J 6.8, 3-CH3 ), 0.93 (3H, t, J 7.3 , (CH2CH3)A,), 0.91 (3H, t, J 7.3 , (CH2CH3)B); 
δC (75 MHz, CDCl3) 174.6 (CO), 72.0 (C-2), 63.8 (C-4) 48.8 ((NCH2)A), 47.9 
((NCH2)B), 39.8 (C-3), 22.0 ((NCH2CH2)A), 20.6 ((NCH2CH2)B), 14.8 
(CHCH3)11.4 ((CH2CH3)A), 11.2 ((CH2CH3)B); m/z (EI+) 218.0 (100%, MH+); 
HRMS Found MH+, 218.15757,. C11H23NO3 requires, MH+ 218.1751. 
 
 
 
(4S*,5S*)-2,2,5-trimethyl-N,N-dipropyl-1,3-dioxane-4-carboxamide163  
(4R*,5S*)-2,2,5-trimethyl-N,N-dipropyl-1,3-dioxane-4-carboxamide 164 
 
 
 
PPTS (6 mg, 2.39 µmol) was added to a 8:3 mixture of alcohols anti- and syn-
158 (18.6 mg, 82.8 µmol) in a 1:1 mixture of acetone/2,2-dimethylpropane (4 
mL) and heated to 56 °C for 2 days.  The reaction was cooled to room 
temperature and dry NEt3 (75 µL, 0.497 mmol) stirred for 5 minutes then diluted 
with water (20 mL), extracted with EtOAc (3 × 20 mL) and the combined 
organics were dried (MgSO4) and evaporated under reduced pressure to give 
the crude product.  Column chromatography, eluting with 7:3 EtOAc–Petrol, 
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afforded the title compound 163 (14.5 mg, 68%) as colourless film; Rf: 0.24 (3:7 
EtOAc–petrol); νmax/cm−1 (film) 2963, 1652, 1456 and 1382; δH (500 MHz, 
CDCl3) 4.18 (1H, d, J 10.7, 4-H), 3.81 (1H, dd, J 11.6 and 5.4, 6-Heq), 3.56 (1H, 
t, J 11.6, 6-Hax), 3.39 (1H, ddd, J 14.8, 10.2 and 5.5, (NCHA) A), 3.32-3.21 (2H, 
m, (NCHA,B) B), 3.16 (1H, ddd, J 14.8, 10.2 and 5.5, (NCHB) A), 2.41-2.30 (1H, m, 
5-H), 1.72-1.52 (4H, m, NCH2CH2), 1.47 (3H, s, 2-C-CH3), 1.40 (3H, s, 2-C-
CH3), 0.92 (3H, t, J 7.4, (NCH2CH2CH3) A), 0.88 (3H, t, J 7.4, (NCH2CH2CH3) A), 
0.77 (3H, d, J 6.6, 5-C-CH3); δC (125 MHz, CDCl3); 168 (C=O), 98.5 (2-C), 73.9 
(4-C), 65.7 (6-C), 49.1 and 47.9 (NCH2), 30.0 and 29.4 (2-C-CH3), 22.6, 20.8 
and 18.6 (NCH2CH2 and 5-C), 12.8 (5-C-CH3), 11.4 and 11.2 (NCH2CH2CH3); 
m/z  (ES+) 280.2 (100%, MNa+); HRMS Found MNa+: 280.1872, C14H27NO3 
requires MNa+ 280.1883. 
 
and the title compound 164 (5.5 mg, 28%) as colourless film; Rf: 0.24 (3:7 
EtOAc–petrol); νmax/cm−1 (film) 3965, 1645, 1464 and 1381; δH (500 MHz, 
CDCl3) 4.73 (1H, d, J 3.0, 4-H), 4.12 (1H, dd, J 11.5 and 3.0, 6-H), 3.63 (1H, dd, 
J 11.5 and 2.2, 6-H), 3.44 (1H, ddd, J 15.0, 10.3 and 5.6, (NCHA)A), 3.31-3.09 
(3H, m, (NCHB)A and (NCHA,B) B), 2.01-1.93 (1H, m, 5-H), 1.68-1.51 (4H, m, 
NCH2CH2), 1.46 (6H, s, 2-CH3), 1.14 (3H, d, J 6.8, 5-C-CH3), 0.90 (3H, t, J 7.3, 
((NCH2CH2CH3)A), 0.89 (3H, t, J 7.3, (NCH2CH2CH3)B); δC (75 MHz, CDCl3); 
169.5 (C=O), 99.6 (2-C), 72.8 (4-C), 66.9 (6-C), 49.6 and 49.0 (NCH2), 31.7 and 
29.5 (2-C-CH3), 23.0, 21.1 and 19.5 (NCH2CH2 and 5-C), 12.4 (5-C-CH3), 11.9 
and 11.5 (NCH2CH2CH3); m/z  (ES+) 280.2 (100%, MNa+); HRMS Found MNa+: 
280.1873, C14H27NO3 requires MNa+ 280.1883. 
 
 
(2R, 3R)-2,3-Dihydroxy-pent-4-enoic acid dipropylamide118 170 
 
 
 
Trifluoroacetic acid−water (9:1, 60 mL) was added to the amide 169 (750 mg, 
2.93 mmol) and evaporated under reduced pressure.  Column chromatography, 
eluting with 1:1 Petrol–EtOAc, afforded the title compound 118 170 (365 mg, 
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58%) as a off white needles; Rf: 0.16 (6:4, petrol-EtOAc); [α]D22: + 13.8º (c. 0.8, 
CHCl3) [lit.118 [α]D22: + 17.1 (c. 0.84, CHCl3)]; max/cm-1 (solid) 3328, 2967, 1626, 
1474, 1431, 1380 and 1317; δH (500 MHz, CDCl3) 5.98 (1H, ddd, J 16.7, 10.3 
and 5.6, 4-H), 5.12 (1H, d, J 16.7, 5-HA), 4.99 (1H, d, J 10.3, 5-HB), 4.20 (1H, d, 
J 4.3, 2-H), 4.11 (2H, br s, 2 × OH), 4.05-4.00 (1H, m, 3-H), 3.37-3.29 (1H, m, 
(NCHA)A), 3.25-3.15 (1H, m, (NCHA)B), 3.01-2.93 (1H, m, (NCHB)A), 2.90-2.82 
(1H, m, (NCHB)B), 1.47-1.28 (4H, m, 2 × (NCH2CH2)), 0.72 (3H, d, J 7.7, 
(CH3)A), 0.69 (3H, d, J 7.3, (CH3)B); m/z (ES+) 216.1 (100%, MH+). 
 
 
 (2R,3S)-2,3-dihydroxy-4-oxo-N,N-dipropylbutanamide118 35a 
 
 
 
Oxygen (15min, 0.6 psi), ozone (6 min, 0.6 psi), and oxygen (15 min, 0.6 psi,) 
were bubbled sequentially through a stirred solution of 170 (150 mg, 0.688 
mmol) in methanol (10 mL) at –78 °C.  DMS (0.15 mL) was added, and the 
mixture was allowed to warm to room temperature, once the ozonide was 
quenched the solvent removed.  The title compound was used in the 
subsequent reaction immediately.  
 
 
(5R, 6R)-6-Dipropylcarbamoyl-2-oxo-4,5,6-trhydroxy-hexanoic acid118 36a 
 
 
 
The aldehyde 35a (150mg, 0.688 mmol)was dissolved in an aqueous potassium 
phosphate buffer (10 mL, 20 mM, pH 7.4), sodium pyruvate (164 mg, 1.5 mmol) 
was added, the pH was adjusted to 7.4 with 2M aqueous solution of NH4OH, 
and E192N (3 mL, 1.62 mg/mL in 50 mM Tris and 50 mM NaCl) was added.  
After stirring at room temperature for 20h further E192N (3 mL, 1.62 mg/mL in 
50 mM Tris and 50 mM NaCl) was added.  After at 24h the pH adjusted to 5.5 
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with aqueous ammonium (1 M) and pyruvate decarboxylases (3 µL, 14 mg/mL 
from Bakers yeast) added. After stirring for a further 16 h the reaction was 
concentrated and ion exchange performed (DOWEX strongly basic X1-2 
formate form) eluting from 0 to1.0 M formic acid, the resultant residue was 
dissolved in an aqueous potassium phosphate buffer (20 mM, pH 7.4) the pH 
adjusted to 5.5 with aqueous ammonium (1 M) and pyruvate decarboxylases 
(20 µL, 14 mg/mL from Bakers yeast) added and reaction stirred for 3 days.  
Dialysis overnight followed by ion exchange (DOWEX strongly basic X1-2 
formate form) eluting from 0 to1.0 M formic acid and column chromatography, 
eluting with 1:3:5 H2O–IPA–EtOAc, afforded the acid118 36a (42 mg, 20%) as a 
colourless film; Rf: 0.6 (5:2:2, EtOAc–H2O–AcOH); νmax/cm−1 (film) 3372, 2967, 
1612 and 1437; H (500 MHz, D2O) 4.37 (1H, d, J 8.5, 6-Hfur(maj)), 3.74-3.11 
(1H, m, 4-Hfur(maj)), 3.39 (1H, t, J 9.4, 5-Hfur(maj)), 3.31-3.11 (4H, m, NCH2), 1.91 
(1H, dd, J 13.3 and 6.0, 3- HBfur(maj)), 1.70 (1H, t, J 12, 3- HAfur(maj)), 1.40-1.20 
(4H, m, NCH2CH2), 0.64-0.54 (6H, m, NCH2CH2CH3); m/z (ES+) 328.3 (80%, 
MNa+), 306.3 (20%, MH+). 
 
The reaction produces two diastereomers which have four forms each. The 
major product is the S diastereomer in one of its furanose forms.  Full 
interpretation of the seven alternative products not achieved but spectra 
obtained were identical to authentic samples.118 
 
 
(3R*,5R*)-6-(dipropylamino)-3,5-dihydroxy-6-oxohexanoic acid 172 
 
 
 
An aqueous hydrogen peroxide solution (24 µL, 0.212 mmol, 30% w/w solution) 
was added to a solution of acid 4a (24 mg, 0.0830 mmol, 82:12 cis:trans) in 
water (500 µL). The pH was adjusted to at pH 2 with a 1M solution of aqueous 
hydrochloric acid at 0 °C.  The reaction was warmed to room temperature and 
stirred for 2 h.  The reaction was neutralised with 2M aqueous sodium 
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hydroxide solution, cooled to 0 °C and sodium sulphite (133 mg, 1.06 mmol) 
added stirred for 20 min.  The reaction mixture was then tested for peroxide with 
starch-iodide paper before the reaction was then concentrated and ion 
exchange performed (DOWEX strongly basic 1X8 200-400 formate form) 
eluting from 0 to2.0 M formic acid which gave the title compound 172 (13.5 mg, 
63%, 78:22 anti:syn) as a colourless film; Rf: 0.41 (5:2:2 EtOAc–H2O–IPA); 
νmax/cm−1 (solid) 3406, 2966, 1718, 1626, 1401 and 1301; δH (500 MHz, D2O) 
4.03-3.94 (1H, m, 5-Hanti), 3.88-3.81 (1H, m, 5-Hsyn), 4.25-4.02 (1H, m, 3-H), 
3.45-2.96 (4H, m, NCH2), 2.58-2.40 (2H, m, 2-H), 1.72-1.62 (2H, m, 4-H), 1.62-
1.36 (4H, m, (NCH2CH2)A,B), 0.80 (3H, t, J 7.7, (CH3)A), 0.77 (3H, t, J 7.7, 
(CH3)B); δC (100 MHz, D2O) 178.7 (C=O), 177.8 (C=O), 67.8 and 67.3 (3-C and 
5-C), 51.8 and 50.7 (NCH2), 44.9 and 43.7 (4-C and 6-C), 24.4 and 23.0 
(NCH2CH2), 13.3 and 13.1 (CH3); m/z (ES+) 262.2 (100%, MH+); HRMS Found 
MH+: 262.1655, C12H23NO5 requires MH+ 262.1649. 
 
 
6-oxo-N,N-dipropyl-3,6-dihydro-2H-pyran-2-carboxamide 171 
 
 
 
TFA (5 µL, 28.4 µmol) was added to the acid 172 (13.0 mg, 49.8 µmol) in MeCN 
(0.50 mL) and stirred at room temperature for 3h.  The reaction was heated to 
50 °C for 20.5 h and further TFA added (20 µL, 113 µmol).  The reaction was 
stirred for a further 7 h and heated to 80 °C for 18 h.  The reaction was cooled 
and diluted with water (20 mL) and extracted with EtOAc (3 × 20 mL), the 
combined organics were dried (MgSO4) and concentrated.  Column 
chromatography, eluting with 1:1 Petrol–EtOAc raising to EtOAc afforded the 
title compound 171 (3.07 mg, 28%) as a colourless oil; Rf: 0.26 (EtOAc); 
νmax/cm−1 (film) 3397, 2917, 1732, 1651 and 1384; δH (500 MHz, CDCl3) 6.95 
(1H, ddd, J 10.1, 5.3 and 3.4, 4-H), 6.04 (1H, ddd, J 10.1, 2.4 and 1.5, 5-H), 
5.17 (1H, dd, J 9.5 and 4.8, 2-H), 3.57-3.12 (4H, m, NCH2), 3.00 (1H, dddd, J 
18.8, 9.5, 3.4 and 2.4, 3-HA), 2.52 (1H, ddt, J 18.8, 5.3 and 1.5, 3-HB), 1.81-1.51 
(4H, m, NCH2CH2), 0.94 (3H, t, J 7.5, (CH3)B), 0.90 (3H, t, J 7.5, (CH3)A); δC (75 
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MHz, CDCl3); 179.3 and 166.2 (6-C and amide), 145.2 (4-C), 120.7 (5-C), 74.1 
(2-C), 49.3 and 48.0 (NCH2), 25.9 (3-C), 22.3 and 20.6 (NCH2CH2), 11.3 and 
11.2 (CH3); m/z (ES+) 226.1 (100% MH+); HRMS Found MH+: 226.1448, 
C12H19NO3 requires MH+ 226.1438. 
 
 
2,4-dihydroxy-N,N-dipropylbutanamide 173 
 
 
 
Alkene 123a (10 mg, 0.0498 mmol) was ozonolysed following General 
Procedure F in MeOH (1.7 mL) quenching with DMS (1.7 mL).  The reaction 
was then concentrated and residue dissolved in dry EtOH (1 mL) and then 
NaBH4 (19 mg, 0.498 mmol) and stirred at RT for 2.5 h.  The reaction was 
cooled to 0 °C and quenched with a 1M aqueous solution of hydrochloric acid.  
The reaction was then extracted with EtOAc (3 × 10 mL) and the combined 
organics dried (Mg2SO4), and concentrated.  Column chromatography, eluting 
with EtOAc afforded the title compound 173 (4 mg, 40%) as as a colourless oil;  
 
The title compound can also be prepared as follows: 
Acetaldehyde (54 µL, 0.955mmol) was added to a mixture of diamine 69 (3.6 
mg, 9.55 µmol) and glyoxylaldehyde 1a (15 mg, 95.5 µmol) in buffer (307 µL, 
pH 7.4, 20 mM potassium phosphate) and reaction stirred for 25 h at RT.  
NaBH4 (37 mg, 0.955 mmol) was added and reaction stirred for 2.5 h at RT then 
quenched with a 1M aqueous solution of hydrochloric acid.  EtOAc (3 × 20 mL) 
and the combined organics dried (Mg2SO4), and concentrated.  Column 
chromatography, eluting with EtOAc afforded the title compound 173 (6 mg, 
32%) as as a colourless oil;  
 
Rf: 0.18 (9:1 EtOAc─MeOH); νmax/cm−1 (film) 3392, 2965, 1633, 1465 and 1402; 
δH (500 MHz, CDCl3) 4.57-4.50 (1H, br s, 2-H), 3.95-3.92 (3H, br s, 4-H and 
OH), 3.59 (1H, ddd, J 14.0, 9.0 and 6.6, (NCHA)A), 3.24 (1H, dt, J 14.2 and 8.1, 
(NCHA)B), 3.12-3.03 (2H, m, (NCHB)A and (NCHB)B), 2.34 (1H, br s, OH), 1.92-
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1.83 (1H, m, 3-HA), 1.73-1.50 (5H, m, 3-HB), 0.93 (3H, t, J 7.3, (CH3)A), 0.90 
(3H, t, J 7.5, (CH3)B); δC (75 MHz, CDCl3); 172 (1-C), 64.6 (2-C), 57.8 (4-C), 
46.3 and 45.4 ((NCH2)A,B), 35.3 (3-C), 19.9 and 18.6 ((NCH2CH2)A,B), 9.3 and 
9.1 ((CH3)A,B); m/z  (ES+) 204.2 (60%, MH+), 226.1 (40%, MNa+); HRMS Found 
MH+: 204.1590, C10H21NO3 requires MH+ 204.1594. 
 
 
(2R*,3R*)-dihydroxy-N1,N1,N4,N4-tetramethylsuccinamide147 156h  
 
 
 
The amide 127h (800 mg, 4.71 mmol) was reacted following General Procedure 
E with NMO in water (606 mg, 5.17 mmol in 1 mL), citric acid (1.82 g, 9.48 
mmol), K2OsO2(OH)4 (88 mg, 0.188 mmol), in 1:1 tBuOH–water (10 mL) for 3 
days.  Column chromatography eluting with 9:1 EtOAc–MeOH gave the title 
compound 147156h (93 mg, 10%) as a colourless film; Rf : 0.31 (8:2 EtOAc–
MeOH); max/cm–1 (film) 3369, 2931, 1634 and 1504; δH(300 MHz, CD3OD) 4.53 
(2H, s, CH), 3.08 (6H, s, (NCH3)A), 2.82 (6H, s, (NCH3)B); m/z (ES+) 227.1 
(100%, MNa+); HRMS Found MNa+: 227.1006. C8H12N2O4 requires, MNa+ 
227.1002.  
 
 
N,N-Dibutyl-2-oxoacetamide 1b 
 
 
 
The amide 127b (1.03 g, 3.03 mmol) was ozonolysed following General 
Procedure F in DCM (50 mL) quenching with DMS (30 mL).  The reaction was 
allowed to warm to room temperature and after stirring overnight the reaction 
was concentrated to give the crude product.  Column chromatography eluting 
with 3:7 to 1:1 EtOAc–petrol afforded the title compound 1b (881 mg, 78%) as a 
colourless oil.  
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The title compound 1b exists as 42% hydrate and 8% aldehyde in CDCl3 with a 
mixture of other oligomers; Rf: 0.42 (1:1 EtOAc–petrol); νmax/cm−1 (film) 3364, 
2959, 1724, 1651, 1466 and 1413; δH (300 MHz, CDCl3) 9.49 (0.08 H, s, 
aldehyde), 5.65 (0.42 H, s, hydrate), 3.62-3.02 (4H, m, (NCH2)A,B), 1.74-1.42 
(4H, m, (NCH2CH2)A,B), 1.42-1.22 (4H, m, (NCH2CH2CH2)A,B), 0.98-0.87 (6H, m, 
(CH3)A,B); δC (75 MHz, CDCl3, hydrate only) 167.8 (amide), 86.1 (hydrate), 47.2 
and 46.6 ((NCH2)A,B), 31.2 and 29.7 ((NCH2CH2)A,B), 20.5 and 20.3 
((NCH2CH2CH2)A,B), 14.2 and 14.1 ((CH3)A,B); m/z  (ES+) 204.2 (100%, MH+); 
HRMS Found MH+: 204.1598, C10H21NO3 requires MH+ 204.1594. 
 
 
2-oxo-2-(piperidin-1-yl)acetaldehyde150 1c 
 
 
 
The amide 127c (1.45 g, 6.42 mmol) was ozonolysed following General 
Procedure F in DCM (30 mL) quenching with DMS (30 mL).  The reaction was 
allowed to warm to room temperature and after overnight stirring concentrated 
to give the crude product.  Column chromatography eluting with 7:3 to 9:1 
EtOAc–petrol afforded the title compound150 1c (448 mg, 69%) as a colourless 
oil.  
 
The title compound 1c  exists as 40% hydrate and 10% aldehyde in CDCl3 with 
a mixture of other oligomers; Rf: 0.25 (7:3 EtOAc–petrol); νmax/cm−1 (film) 3369, 
2938, 1735, 1649, 1447 and 1252; δH (300 MHz, CDCl3) 9.51 (0.10 H, s, 
aldehyde), 5.65 (0.40 H, s, hydrate), 3.69-3.30 (4H, m, (NCH2)A,B), 1.77-1.45 
(6H, m, (NCH2CH2)A,B and (NCH2CH2CH2)A,B); δC (75 MHz, CDCl3, hydrate only) 
166.2 (amide), 86.3 (hydrate), 46.6 and 44.5 ((NCH2)A,B), 26.2, 25.9 and 24.7 
((NCH2CH2)A,B and (NCH2CH2CH2)A,B); m/z (ES+) 160.1 (60%, MH+), 182.1 
(20%, MNa+); HRMS Found MH+: 160.0974, C7H13NO3 requires MH+ 160.0968. 
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N-methyl-2-oxo-N-propylacetamide 1e 
 
 
 
The amide 127e (928 mg, 4.10 mmol) was ozonolysed following General 
Procedure F in DCM (50 mL) quenching with DMS (30 mL).  The reaction was 
allowed to warm to room temperature  and after 2 h concentrated to give the 
crude product.  Column chromatography eluting with 7:3 EtOAc–petrol afforded 
the title compound 1e (839 mg, 79%) as a colourless oil.  
 
The title compound 1e exists as 60% hydrate in D2O with a mixture of other 
oligomers; Rf: 0.29 (7:3 EtOAc–petrol); νmax/cm−1 (film) 3363, 2963, 1732, 1648 
and 1459; δH (500 MHz, D2O, ca. 1:1 mixture of rotomers) 5.45 (0.30 H, s, 
hydraterotA), 5.43 (0.30 H, s, hydraterotB), 3.21 (1H, t, J 7.3, NCHArotA), 3.18-3.10 
(1H, m, NCHArotB and NHB), 2.92, 2.85, 2.76 and 2.73 (3H, s, NCH3), 1.56-1.32 
(2H, m, NCH2CH2), 0.80-0.63 (3H, m, NCH2CH2CH3); δC (75 MHz, D2O, hydrate 
only) 170.7 and 170.5 (amide), 84.5 and 84.1 (hydrate), 51.1 and 50.4 (NCH2), 
34.8 and 33.8 (NCH3), 20.9 and 19.9 (NCH2CH2), 10.7 and 10.4 
(NCH2CH2CH3); m/z (ES+) 170 (80%, MNa+), 148.1 (20%, MH+); HRMS Found 
MH+: 148.0968, C6H14NO3 requires MH+ 148.0968. 
 
 
N-methoxy-N-methyl-2-oxoacetamide149 1f 
 
 
 
The title compound 1f was prepared following General Procedure F with amide 
127f (255 mg, 1.08 mmol) in DCM (5 mL) quenching with DMS (5 mL).  
Reaction was allowed to warm to room temperature and after 2 h concentrated 
to give the crude product149 which was used directly in subsequent reactions. 
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N,N-diethyl-2-oxoacetamide 1g 
 
 
 
The amide 127g (577 mg, 2.31 mmol) was ozonolysed following General 
Procedure F in DCM (50 mL) quenching with DMS (30 mL).  The reaction was 
allowed to warm to room temperature  and after 2 h concentrated to give the 
crude product.  Column chromatography eluting with 7:3 EtOAc–petrol afforded 
the title compound 1g (1.03 g, 62%) as a colourless oil.  
 
The title compound 1g exists as 50% hydrate in D2O with a mixture of other 
oligomers.  The data presented is for the hydrate only; Rf: 0.33 (7:3 EtOAc–
petrol); νmax/cm−1 (film) 3368, 2979, 1738, 1645, 1462 and 1215; δH (300 MHz, 
D2O) 5.58 (0.50 H, s, hydrate), 3.64-3.32 (4H, m, (NCH2)A,B), 1.70-1.45 (6H, m, 
(CH3)A,B); δC (75 MHz, D2O, hydrate only) 168.7 (amide), 84.3 (hydrate), 46.9 
and 44.4 ((NCH2)A,B), 25.6 and 24.1 ((CH3))A,B; m/z (ES+) 148.1 (70%, MH+), 
170.1 (30%, MNa+); HRMS Found MH+: 148.0971, C6H13NO3 requires MH+ 
148.0968. 
 
 
N,N-dimethyl-2-oxoacetamide148 1h 
 
O
N
O
 
 
Water (0.4 mL) was added dropwise to a vigorously stirred suspension of 
sodium periodate (178 mg, 0.833 mmol), diol 156h (85 mg, 0.42 mmol) and 
DCM (1.6 mL).  The reaction was stirred at room temperature for 6 h, diluted 
with DCM (40 mL) and Na2SO4 (10g) added. The reaction was the filtered and 
evaporated under reduced pressure to give to give the crude product as a 
colourless oil.  Column chromatography, eluting with 9:1 EtOAc–petrol, afforded 
the title compound148 1h (22 mg, 26%) as colourless oil.  
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The title compound 1h can also be prepared following General Procedure F 
with amide 127h (300 mg, 1.75 mmol) in MeOH (20 mL) quenching with DMS 
(20 mL). Reaction was allowed to warm to room temperature and after 2 h 
concentrated to give the crude product.  Column chromatography eluting with 
EtOAc afforded the title compound 1h (272 mg, 76%) as a colourless oil.  
 
the title compound 1h was fully characterised was as the hydrate; Rf: 0.30 
(EtOAc); νmax/cm−1 (film); 3273, 2470, 1659, 1509 and 1459; δH (500 MHz, D2O) 
5.55 (1H, s, 1-H), 3.04 (3H, s, (NCH3)A), 2.89 (3H, s, (NCH3)B); δC (75 MHz, 
D2O) 170.8 (1-C), 84.5 (2-C), 36.9 and 36.17 ((NCH3)A,B); m/z (EI+) 101.0 (M+, 
100%); HRMS Found M+: 101.0478, C4H7NO2 requires M+101.0477. 
 
 
One-Pot Reactions 
Please note that acids the 4a, 4c, and 4e prepared using the one-pot reaction 
are described earlier alongside the procedure describing their preparation from 
the homoallylic 123. 
 
(4R*,6R*)-6-(Diethylcarbamoyl)-2,4-dihydroxytetrahydro-2H-pyran-2-
carboxylic acid and (4S*,6R*)-6-(diethylcarbamoyl)-2,4-
dihydroxytetrahydro-2H-pyran-2-carboxylic acid 4g 
 
 
 
Glyoxylaldehyde 1g (13.5 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (54µL, 0.955 mmol) diamine 69 (1.81mg, 4.76 µmol), diluted with 
sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 0-30% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
reaction gave the title compound 4g (13.2 mg, 51%, 61:39 cis:trans) as a 
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colourless film; νmax/cm−1 (film) 3369, 2979, 1761, 1627, 1462 and 1202; δH 
(500 MHz, D2O) 5.13 (0.20H, dd, J 9.2 and 3.4, 6-Htrans(maj)), 5.07 (0.20H, dd, J 
6.4 and 4.2, 6-Htrans(min)), 4.84 (0.53H, dd, J 11.7 and 1.6, 6-Hcis(maj)), 4.56-4.51 
(0.28H, m, 6-Hcis(min) and 4-Htrans(min)), 4.26 (0.20H, br s, 4-Htrans (maj)),4.14-4.04 
(0.53H, m, 4-Hcis(maj)), 3.94-3.84 (0.08H, m, 4-Hcis(min)) 3.40-3.06 (2H, m, NCH2), 
2.15-1.48 (2H, m, H-5 and H-3), 1.12-1.02 (3H, m, CH3), 0.96 (3H, t, J 6.8, 
CH3); δC (100 MHz, D2O, cis(maj) only) 163.2 (amide or 1-C), 67.2 and 62.7 (6-
C and 4-C), 42.5, 14.2, 39.1 and 35.3 (5-C, 3-C and NCH2), 13.4 and 11.7 
(CH3); m/z (ES─) 260.1 (100%, [M–H]─); HRMS Found [M–H]─: 260.1152, 
C11H20NO6 requires [M–H]─ 260.1140.  Correlation of the 1H NMR spectrum with 
that of the acid 4a allowed the identification of the anomers of the cis and trans 
diastereoisomers.   The ratio of the species were determined by the integration 
of the signals at: 5.13 ppm (trans(maj)), 5.07 ppm (trans(min)), 4.14-4.04  ppm 
(cis(maj)), 3.94-3.84 ppm (cis(min)).  )).  Analysis by 500 MHz 1H NMR revealed 
that a 61:39 mixture of cis  and trans diastereomers was present and that the 
cis isomer existed as an 87:13 mixture of anomers and the trans isomer existed 
as a 50:50 mixture of anomers. 
 
 
(4R*,6R*)-6-(dimethylcarbamoyl)-2,4-dihydroxytetrahydro-2H-pyran-2-
carboxylic acid and (4S*,6R*)-6-(dimethylcarbamoyl)-2,4-
dihydroxytetrahydro-2H-pyran-2-carboxylic acid 4h 
 
 
 
Glyoxylaldehyde 1h (38.6 mg, 0.382 mmol l) in buffer (1.23 mL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
acetaldehyde (216µL, 3.82 mmol) diamine 69 (7.26 mg, 19.1 µmol), diluted with 
sodium pyruvate (420 mg, 3.82 mmol) in buffer (460 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (1.66 mL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 0-20% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
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reaction gave the title compound 4h (40.3 mg, 45%, 71:29 cis:trans) as a 
colourless film; νmax/cm−1 (film) 3293, 2916, 1678 and 1595; δH (500 MHz, D2O) 
5.27-5.17 (0.29H, m, 6-Htrans(maj) and 6-Htrans(min)), 4.97 (0.57H, d, J 11.5, 6-
Hcis(maj)), 4.70-4.63 (0.27H, m, 6-Hcis(min) and 4-Htrans(min)), 4.48-4.38 (0.16H, m, 4-
Htrans (maj)), 4.26-4.17 (0.57H, m, 4-Hcis(maj)), 4.09-3.99 (0.14H, m, 4-Hcis(min)), 3.07 
(3H, s, NCH3), 2.94 (3H, s, NCH3) 2.25-2.11 (2H, m, 5-HA and 3-HA),1.70-1.47 
(2H, m, 5-HA and 3-HA); δC (125 MHz, D2O, cis(maj) only) 172.0, 163.6 and 
163.2 (amide and 1-C), 68.2 (6-C), 63.2 (4-C), 39.5, 37.2, 36.2 and 35.1 (5-C, 
3-C, (NCH3)A and (NCH3)B); m/z  (ES─) 232.1 (100%, [M–H]─); HRMS Found 
[M–H]─: 232.0824, C9H15NO6 requires [M–H]─ 232.0827.  Correlation of the 1H 
NMR spectrum with that of the acid 4a allowed the identification of the anomers 
of the cis and trans diastereoisomers.  The ratio of the species were determined 
by the integration of the signals at 5.27-5.17 ppm (trans(maj) and (trans(min)), 
4.70-4.63 ppm (trans(min) and(cis(min)), 4.26-4.17 ppm (cis(maj)), 4.09-3.99  
ppm (cis(min)).  Analysis by 500 MHz 1H NMR revealed that a 71:29 mixture of 
cis  and trans diastereomers was present  and that the cis isomer exists as a 
80:20 mixture of anomeric forms; the trans isomer exists as a 56:44 mixture of 
anomeric forms. 
  
 
(4S*,5R*,6R*)-6-(dipropylcarbamoyl)-2,4-dihydroxy-5-methyltetrahydro-2H-
pyran-2-carboxylic acid 174a 
 
 
 
Glyoxylaldehyde 1a(15.0 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
propionaldehyde (69µL, 0.955 mmol) diamine 69 (1.81mg, 4.76 µmol), diluted 
with sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate). The product was purified using preparative HPLC 
eluting with 15-46% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
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reaction gave the title compound 174a (29.1 mg, 70%, 55:45 maj:min) as a 
colourless film; δH (500 MHz, D2O) 4.91-4.80 (0.45H, m, 6-Hmin), 4.53 (0.50H, d, 
J 10.3, 6-Hmaj(maj anomer)), 4.22 (0.05H, d, J 10.3 Hz, 6-Hmaj(min anomer)), 4.06-4.00 
(0.45H, m, 4-Hmin), 3.72 (0.50H, td, J 11.5 and 4.7, 4-Hmaj(maj anomer)), 3.61-3.51 
(0.05H, m, 4-Hmaj(min anomer)), 3.49-2.85 (4H, m, (NCHA,B)A,B), 2.18-2.10 (1H, m, 3-
HA), 1.82-1.65 (2H, m, 3-HB and 5-H), 1.65-1.41 (4H, m, (NCH2CH2)A,B), 0.86 
(1H, d, J 6.5, 5-C-CH3), 0.83-0.72 (6H, m, (NCH2CH2CH3)A,B); δC (125 MHz, 
D2O, major diastereomer (maj anomer) only) 70.9 (6-C), 67.8(4-C), 49.7 and 
48.5 (NCH2), 39.7 and 39.0 (3-Cand 5-C), 21.7 and 19.8 (NCH2CH2) 10.9, 10.2 
and 10.0 (NCH2 CH2CH3 and 5-CH3),; m/z (ES+) 302.2 (100%, MH+); Found 
MH+: 302.1620, C14H24NO6 requires MH+ 302.1609. Maj refers to the major 
(4S*,5R*,6R*)-174a product as depicted above and min refers to all other 
diastereomers.  TOCSY and NOESY analysis allowed the identification the maj 
and min anomers of the 4S isomer. The ratio of the species were determined by 
the integration of the signals at:4.91-4.80  ppm (minor diatereomers), 3.72 ppm 
(major diastereomer(major anomer)), 3.61-3.51 ppm (major diastereomer 
(minor anomer)).  Analysis by 500 MHz 1H NMR revealed that a  55:45 mixture 
of maj and min diastereomers was present and that the major (4S*,5R*,6R*)-
174a product exists as a 90:10 mixture anomers. 
 
 
(4S*,5R*,6R*)-2,4-dihydroxy-5-methyl-6-
(methyl(propyl)carbamoyl)tetrahydro-2H-pyran-2-carboxylic acid 174e 
 
 
 
Glyoxylaldehyde 1e (13.5 mg, 95.5 µmmol) in buffer (308 µL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
propionaldehyde (69µL, 0.955 mmol) diamine 69 (1.81mg, 4.76 µmol), diluted 
with sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
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eluting with 0-100% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
reaction gave the title compound 174e (12.3 mg, 47%, 56:44 maj: min) as a 
colourless film; νmax/cm−1 (film)3249, 2098 and 1644; δH (500 MHz, D2O) 5.09-
4.58 (0.44H, m, 6-Hmin), 4.71 (0.36H, d, J 10.4 Hz, 6-Hmaj(maj anomer)),, 4.45 (0.10 
H, d, J 10.4, 6-Hmaj(min anomer)rotA),4.44 (0.10H, d, J 10.4, 6-Hmaj(min anomer)rotB) 4.23-
4.15(0.44H, m, 4-Hmin), 3.92-3.82 (0.36H, m, 4-Hmaj(maj anomer)), 3.78-3.68 (0.20 
H, m, 4-Hmaj(min anomer)), 3.40-3.05 (2H, m, NCH2), 3.07-2.93 (3H, m, NCH3rotA), 
2.88-2.72 (3H, m, NCH3rotB), 2.10-2.59 (3H, m, 5-H and 3-H), 1.58-1.32 (2H, m, 
NCH2CH2), 0.85-0.65 (6H, m, NCH2CH2CH3 and 5-C-CH3); δC (125 MHz, D2O, 
major diastereomer (maj anomer) only); 173.4 and 166.0 (amide and 1-C), 
101.4 (2-C), 74.3, 74.1 and 71.2 (6-C and 4-C), 54.7 and 53.6 (NCH2), 42.9 and 
42.7 (3-C), 42.3 and 42.2 (5-C), 38.5 and 37.1 (NCH3), 24.5 and 22.5 
(NCH2CH2), 14.3, 14.2, 13.3 and 13.0 (5-C-CH3 and NCH2CH2CH3); m/z  (ES─) 
274.1 (100%, [M–H]─); HRMS Found [M–H]─: 274.1287, C12H21NO6 requires 
[M–H]─ 274.1296.  Maj refers to the major (4S*,5R*,6R*)-174e product as 
depicted above and min refers to all other diastereomers.  Correlation with the 
acid 174a allowed the identification the maj and min anomers of the 4S isomer.  
The ratio of the species were determined by the integration of the signals at  
5.09-4.58 (minor diatereomers), 4.71ppm (major diastereomer(major anomer)), 
4.45 ppm (major diastereomer (minor anomer) rotomer A) 4.44ppm (major 
diastereomer (minor anomer) rotomer B).  Analysis by 500 MHz 1H NMR 
revealed that a 56:44 mixture of maj and min diastereomers was present that 
the major (4S*,5R*,6R*)-174e product exists as a 65:35 mixture of anomers and 
as a 1:1 mixture of rotomers. 
 
 
(4S*,5R*,6R*)-6-(diethylcarbamoyl)-2,4-dihydroxy-5-methyltetrahydro-2H-
pyran-2-carboxylic acid 174g 
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Glyoxylaldehyde 1g (13.5 mg, 95.5 µmmol) in buffer (0.308 mL, pH 7.4, 20 mM 
potassium phosphate) was reacted following General Procedure J with 
propionaldehyde (69µL, 0.955 mmol) diamine 69 (1.81mg, 4.76 µmol), diluted 
with sodium pyruvate (105 mg, 0.955 mmol) in buffer (115 µL, pH 7.4, 20 mM 
potassium phosphate) and E192N (416 µL, 6.98 mg/mL in pH 7.4, 20 mM 
potassium phosphate).  The product was purified using preparative HPLC 
eluting with 0-100% (1% TFA in H2O–1% TFA in MeCN) over 30 minutes.  The 
reaction gave the title compound 174g (18.8 mg, 69%, 75:25 maj:min) as a 
colourless film; νmax/cm−1 (film) 3398, 1679, 1629, 1364 and 1206; δH (500 MHz, 
D2O) 4.81-4.70 (0.25H, m, 6-Hmin), 4.44 (0.62H, d, J 10.5, 6-Hmaj(maj anomer)), 4.14 
(0.13H, d, J 10.5 Hz, 6-Hmaj(min anomer)), 3.97-3.92 (0.25H, m, 4-Hmin), 3.65 
(0.62H, td, J 11.3 and 4.7, 4-Hmaj(maj anomer)), 3.59-3.52 (0.13H, m, 4-Hmaj(min 
anomer)), 3.43-3.02  (4H, m, NCH2), 2.10-1.98 (1H, m, 3-HA), 1.75-1.55(2H, m, 3-
HB and 5-H), 1.02 (3H, t, J 7.2 Hz, (NCH2CH3)A), 0.98 (3H, t, J 7.3 Hz, 
NCH2CH3)B  ),0.80-0.69 (3H, m, 5-C-CH3); δC (125 MHz, D2O, major 
diastereomer (maj anomer) only) 170, 163.5 and 163.2 (amide and 1-C), 71.6 
(6-C), 68.5 (4-C), 43.4 and 42.1 (NCH2), 40.4 (5-C), 39.6 (3-C), 14.2, 12.2 and 
11.7 (5-C-CH3 and NCH2CH3); m/z  (ES─) 274.1 (100%, [M–H]─); HRMS Found 
[M–H]─: 274.1282, C12H21NO6 requires [M–H]─ 274.1282.  Maj refers to the 
major (4S*,5R*,6R*)-174g product as depicted above and min refers to all other 
diastereomers.  Correlation with the acid 174a allowed the identification the maj 
and min anomers of the 4S isomer.  The ratio of the species were determined 
by the integration of the signals at:4.81-4.70 (minor diatereomers), 3.65ppm 
(major diastereomer(major anomer)), 3.59-3.52 ppm (major diastereomer 
(minor anomer)).  Analysis by 500 MHz 1H NMR revealed that a 75:25 mixture 
of maj and min diastereomers was present and that the major (4S*,5R*,6R*)-
174g product exists as a 82:18 mixture of anomers.   
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Chapter 6 
6 Material and Methods 
6.1 Bacterial strains, plasmids and media 
 
Proteins were overexpressed using E. coli strains: EP-Max10B F' cells (Bio-
rad).  The plasmid used was pKK233-3 and was from Amersham Biosciences. 
The construct pKnanA-His6 was previously described47 and was provided by 
Amanda Bolt, University of Leeds.  Bacterial cultures were grown in 2 × YT rich 
media consisting of 16 g/L of tryptone, 10 g/L of yeast extract and 5g/L of NaCl.  
Glycerol stocks were prepared by adding 0.5 mL of an overnight culture to 0.5 
mL sterile glycerol and was stored at –20 °C. 
6.2 Chemicals and Enzymes  
 
Nicotamide adenine dinucleotide (reduced form) [NADH] sodium salt, sodium 
pyruvate, agarose, imidazole and TEMED were from Sigma Chemicals Ltd. 
(Poole, U.K.). Sodium chloride and ampicillin sodium salt was supplied by 
Fisher Scientific (Loughborough, U.K.).  Sodium dodecyl sulphate and 
acrylamide were from BDH Chemicals Ltd. (Essex, U.K.). L-Lactate 
dehydrogenase was supplied by Roche.  Trytone, yeast extract, 
tris(hydroxymethyl)aminomethane (Tris) were supplied by Melfor Laboratories 
(Ipswich, U.K.).  Ni2+ resin for protein purification “Chelating Sepharose® Fast 
Flow” was supplied by Pharmacia.  
 
6.3 Over-expression and purification of His-tagged proteins 
form E.coli 
 
E. coli cells harbouring the plasmid pKK233-3 were grown overnight at 37 °C in 
5 mL of 2 × YT supplemented with 50 µg/mL ampicillin. The overnight culture 
was used to inoculate 3 L of 2 × YT supplemented with 50 µg/mL ampicillin and 
0.1 mM IPTG, which was grown overnight at 37 °C. The cells were harvested by 
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centrifugation at 4000g and 4 °C and the pellet suspended in 50 mL of loading 
buffer (containing 16.2 mM potassium phosphate dibasic and 3.8 mM 
potassium phosphate monobasic (pH 7.4), and 300 mM NaCl and 10 mM 
imidazole).  The cells were lysed using a Constant Systems cell disrupter (20 
kpsi) and the cell debris was collected by centrifugation at 10 000 g for 50 min 
at 4 °C.  The supernatant was aliquoted into 2 portions, each of which were 
loaded onto 15 mL of Ni2+ charged resin that had been pre-equilibrated with 
loading buffer.  The resin was centrifugated at 3000 rpm at 4 °C and the 
removed and fresh loading buffer added. Contaminanting proteins were 
removed by washing resin with wash buffer a total of 5 times. The aldolase 
enzyme was eluted from the column using elution buffer (containing 20 mM 
potassium phosphate buffer (pH 8.0), 200 mM NaCl and 200 mM imidazole).  
Fractions were analysed by SDS-PAGE. 
6.4 Dialysis 
Protein samples were dialysed with dialysis tubing (molecular weight cut-off of 
12-14 kDa) against 50-100 times the volume overnight at 4 °C. 
6.5 SDS-PAGE 
 
Proteins were separated by SDS-polyacrylamine gel electrophoresis using a 
20% resolving gel with 5% stacking gel of the following composition: 
 
Gel component Volume required 
for resolving gel 
(µL) 
 Volume required 
for stacking gel (µL) 
30% (w/v) acrylamide/ 0.8% 
(w/v)  bisacrylamide solution 
1.5 M Tris/HCl pH 8.8 
10% (w/v) SDS 
25% (w/v) ammonium 
persulfate 
TEMED 
H2O 
 
7500 
3750 
150 
50 
5 
3500 
 
625 
625 
50 
200 
5 
3650 
Buffers utilised in SDS-PAGE were composed as follow: 
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2 × SDS Sample Buffer 
Buffer component Quantity  
Dithiotheritol 
10% (w/v) SDS 
Glycerol 
1M Tris/HCl pH 6.8 
H2O 
0.2% (w/v) bromophenol blue 
154.0 mg 
2.0 mL 
1.0 mL 
170 mL 
1.63 mL 
200 µL 
 
 
SDS Running Buffer 
Buffer component Quantity 
Tris 
Glycine 
SDS 
β-mercaptoethanol 
H2O 
3.0 g 
14.4 g 
1.0 g 
0.14 mL 
to 1.0 L 
 
Before loading onto gel, protein samples were mixed in a 1:1 ratio with sample 
buffer and boiled for 5 minutes. SDS-PAGE was performed at 60 mA for 2-3 h 
and stained with a 5:1:1 (v/v/v) methanol: acetic acid: water solution containing 
0.1% (w/v) Coomasine Brilliant Blue R-250 for 1 h then destained in the same 
solution not containing Coomasie Brilliant Blue R-250. 
 
6.6 Determination of Protein Concentration 
 
Protein concentrations were determined by measurement of optical density of 
sample (10 µL in 1 mL) at 280 nm with a Jasco V-560 UV/VIS 
spectrophotometer assuming that a 1 mg/mL protein concentration equates to 
an optical density of 1. 
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6.7 Robotic liquid handling  
Robotic liquid handling was performed using a Hamilton Microlab Star robot 
with Hamilton pipette tips and Vector software.  
 
6.8 Thiobarbituric Acid Assay 
 
The effect of various potential one-pot reaction conditions on the E192N 
aldolase variant were analysed by using an adapted literature method: 
thiobarbituric acid (TBA) assay.    
 
The assay was performed in Varian TM glass 1.0 mL conical vials in a 96 well 
plate into which the diamine 69 (10% w/v in ethanol) was pipetted using a liquid 
handling robot into appropriate wells and solvent removed in vacuo.  The robot 
pipetted as appropriate the acid 36a (20 mM in 100 mM, pH 7.4 potassium 
phosphate buffer), the aldehyde 35a (20 mM in 100 mM, pH 7.4 potassium 
phosphate buffer), the glyoxylaldehyde 1a (50 mM in 100 mM, pH 7.4 
potassium phosphate), sodium pyruvate (100 mM in 100 mM, pH 7.4 potassium 
phosphate buffer) and buffer (100 mM, pH 7.4 potassium phosphate buffer).  To 
the appropriate wells propionaldehyde was added pipetting manually followed 
by E192N (6.2 mg/mL, in 100 mM, pH 7.4 potassium phosphate buffer) 
manually using a multi-channel pipette.  The plates were shaken, sealed with 
microplate film and plate left overnight at room temperature.  Water was added 
to the plate (300 µL) followed by CHCl3 (100 µL) and each well mixed with 
pipette to aid extraction.  A portion of the aqueous layer (150 µL) was aliquoted 
from each well and transferred into a plastic shallow-well plate and solvent 
removed using a GeneVacTM centrifugal evaporator.   
 
To each well water (20 µL) and sodium periodate (11 µL, 0.2 M in 9 M H3PO4) 
was added and allowed to stand at room temperature. After 20 minutes sodium 
arsenite (45 µL, 10% (w/w) in 0.5 M Na2SO4 containing 0.05 M H2SO4) was 
added and plates shaken for 2 minutes to assure the complete discharge of 
yellow-brown colour, TBA added (135 µL, 0.6% (w/w) aqueous solution) was 
added and plates sealed and heated to 100 °C in an oven for 30 minutes.  
 
Angela Kinnell, University of Leeds 
 165 
6.9 Coupled enzyme assay for determination of the steady 
state kinetic parameters kcat and KM 
 
A coupled NADH and aldolase enzyme assay was used to determine aldolase 
activity as developed within the group.49  The assay was performed in a 1 mL 
cuvette containing 50 mM Tris/HCl buffer pH 7.5, 1 mM NADH, 2 µL coupling 
enzyme (lactate dehydrogenase, 550 U/mg), a suitable aliquot of purified 
E192N and varying concentrations of substrate.  All substrate were dissolved in 
50 mM Tris/HCl buffer pH 7.5, and the pH adjusted to pH 7.5 as required using 
a saturated aqueous solution of NaOH.  The initial rate of decrease of A340 was 
recorded as the measure of enzyme activity on an Ubikon 930 
spectrophotometer.  One unit of aldolase activity is defined as the amount of 
enzyme which catalyses the oxidation of 1 µmol NADH/min in this system, using 
the molar extinction coefficient of NADH as 6220 M-1cm-1.  The rates of change 
of A340 with different substrate concentrations and a single aldolase 
concentration were used to determine the steady state kinetic parameters kcat 
and KM, using Michaelis–Menton kinetics 
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Appendix i 
Chiral Reverse Phase Chromatography of Racemate Lactone 
 
O O
Pr2N
O
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Appendix ii 
Chiral Normal Phase Chromatography of Racemate Diol 
Pr2N
O
OH OH
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Appendix iii 
 
 
Cis maj 
H6eq H4-eq 
 
Cis Min 
H6eq H4-eq 
 
Trans maj 
H6eq H4-ax 
 
Trans Min 
H6eq H4-ax 
Compound 
6-H δ 
ppm 
4-H δ 
ppm 
J Hz H6-
H5 
6-H δ 
ppm 
4-H δ 
ppm 
J Hz 
H6-H5 
6-H δ 
ppm 
4-H δ 
ppm 
J Hz 
H6-H5 
6-H δ 
ppm 
4-H δ 
ppm 
J Hz 
H6-H5 
 
4.83 4.17-
4.08 
10.5 4.69-
4.63 
4.01-
3.93 
m 5.18 4.30 9.5, 
3.3 
5.10 4.69-
4.63 
6.7, 4.9 
 
4.85 4.17-
4.08 
12.0 4.62-
4.53   
4.00-
3.90 
m 5.23-
2.02 
4.33-
4.26 
m 5.23-
5.02 
4.62-
4.53   
m 
 
4.84 4.14-
4.04 
11.7 and 
1.6 
4.56-
4.51 
3.94-
3.84 
m 5.13 4.26 9.2 
and 
3.4 
5.07 4.56-
4.51 
6.4 and 
4.2 
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4.84 4.14-
4.04 
11.7 and 
1.6 
4.56-
4.51 
3.94-
3.84 
m 5.13 4.48-
4.38 
9.2 
and 
3.4 
5.07 4.56-
4.51 
6.4 and 
4.2 
 
4.97 4.26-
4.17 
11.5 4.70-
4.63 
4.09-
3.99 
m 5.27-
5.17 
4.48-
4.38 
m 5.27-
5.17 
4.70-
4.63 
m 
Summary and comparison of H-4 and H-6 chemical shifts and coupling constants of the acids 4 for both cis and trans 
diastereomers and their respective major (maj) and minor (min) anomeric species; m multiplet  
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Appendix iv 
 
 
 
 
 
 
 
 
 
 
 
         0                               +                             ++                        +++ 
 
 
 
The level of E192N activity was assessed by the amount of pink observed in each well.  The above diagram shows the level of 
“pinkness” which corresponds to each level of E192N activity.  
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